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Abstract

STRUCTURAL INTERACTIONS BETWEEN THE α3β1 INTEGRIN AND MMP-2: A
POTENTIAL FUNCTIONAL ROLE IN CELL ADHESION.
By James Russell Bowman, III MS
A Dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director: David G Simpson, PhD
Assistant Professor, Anatomy and Neurobiology

During cardiac development and in cardiac disease changes in hemodynamic load
initiate events leading to remodeling of the ECM. This study addresses the hypothesis that
interactions between Integrins and Metalloprotienases function to modulate cell adhesion
in the cultured cardiac fibroblast. The fibroblast is positioned to detect and respond to
changes in the mechanical load on the heart. Functionally the cardiac fibroblast is the
primary cell type responsible for the production, maintenance, and remodeling of the
xi

cardiac interstitium. Matrix Metalloproteinases, specifically the Gelatinases, are expressed
in concert during development and in disease with changes in the hemodynamic loading of
the heart.
Our studies have identified by a complex on the surface of the cardiac fibroblast
composed of the a3b1 integrin, MMP-2, and TIMP-2. Putatively, this complex is involved
in the maturation of adhesions. Inhibition of MMP-2 was associated with a decrease in the
strength of adhesion of cell plated on collagen and fibronectin. Confocal imaging and
analysis indicate that a predominate interaction occurs between MMP-2 and the a3 integrin
chain.
Taken together biochemical, functional, and microscopic data have identified a complex
on the surface of the cardiac fibroblast that represents elements of mechanotransduction
and matrix metabolism in a single site that functions in the maturation of adhesion

xii

CHAPTER I
Introduction and Overview of Project

Cell adhesion is the process by which cells become adherent to various surfaces
and is a necessary requirement for the existence multicellular organisms. In the most
general sense, cell adhesion may be cellular or non-cellular in nature. The adhesion of cells
to one another is commonly referred to as intercellular adhesion or cell-to-cell adhesion.
Cell adhesion to non-cellular constituents present in the extracellular environment is
denoted as cell-matrix adhesion. Adhesion events may be non-specific or specific in
nature. In non-specific adhesion, cells can undergo attachment to one another or other
surfaces as a consequence of physical entanglements or electrostatic interactions. These
non-specific events often represent a preamble to the formation of a specific adhesion site.
Specific adhesion processes are mediated through the interactions of cell surface receptors
that recognize specific binding sites on adjacent cells and/or in the surrounding
extracellular environment. While all adhesion events may induce a cascade of intracellular
responses, the binding of cells to a specific site(s) provides an increased measure of control
over intercellular signals and downstream processes.
The modulation of adhesion is central to the fundamental processes of cell
migration during development, normal neonatal growth, the maintenance of normal
homeostatic physiological states and at the onset of disease. The loss of normal cell-to-cell
1

or cell-matrix interactions during the critical early stages of development can lead to a
nearly endless variety of congenital defects; many of these defects are lethal. For example,
changes in adhesion underlie stem cell differentiation and the formation of the blastocyst 1,
embryonic cell sorting and migration 2, tissue patterning 3 and the generation of organ and
tissue architecture 4.
The pervasive role of cell adhesion is evident during many specific stages of
development. Blocking the cell surface receptors that mediate the migration of epithelial
cells in the apical ectodermal ridge disrupts the evolution of normal limb architecture 5.
The loss of normal neuronal cell-matrix interactions is believed to cause the X-linked,
Kallmann syndrome, a defect characterized by hypogonadotrophic hypogonadism and
anosmia 6. Homozygous knockouts of the cell-matrix receptor α4 integrin, prevents
placentation and is associated with defects in the epicardium and coronary vessels that
result in cardiac hemorrhage and embryonic death 7. Cardiac looping and the subsequent
stages of ventricular wall morphogenesis are mediated by homotypic and heterotypic cellto-cell interactions driven by members of the Connexon and Cadherin families of receptors
8

. Signals generated through members of the integrin and cadherin families are both

necessary for the apposition and closure of palatal shelves 9. Blocking signals normally
passed through E-Cadherin during early embryonic development results in dysgenesis and
embryonic death in the Zebrafish

10

. This list of defects associated with the disruption of

normal cell-to-matrix and cell-to-cell adhesion is by no means comprehensive.
In adult life changes in cell adhesion continue to play a persistent and central role
in such diverse processes as clot formation during hemostasis
2

11

, the modulation of

immune response

12

, cell migration and targeting during wound healing, and cell motility

during routine remodeling throughout the tissue compartments and organ systems 13.
Cell adhesion is a dynamic process. This dynamic aspect allows a cell to release
from a specific site in response to various environmental conditions, undergo motility, and
subsequently cease migration and establish stable long term, residency in a particular
location. Non-specific and specific interactions may be disrupted by physical processes,
electrostatic challenges, and or chemical insults. In addition to these general mechanisms
of “control” (or perhaps lack there of), sites of specific cell-to-cell and cell-matrix adhesion
are subject to more extensive regulation from the onset, by definition, this type of
interaction is more “selective“ in nature. At one level of control specific adhesion events
are mediated by the structural characteristics of the receptor in question and the chemical
identity, availability and tertiary structure of the target ligand. A cell may express any
number of cell surface receptors; if, however, the target ligand is absent or otherwise
masked there can be no specific adhesion event. At the other end of the spectrum, once
specific adhesion has been established it may be lost in response to the global
physiologically processes that underlie motile activity (e.g. de-adhesion) and/or though
more subtle molecular events associated with the routine turnover of cell adhesion
molecules.
The onset of specific cell adhesion is subject to regulation at several different sites.
Beyond the notion that specific binding is regulated by receptor ligand interactions,
specific adhesion can be subject to modulation by events initiated within the intracellular
environment as well as through various external cofactors, including ions and/or other
3

peptides 14, 15, 16. This study defines a potential role for proteases of the MMP family in the
regulation of specific cell adhesion by the α3β1 integrin to the ECM ligands, collagen and
fibronectin. The present work developed from experiments designed to examine how
adhesion to these ECM components and mechanical forces might regulate the expression
of MMP-2 and MMP-9, extracellular proteases of the gelatinase family, in the cultured
cardiac fibroblast

17, 18

. This preliminary work indicated that the expression of protease

activity mediated by these enzymes in response to stretch was different when this cell type
was plated onto collagen, laminin or fibronectin. Preliminary experimentation leading to
the present document was conducted to extend these observations. These experiments were
designed to use various molecular interventions to alter the relative number of specific
integrins expressed by the cultured neonatal cardiac fibroblast. The aim of this approach
was to determine if changes in MMP expression in response to stretch where more closely
associated with the absolute number of integrins or the specific identity of the integrins
present on the cell surface (e.g. more receptors = more binding sites = tighter adhesion =
more response to strain: or, changes in receptor identity = changes in cellular response to
stretch).
Technical and biological limitations limited interpretation of the data generated in
these experiments; unfortunately, there was considerable noise in the experimental system
ultimately used to test this hypothesis. However, in the course of these early experiments
data was generated to suggest that MMPs may regulate integrin function to a greater extent
than the opposite condition, notably, that integrins regulate MMP accumulation and
activation in the cardiac fibroblast. The present study was developed as a consequence of
4

these observations. The overall objective of the present study is to test the hypothesis “that
MMPs of the gelatinase family play an active role in modulating integrin mediated cell
adhesion. To address this hypothesis four specific aims were developed:

1. Define the structural relationships that exist between specific integrin sub-types and
members of the MMP family of gelatinases.
2. Optimize the binding conditions necessary to achieve maximal adhesion of
neonatal rat cardiac fibroblasts to collagen, laminin and fibronectin using
conventional adhesion assays.
3. Define the strength of adhesion that develops as the cells attach to different ECM
substrates using centrifugal adhesion assays.
4.

Define the functional relationships that link extracellular protease activity with the
integrin mediated adhesion of cardiac fibroblasts to collagen, laminin and
fibronectin.

5

CHAPTER II

Cell Adhesion Molecules

There is a broad spectrum of cell surface molecules that mediate cell adhesion. This
discussion will focus on the cell adhesion molecules (CAMs) that mediate specific binding
events. Principle members of the CAM family include, the Cadherins
Immunoglobulin superfamily-like molecules (Igsf-CAM, I-CAM)
the Integrins

22

20

, the Selectins

19

, the

21

, and

. The CAMs can be further sub-divided into two main categories; those

receptors that mediate intercellular (cell-to-cell) adhesion (ICAM) and those that mediate
cell-ECM adhesion.
The Cadherins mediate calcium dependent cell-to-cell adhesion, most often through
homotypic (cadherin-cadherin) interactions 23.This diverse class is composed of at least 80
different members that are differentially expressed during development and are present in a
wide variety of different tissue types

24

. These ICAM molecules span the plasma

membrane and typically exhibit an intracellular domain, a transmembrane domain and an
extracellular domain. The intracellular domain can bind and signal though the catenin
system

25, 26

. During development, signals propagated by the cadherins play a well

documented, and prominent role in cell sorting during early embryogenesis

27

and in the

formation of the extremities 28 and the digits 29 and in myogenesis 30. In the central nervous
system, N-Cadherin (neural cadherin) plays a role in growth cone mechanics and in the
6

interactions of neurites with glial cells and with glial cells interacting with each other 31. In
adult tissues, cadherins are prominently localized within the epithelial tissues

32

. These

receptors are present in the adherens junctions of the keratinocytes. Adherens junctions
form a nearly continuous band around the periphery of these cells and serve to anchor the
lateral aspects of adjacent cells together. Within the intracellular space filaments of the
actin-based cytoskeleton insert into the electron dense plaque that characterizes these
junctions, providing a site for the distribution of mechanical forces across the cell
population. Adhesion, at the molecular level, is mediated through homotypic bonds
(cadherin-to-cadherin). Members of the cadherin family also are present within the
desmosomes of the epithelium, these junctions, also called macula adherens junctions;
appear as “spot-welds” between adjacent cells. Intermediate filaments insert into the
cytoplasmic face of the desmosome.
Members of the Immunoglobulin superfamily-like CAM family comprise a second
group of cell adhesion molecules. The transmembrane Ig-CAMs mediate cell-to-cell
adhesion through homotypic and heterotypic interactions. These proteins are designated as
part of the Immunoglobulin superfamily because they exhibit immunoglobulin like
structural domain(s). Adhesion proteins of the Ig-CAM family have a wide tissue
distribution. Representative of this Ig-CAM subfamily are Vascular Cell Adhesion
Molecules (V-CAM), Intercellular Adhesion Molecules (I-CAM), and Neural Cell
Adhesion Molecules (N-CAM) 33 and L1, a subset of the Ig-CAM family that functions in
neuronal outgrowth, fasciculation and interneuronal adhesion 34. Ig-like CAM heterotypic
interactions often partner with a receptor of the integrin family of cell-matrix receptors.
7

For example, the heterotypic binding of VLA-4 (α4β1 integrin) with VCAM-1 provides
leukocytes with firm adhesion to the vascular wall in the process of diapedisis

35

.

Heterotypic interactions between the Nectin class of Ig-like CAM and the cadherins also
have been described 36.
Members of the Selectin family are concentrated in the endothelium and the
leukocyte cohort of blood

37, 38

. These CAMs mediate adhesion to carbohydrate moieties

through specific binding events; however, these cell-to-cell adhesions represent relatively
low avidity (strength) contacts

39

. Selectins are type-1 transmembrane glycoproteins that

display calcium dependant binding and, as the name implies, bind to selected
polysaccharide residues. This group of CAMs is part of the C-type lectin family and
subtypes are based on distribution and include; the L-(Leukocyte), the E-(Endothelial), and
the P-(Platelet) selectins. Selectins function in the trafficking and accumulation of
inflammatory cells in the vicinity of a wound

40

. In response to injury both selectins and

selectin ligands are rapidly expressed, from intracellular granules, onto the surface of the
endothelium. These molecules can then interact with the selectins and selectin ligands
present on the surface of circulating leukocytes. Selectin-to-selectin interactions mediate
the initial aspects of adhesion that allow leukocytes to roll along the luminal surface of
blood vessels. This low affinity adhesion process, which is reversible, represents a
preamble to the subsequent formation of more “mature”, stable adhesions that are mediated
by integrins.
Integrins comprise the last major family of CAMs. These receptors are widely
expressed and are present in nearly all cell types. These transmembrane heterodimeric
8

glycoproteins bind to a broad spectrum of ECM components 41. Integrin dependent events
take place throughout life from the earliest stages of embryogenesis. The receptors of this
family represent integral components of the cellular machinery that mediates motility

42

.

Loss of integrin mediated adhesion frequently results in apoptosis or more specifically
anikosis

43

. The binding properties of the Integrins are subject to considerable regulation

from intrinsic and extrinsic factors, this study describes results suggesting that these
proteins interact in a unique fashion of members of the MMP family of proteases. This
interaction has potential consequences in the regulation of integrin biology during cardiac
development and at the onset of disease in this organ. The biology of the integrin family
will be considered in more detail in the subsequent chapters.

9

CHAPTER III
Integrin Biology

Integrin fine structure.
The functional integrin receptor is composed of an α and a β chain, the specific
complement of subunits that are present within a given integrin receptor define its binding
specificity. At least 18 α and 8 β subunits have been described and in all at least 26
different functional heterodimers have been identified. Splice variants of the β chain inflate
the actual number of functional receptors to a small degree. Each transmembrane
glycoprotein chain that makes up the integrin complex is expressed from a unique gene
sequence; the subunits are linked in a non-covalent fashion with one another and arrive on
the cell surface as an intact receptor 44.
The integrins can be grouped into a series of subcategories based on the identity of
the β chain. For example, the β1 family of integrins is composed of all the α chains that can
combine with this subunit to form a functional receptor (α1-α11). The β2 family combines
with the αL, αM, αX, and the αD subunits. Integrin families based on the β3, β4, β5, β6, β7,
and β8 chains have been described.
Each integrin chain displays an intracellular, a transmembrane and an extracellular
domain. The intracellular domain, or cytoplasmic tail, of the prototypic β chain is
composed of 20-50 amino acid residues, this domain represents a target for intracellular
10

regulatory factors and ultimately, as a docking site for cytoskeletal proteins and signal
molecules. Integrin binding events are believed to be initiated by the interaction of Talin, a
cytoskeletal associated protein, with the cytoplasmic tail of the β chain. This intracellular
binding event, called integrin activation, promotes a conformational change in the receptor
that leads to increased adhesion avidity for target substrates in the extracellular
environment 45. In cells of hematopoietic origin talin function can be replaced by kindlin-3
46

. The cytoplasmic tail of the β chain also is a target for tyrosine phosphorylation. The

addition of phosphates to this domain may be a component element of the signal
transduction pathway that destabilizes the association of the integrin complex with the
actin based cytoskeleton, thereby facilitating the onset of motility

47

. The α chain

cytoplasmic domain is variable, but typically very limited in length. This domain
participates in the interactions that ultimately generate the functional integrin complex 48.
The helical transmembrane domains of the α and β chains function to localize, and
anchor, the receptor in the plasma membrane 49. Interactions of these domains orchestrate
the assembly of the non-covalently linked α and β heterodimer and participate in the
formation of higher order interactions between other integrin complexes (clustering).
In the extracellular space the integrin chains extend from the surface of the cell
through a series of domains that exhibit structural, regulatory, cation binding, or ECM
binding activity. The extracellular domains of the β chain exhibit several epidermal growth
factor-like (EGF) repeats, a plexin, a semphorin, and integrin (PSI) domain, a hybrid
domain, and a terminal β-A domain

44

. The prototypical α integrin extends from the cell

11

surface and contains a “calf” domain, a “thigh” domain, a β propeller, and a variable α-A
domain inserted in the β propeller. Integrin α chains can be further subclassified based on
the presence of the A-α domain, this sequence helps to define ligand binding 50.
The structural/functional properties of the A-α domain are dependent upon the
binding of metal ions to adjacent domains in the α chain. The αvβ3 integrin binds to
fibronectin in an RGD dependent fashion. For this binding event to take place metal ions
must be present in three adjacent domains; the MIDAS (Metal Ion Dependant Adhesion
Site) domain, the adjacent MIDAS (ADMIDAS) domain, and in the neighboring LIMBS
(Ligand associated metal binding site) domain of A-α sequence 51. The occupation of these
metal ion binding sites stabilizes the tertiary structure and architecture of the ligand
binding pocket. Crystallographic analysis of the αvβ3 integrin demonstrates that ligand
binding occurs within the groove that is present between the α and β chains, providing a
structural correlate to explain how the complement of integrin subunits present in a given
receptor can define binding specificity.

Integrin activation.
There is evidence that the functional integrin complex exists in 3 distinct structural
states

52

. Each of these states, the folded closed state, the folded open state and the

extended open state, exhibits unique binding properties against the target substrate. In the
folded closed state, or non-activated state, the integrin resides on the cell surface in a
somewhat folded conformation that exhibits low binding affinity. In this folded

12

conformation the calf and thigh of the α chain exist in a “knees” bent state and the PSI
domain of the β chain is folded in a fashion thought to sequester the binding domains from
ECM ligation

53

. During activation the entire integrin complex is believed to undergo a

conformational change that is initiated by the binding of talin to the cytoplasmic tail of the
β chain

45

. This binding event leads to the extension of the entire molecule; a

transformation that is marked by a marked increase in the binding affinity of the receptor
for the target ligand. The conformation that is intermediate to the folded state and the
extended fully activated state is transitory in nature; however, it does appear to exhibit
intermediate binding properties.
Integrin activation can occur through “outside-in” and “inside-out” mediated
events. Outside-in activation occurs in response to cues, such as structural motifs, that exist
in the surrounding ECM

54

. However, the final pathway to integrin activation ultimately

involves the binding of talin (or the analog kindlin) to the intracellular domain of the β
chain. Talin, itself, exists in at least 2 states, a masked, auto-inhibited and an unmasked,
active state 55. In the masked state talin exists in a cytoplasmic compartment and does not
interact with the integrin. At unmasking, talin binds to the integrin and initiates the
conformational change associated with activation. It is not known how the binding of talin
to the cytoplasmic tail of the β chain might induce structural changes in the extracellular
domain of the integrin.
Talin represents a pivotal regulator protein for integrin activation. This small
peptide is directed to the plasma membrane by Rap1-GTP-interacting adaptor molecule,
(RIAM) mediated linking of Rap 1, a ras GTPase that serves as a targeting sequence
13

56

.

This complex places RIAM as an intermediary for the docking of Talin between the
plasma membrane and integrins. Typically RIAM is distributed throughout the cytosol and
is focused to the plasma membrane by Rap1. The physiological basis for the unmasking of
talin

remains

unclear;

however,

phosphatidylinositol 4,5-bisphosphate

this
55

process

can

be

driven

by

increased

. In vitro, the proteolytic processing of the

extended talin molecule with the enzyme calpain II dissociates the head from the tail of
talin, allowing it to bind to the β integrin chain. Phosphorylation also appears to regulate
the stability of the association of the talin head domain with β chain and the overall
stability of focal adhesions 57. Beyond the effects on integrin activation, the tail section of
talin serves as a mechanically sensitive site for the incremental accumulation of the actin
binding protein vinculin 58.

Integrin binding properties.
As a family, Integrin binding activity can be unique towards a specific moiety in
the ECM; however, different integrins may exhibit considerable overlap in binding
specificity. Multiple integrins exhibit binding activity against the same ECM protein and a
given ECM target may be recognized by more than one integrin subtype. In addition,
selected integrin subtypes are highly promiscuous and may bind to a variety of different
ECM substrates. Integrin binding to a target may be mediated by specific amino acid
sequences or by the presentation of a defined tertiary structure in the target molecule. See
table 1 for representative binding properties of specific integrins

14

Integrin chains and Classic Binding Partners
Table 1
Integrin β chain Integrin α chain
β1

Family α1, α2

Classic binding partner
Collagen, laminin

(VLA)
α3

Collagen, laminin and fibronectin

α4

VCAM-1

α5

Fibronectin, RGD sequence

α 6 , α7

Laminin

α8

RGD sequence

α9

Tenascin

α10, α11

Collagen

β2 Family (LFA)

αL,αM,αX,αD

Leukocyte specific receptors

β3 Family

αΙΙb

RGD sequence, highly promiscuous

β4 Family

α4

Plaque proteins and plectin

α6

Laminin

αE

Leukocyte specific receptor

α4

Lymphocyte trafficking, VCAM-1

αV

RGD Sequence

β7 Family

Other
β1, β3, β5, β6, β8

15

This discussion will focus on the binding properties of the α1β1, α2β1, α3β1, and the
α5β1. These receptors represent the principle integrins expressed in the neonatal rat
myocardium 59. The α1β1 and α2β1 integrins both bind to collagen and laminin. The α3β1 is
highly promiscuous and exhibits binding activity against collagen, laminin and fibronectin.
The α5β1 integrin is highly specific to fibronectin. These receptors of the β1 family are
expressed in a developmental pattern and the profile of integrins present in the adult rat
heart undergoes a shift during ventricular wall hypertrophy 60. The expression of the α1β1
and the α3β1 integrins are low in fetal life and increase with age, both are prominently
expressed in neonatal life. The α2β1 is not detectable by immunoprecipitation in fetal life
and is expressed at relatively modest levels later in development. The α5β1 is expressed at
substantial levels throughout life. In sedentary adults and during the onset of pressure
overload hypertrophy α1β1 expression is depressed, α3β1 expression is regulated in a nearly
opposite fashion under these conditions.
The α1β1 and α2β1 integrin both exhibit binding activity against Type I collagen 61
and EHS laminin 62, 63. However, these integrins recognize distinctly different binding sites
within these ECM molecules
than the α2β1 integrin

65

64

. The α1β1 integrin exhibits a lower affinity to collagen

. This integrin (α1β1) binds to type I collagen in an RGD

independent manner sites that is dependant upon the topography of the triple-helical
conformation of the collagen molecule

66,67

. In contrast, α2β1 integrin binds to a specific

peptide sequence (GFOGER) that is present in the α1(I) chain of type I collagen

68

.

Laminin is comprised of an alpha, beta, and gamma chain arranged in a cruciform shape.
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Proteolytic dissection of the laminin molecule indicates that α1β1 and α2β1 bind to
different domains within this basement membrane protein

69

. Further, the binding of the

α2β1 integrin to laminin-1 is dependent on the extended open conformation and the
activation state of the integrin 70.
The α3β1 integrin exhibits binding properties that are described as promiscuous
because it participates in the adhesion of cells to collagen, laminin, and fibronectin. The
binding of the α3β1 integrin to each of these ECM substrates exhibits varying sensitivity to
cations and challenge with RGD antagonists

71

. Binding appears to be mediated by RGD

dependent and RGD independent events. While this integrin is described as promiscuous in
its binding properties with respect to collagen, laminin and fibronectin the α3β1 integrin
certainly does not exhibit pan ECM adhesion properties. Over expression of the α3β1
integrin enhances cell adhesion to the RGD motif present in entactin but does enhance the
RGD dependent adhesion of cells to fibronectin 72. One possible explanation for the unique
binding properties of this integrin, the α3β1 molecule may not mediate the initial events of
adhesion to ECM target substrates. Rather, this integrin may become secondarily localized
to developing focal adhesion sites in association with other integrins

73

. Intracellular

signals induced by this integrin complex play a role in regulating the expression of
pericellular matrix constituents, a reasonably common theme in integrin biology 72.
The α5β1 integrin is an example of an integrin that exhibits unique binding activity
against a target ligand. This receptor mediates specific and high affinity binding to the
glycoprotein fibronectin

74

; this binding event enhances fibronectin expression and the
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assembly of this protein into fibers in the vicinity of the cell surface 75,76. The specificity of
the α5β1 integrin for fibronectin is derived from a target RGD sequence as well as the
conformation of this ECM molecule. Fibronectin is a dimeric protein that contains three
distinct, and repeating, structural modules, type I, type II and type III. All three modules
contain anti-parallel β sheets, the type I and type II domains are stabilized by disulfide
bonds

77

. The integrin RGD target sequence resides within the ninth fibronectin type III

repeat (FNIII9). The FNIII10 repeat site contains a sequence called the synergy site
(PSHRN). The initial binding of the α5β1 integrin to the fibronectin molecule is driven
primarily by an interaction between the β1 chain and the RGD sequence; full engagement
of the integrin can only occur if the synergy site is present in an accessible conformation.
This synergy site can be exposed by strain induced changes in fibronectin conformation 78.
Proteolytic processing of fibronectin increases the number of available RGD sites 79.
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Chapter IV.

Cell Adhesion
Cell adhesion is an umbrella term that encompasses a variety of concepts and in
reality the term has a number of working definitions. Typically, the term cell adhesion
refers to the attachment of a cell to a surface, usually one that is coated with an ECM
protein, a carbohydrate moiety and/or other candidate molecule, under controlled
conditions in the tissue culture environment. However, cell adhesion routinely takes place
in vivo. Regardless, cell adhesion is a process that is subject to a variety of checkpoints.
These checkpoints “allow” cells that are “designed” to be mobile to remain mobile. At the
same time the regulation of cell adhesion enables a cell that is resident to a particular place
to form stable, long term adhesions (both cell-cell and cell-matrix), allowing that cell to
remain in place for extended periods of time.
As a working definition of adhesion for this discussion, cell adhesion represents the
specific adhesion of neonatal rat cardiac fibroblasts to a 2D surface coated with collagen,
laminin, or fibronectin in tissue culture at 370C. This working definition requires yet more
refinement as cell adhesion is a dynamic process that takes place in time, the nature of the
interaction between cells and the surrounding environment changes rather dramatically
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over a 1-2 hour interval

80

, the time frame used in this study. When applied to a surface,

cells initially interact with the surrounding micro-environment through physical
entanglements and/or charge-based interactions. These non-specific interactions represent
a prelude to adhesion events driven by CAMs. Once specific adhesion events have taken
place many cell types spread out over a 2D surface and assume a highly flattened and
spread morphology. Subsequently, cells typically undergo some degree of motility once
they have reached “a spread equilibrium” with their surroundings.
For integrin-mediated events that take place in tissue culture the process of specific
cell adhesion is initially marked by the formation of the focal contact (complex). This
structure represents the transition from non-specific adhesion interactions to an event
associated with the talin-initiated activation and ligation of an integrin with a target ligand
81

. During the initial phases of contact with a surface in 2D culture these structures are

scattered over the basal surface of the cells in a punctate pattern. Over time, and given the
appropriate circumstances, this structure evolves into the much more elaborate focal
adhesion site. The classical focal adhesion exhibits a much larger surface area than the
focal contact and generally has a triangular-like shape. This structure is composed of a
population of integrins packed into a defined area on the cell surface. It is essential to
recognize the equally important role of de-adhesion in the regulation of cell adhesion.
Without this aspect of the process cells could not change shape and/or undergo motile
activity.
The transition from the focal contact to the focal adhesion begins with the
accumulation and clustering of integrin receptors with one another into a higher order
20

structure

82

. A pool of integrins that is freely mobile within the plane of the plasma

membrane (lateral diffusion) is recruited to the developing focal adhesion

83

. This

recruitment process requires a minimal threshold of mechanical loading in the guise of
strain (stretch), this loading may originate from intracellular or extracellular sources 84. The
disruption of the actin based cytoskeleton with drugs such as cytochalasin b
latrunculin

85
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or

suppresses the maturation process. This occurs, presumably, because the

actin based cytoskeletal network generates the internal tension necessary to promote focal
adhesion assembly. Similar effects are observed when actin mediated contraction is
suppressed

86

. Models of assembly predict that strain literally pulls the integrins into

clusters, leading to the formation of the focal adhesion site. Early models were based on
the assumption that actin was polymerized into cables from the forming focal adhesion;
however, with the advent of more sophisticated imaging techniques it has become clear
that the actin fibers exist prior to the adhesion site 87.
In parallel with integrin clustering there is a marked up-regulation of intracellular
signal cascades and a continuing reorganization of the cytoskeleton, these events result in
assembly of the multi-molecular complex that typifies the focal adhesion site. In the fully
mature adhesion site, large scale actin bundles approach and terminate into an electrondense, sub-plasmalemma plaque. This plaque contains structural proteins, including, talin,
vinculin, and α-actinin
(integrin linked kinase)

88, 89

as well as signal molecules including FAK, Paxillin and ILK

90, 91

. The strength of the focal contact is weak in the prototypic

cell-substrate interaction and increases in strength as cells develop mature focal adhesions
92

.
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The maturation of initial contacts into the mature focal adhesion is intertwined with
the process of cell spreading. In turn, cell spreading encompasses many of the events that
take place during cell motility. During cell spreading, nascent focal contacts present at the
cell periphery provide traction for the protrusion of lamellapodia. The formation of these
membrane processes is driven by the polymerization of actin fibers in the core of the
lamellapodia 94. The focal contacts present at the protruding margin of the cell are “pulled”
centripetally under the motive force of actin “tread milling”, an action that generates the
internal strain necessary to induce integrin clustering and the elaboration of the
prototypical triangular focal adhesion site

85

. The assembly and contraction of the actin

based cytoskeleton is regulated through the Rac/Rho signal transduction pathway 94. RAC,
a small GTPase, induces actin polymerization. Subsequently, RHO drives the
accumulation of smaller actin-based fibers into stress fibers through ROCK, a downstream
kinase that promotes actin contractility 95.
Cell migration can be viewed as an extension of the cell spreading phenomena. In
the case of motility, adhesion sites, spreading and the release of adhesions must be
sequentially regulated to enable the cell to undergo movement. The rates at which adhesion
sites are lost are believed to represent the rate limiting step in cell motility

96

. The

disassembly of integrin mediated adhesions is a distinct process and it is not a simple
reversal of the assembly process. Determining the events, and signal molecules that
regulate the disassembly of adhesion sites has proved difficult, these factors are in
continual flux between the cytosolic compartment and the existing adhesion sites.
However, experimental evidence points to a microtubule-based process. Blocking the
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formation of microtubules with Nocodazole promotes the formation of extensive focal
adhesions under the direction of Rho. Upon subsequent washout of this agent, focal
adhesions are disassembled in concert, and in parallel, with the formation and growth of
microtubules 97. The disassembly of the existing focal adhesions is not affected by changes
in Rho GTPases activity, rather, the disassembly process is sensitive to the formation of a
FAK: dynamin: Grb2 complex. Based on these findings and morphological data, it appears
that focal adhesion disassembly is dependant upon endocytosis 97, 98, 99. Consistent with this
model of regulation there is an increased concentration of integrins within endocytic
compartments when dynamin becomes associated with FAK 100.
Grossly, the nature of the adhesions that cells make in tissue culture and the
strength of these adhesions are dependent upon several variables. First, if the adhesion
process is to transition beyond the initial contact stages that are non-specific in nature, the
cells under consideration must express the appropriate complement of receptors to the
candidate substrate. The target ligand must be present, and accessible, in sufficient density
to support cell spreading. Next, metabolic activity (i.e. viable, living cells) must be utilized
to re-organize the cytoskeleton and enable cell spreading to take place. Lastly, mechanical
signals, originating from the cytoskeleton or from the external environment, are needed to
drive the elaboration of the fully mature adhesion site 101. A variety of different techniques
and model systems have been used to define the processes and events that lead to cell
adhesion and the assembly of the focal adhesion. Each of these paradigms has its own
attendant strengths and weaknesses. Some assays are designed to look at population
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dynamics while others are more subtle and are designed to examine specific events at the
level of the single cell.

Conventional adhesion assays
In a classical approach, often denoted as the conventional adhesion assay, a tissue
culture dish is coated with a substrate of interest

102.

In this study these assays were

conducted to define the baseline kinetics and binding characteristics of the cultured
neonatal cardiac fibroblast to different ECM substrates. For these experiments a
suspension of cells is applied to a surface of interest for a defined interval of time, usually
30 to 60 minutes. This time interval, for many cell types, encompasses the critical time
period where cell adhesion is transitioning from non-specific processes to events that are
mediated by specific, receptor-driven interactions. At the conclusion of the plating interval
the culture plate is inverted and the cells are “dumped”, adherent cells are retained, stained
and quantified in some fashion. One aspect of this assay that remains an art form is the
dumping phase. The amount of force that is used to invert and displace non-adherent cells
can vary considerably from one investigator to another and as a result this phase of the
experiment can be subject to variability from one lab to the next. However, in practice, and
with experience, individual investigators can conduct this type of assay with remarkable
consistency. By varying the plating interval used, the rate at which cells become adherent
to the candidate substrates can be evaluated on a population wide basis.
The conventional adhesion assay is a very effective approach to study population
dynamics and characterize the basic rate at which cells undergo adhesion to different types
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of surfaces. However, given that integrin binding can be redundant and overlapping (with
other integrins and even other CAMs) it can be difficult to ascribe a result to a specific
receptor subtype. This limitation can be circumvented to some degree by using a cell line
that is engineered to express a limited repertoire of receptors

103

or by examining how

adhesion is effected when specific receptors are blocked. This later condition can be
achieved through the use of antagonistic peptides like cyclic RGD peptides
through the use of function blocking antibodies

105

104

and/or

. By eliminating one class of receptors

and then evaluating the rate of cell adhesion, it is possible to extrapolate the contributions
that the inhibited receptor might have in the outcome of the experiment. Alternatively,
cells also can be transfected to express increased (or decreased) levels of receptors or other
components of the cell adhesion machinery. From a functional prospective, the relatively
brief interval between the initial adhesion events and the elaboration of the fully mature
focal adhesion site results in a highly synchronized population of cells. This characteristic
can be exploited to examine the biochemical correlates of the various events of adhesion.

ECIS assays
Conventional adhesion assays essentially take a snap shot of information at defined
intervals of time, however, attachment and spreading can be continually monitored in a cell
population with an ECIS (Electric Cell-Impedance Sensing) device106. This platform is
fabricated on a microscope slide and consists of a series of miniature tissue culture wells
(the volume of each well in this device is on the order of the volume found in an individual
well in 96 well plate). At the floor of these miniature tissue culture wells is a conductive
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grid that is linked through a circuit to a detector. This grid surface can be coated with ECM
proteins, or other materials, prior to cell plating. When cells are applied to the wells they
settle out onto the grids and there is a change in the electrical impedance that is present
across the circuit

107

. Over time, the impedance decreases as the cells spread out over the

surface of the grid, essentially insulating the surface and changing the conductive
properties of the circuit as a consequence. By adding various reagents, for example drugs
that inhibit components of the cytoskeleton and/or specific signal molecules, the ECIS
assay makes it possible to evaluate the dynamics of cell attachment and subsequent cell
spreading.

Centrifugal adhesion assays
Conventional adhesion assays have limited utility at defining the absolute strength
of adhesion that takes place between the cell and the target substrate. As noted there is too
much variability in the “dump phase” in this type of assay. This limitation can be
circumvented through the use of the centrifugal adhesion assay. In this application, cells
are usually labeled with a vital dye (often a fluorescent metabolic reagent that is taken up
and retained by live cells) and plated out onto a substrate of interest for a defined interval
of time. At some point in the assay after the metabolic labeling has been completed an
initial reading is taken of the plate to generate an estimate of cell number. The plates are
then sealed and placed in an inverted position within a centrifuge equipped with a
swinging arm rotor and an appropriate carrier for the culture plate and spun for a specific
time and rotation per minute (RPM.) By knowing the radius of the rotor arm the actual
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force experienced by the cultures can be estimated. At the completion of the centrifugation
interval the plates are gently rinsed and a final determination of adherent cells is
determined. A comparison of the initial cell number before and after centrifugation
provides a measure of adhesion.

Molecular adhesion
“Adhesion” has been examined at the “molecular level” using atomic force
microscopy and magnetic twisting. These experiments for the most part are designed to
examine the forces that are present at the interface of the integrin and ECM (atomic force)
or at the interface of the integrin and the cytoskeleton (magnetic twisting). In atomic force
microscopy beads coated with various peptides are linked to the cantilever arm of the
microscope. As the cantilever arm is brought into contact with the cell surface binding
events are initiated, the physical nature of this interaction is then characterized by
determining the amount of force that is necessary to deflect the cantilever

108

. A similar

approach has been used to characterize the association of specific integrins with the actin
based cytoskeleton. In these experiments a magnetic bead can be coated with various
peptides that will bind to a given class of integrins and allowed to interact with the cell
surface. When these experiments are conducted in the presence of drugs that alter actin
stability the amount of force necessary to twist the bead is substantially decreased with
respect to untreated samples

109

(Wang 1999); a result that demonstrates the physical

association of actin fibrils and the cytoplasmic domain of the integrin receptor.
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Morphological Assessment of Cell Adhesion.
The principal strength of the conventional adhesion assay is in its simplicity and
utility at generating adhesion data for a large population of cells to a defined surface over a
defined interval of time. This assay and the related centrifugal adhesion assay are not
particularly effective at examining the dynamics of adhesion, the processes that underlie
cell spreading, or the relative distribution of different proteins with respect to one another.
High resolution light or fluorescence microscopy designed to examine these events in
single cells are more appropriate for this type of analysis. In early experimentation, this
work was conducted on fixed samples, cells were plated for varying lengths of time and
processed for microscopic examination

110

. Occasionally, transmission and scanning

electron microscopy techniques have been applied to study cytoskeletal organization 111,112.
Considerable insight has been provided by this strategy concerning how cell structure
changes over time during cell adhesion and spreading. These experiments essentially
generated a static map of cytoskeletal changes (and signal cascades) associated with the
different steps in the adhesion process.
The actual site of cell-substratum interaction can be unambiguously defined by the
technique of interference reflection microscopy. This form of light microscopy uses a high
numerical aperture lens constructed with strain free optics. When light is passed through a
cell and focused on a cover glass the light is reflected off the surface of the substratum, a
fraction of this light passes back along the original light path. When the optics are focused
on the cover glass the maximal amount of light is passed back to the detector (eye, camera,
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photo-detector etc.). At sites where a cell is in contact with the cover glass the amount of
light that is reflected back into the detector is decreased, the extent to which the light
reflection is decreased is proportional to the distance the intervening structure is from the
glass reflecting surface

113

. In practice a cover glass produces a bright reflection, focal

contacts will appear as punctate spots that are somewhat gray. A fully mature focal
adhesion site appears as a much darker structure. Within a given cell the darker the area
associated with the contact the more intimately applied that structure is to the underlying
surface. This technique can be used in living or fixed samples. However, for live cell
imaging the heating effects of the illuminating light must be minimized, fixation tends to
collapse the cell to a degree.
Real-time observations of living cells with high resolution optics make it possible
to study the dynamics of adhesion and cell spreading. This method can be coupled with the
micro-injection of mutant or fluorescently labeled proteins that target different elements of
the cytoskeleton or the focal adhesion complex

114

. The true dynamics of protein turnover

in these structures has been evaluated with the technique of fluorescence recovery after
photobleaching (FRAP). Once an injected fluorescently labeled protein has been allowed
to come to equilibrium within the cell, the fluorescent tag present in a specific domain of
the cell is bleached with a pulse of light

115

. The site of bleaching is then monitored over

time as the bleached proteins are replaced with tagged proteins. This turnover is a
reflection of the stability of the structure under investigation, the bleached and unbleached
proteins exchange with one another from the structural compartment and the cytosol.
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Chapter V.

The Matrix Metalloprotienases
While there are clear homologies, the binding events and processes that underlie
cell motility in vivo are different than the binding events that take place in the simplified
2D microenvironment of tissue culture. In vivo the cell is enmeshed within a 3D
microenvironment consisting of cells and the ECM. This complex matrix is composed of a
heterogeneous array of interconnected fibrous proteins and other macromolecules that
define tissue architecture. This heterogeneous mixture of proteins and proteoglycans
provide the cellular compartment with a diverse variety of potential binding sites. Unique
cell-matrix interactions between a single cell surface receptor subtype and a single unique
moiety are rarely, if ever, encountered within intact tissues.
Like the cell:ECM interaction in vitro, the cell:ECM interaction in vivo is highly
dynamic. In both environments there is evidence of two-way regulation across the plasma
membrane (i.e. inside-out as well as outside-in signaling) on a local, as well as a global
scale. The chemical identity, and physical arrangement, of the ECM interact to regulate the
function of the resident cellular population. In turn changes in the steady state physiology
of the cellular compartment can lead to changes in the composition and organization of the
ECM.
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Under steady state conditions an external signal or other change in the status quo
must ordinarily alter the balance of information passing between from the cellular and
extracellular compartments. Signals that initiate or modulate this two-way pattern of
signaling often originate from soluble factors present in the local microenvironment.
These signals can have direct consequences on the expression and/or deposition of specific
ECM constituents 116. Sustained changes in mechanical load can also impact the cell:ECM
interaction and thereby alter the steady state conditions. These forces can be detected
directly in the cellular compartment and transduced into intracellular signal cascades that
modulate cell phenotype and/or ECM metabolism 117, 118.
In native tissues many cell types express a variety of integrin subtypes (and other
CAMs). Within this complex 3D environment any given cell can be linked to a variety of
different binding moieties, providing several different potential conduits for the
transmission of information across the plasma membrane. For integrin-based binding
events it is unclear how or if a cell discriminates between these different signals. The
observation that different integrin:ECM interactions exhibit different binding constants
(e.g. strength of adhesion), suggests that information concerning the local mechanical
environment might be detected in a biased fashion 64. For example, an integrin with a high
avidity interaction with a target molecule can be expected to transduce mechanical
information in a different pattern than an integrin that is weakly linked to the surrounding
environment. Ultimately, the physiological status of the cell must be the sum of the
individual binding events; cell adhesion does not take place in a vacuum. Preliminary
experimentation conducted for this study was designed to determine if the absolute number
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of a specific integrin subtype or the identity of integrins present on the cell surface dictated
cellular response to strain and the expression of the gelatinases, MMP-2 and MMP-9. As
noted in the introductory remarks of this study the results of these experiments suggested
that MMP-mediated protease activity modulated cell adhesion to a greater extent than the
converse circumstance (cell adhesion modulating MMP expression).
The characteristic specificity of MMP-2 and MMP-9 for ECM proteins suggests
that these proteases might impact cell adhesion by altering the structure and/or availability
of cell binding sites in the surrounding matrix. Native proteins can contain adhesion sites
that are sequestered and not presented to the cellular compartment in an orientation that is
available for binding activity. These sites, called cryptic sites, can be unmasked by changes
in mechanical loading and/or through the proteolytic processing of ECM components. For
example, increased mechanical loading can act to uncoil or otherwise alter the tertiary
structure of the protein(s) under consideration, thereby exposing these hidden binding sites
78

. While changes in strain are often associated with an increase in mechanical load, the

converse circumstance, a decrease in mechanical load, can also induce changes in protein
structure that result in the exposure of previously unavailable binding sites. This
unmasking process is undoubtedly facilitated by the highly interconnected nature of the
ECM and cellular compartments.
Proteolytic processing of ECM components or the denaturation of proteins through
physical, chemical or through radiation can directly alter protein structure and unmask
cryptic sites contained within individual proteins. Such degradative events also can
unmask hidden sites indirectly by altering the degree of strain that is present across an
32

individual protein119 or even across a relatively large volume of tissue

120

. In dermal burn

injuries, native collagen fibrils are physically damaged, this serves to unmask specific
integrin binding sites that are not ordinarily available

121, 122

. Once these sites become

available the keratinocyte population begins to shift in phenotype to mediate the reepithelialization of the wound bed. A variety of proteolytic enzymes can mediate the
processing of ECM proteins, not surprisingly; these degradative events are subject to a
considerable degree of regulation. Relevant to this study are the extracellular enzymes of
the Matrix Metalloprotienase Family.

The Matrix Metalloprotienases
The Matrix Metalloprotienases (MMP) is a family of zinc dependant enzymes that
collectively degrade most ECM proteins. These extracellular proteases are expressed
broadly in the animal kingdom. First identified in the tail of the metamorphosing frog these
enzymes play a central role in regulating the turnover and remodeling of the ECM in
development

123

, normal homeostasis and in disease

124

. Subsequent to this initial

identification 28 different MMP have been identified. A defining feature of this class of
endopeptidases is the Zn+2 ion that is an integral component of the active enzyme.
Members of this family are classified into subfamilies based on functional and structural
criteria. Substrate specificity serves as a functional criteria; the primary and tertiary
structure of the peptide define the structural characteristics. The MMP subfamilies include;
(i) the Collagenases, (ii) the Stromelysins, (iii) the Gelatinases, (iv) other MMP, and (v)
the Membrane-type MMPs.
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Structural domains present in MMPs underlie the functional differences used to
define the subfamilies. Common to all MMP is the Zn+2 cation that is necessary for the
function of the catalytic domain. Other divalent cations such as Ca+2 serve to stabilize the
tertiary structure of the enzymes. The molecular weight of these proteases can vary
considerably; the actual mass of each MMP is determined by the number of functional
domains that are present in the enzyme 17 For example, the smallest protease of the family,
MMP-7 or Matrilysin (28 kD, classified as an “other MMP”), is a soluble enzyme that is
composed a signal domain, a pro-domain, and a catalytic domain. In contrast, MMP-9, also
a soluble protease, is considerably larger (92kDa). In addition to a signal domain, a prodomain and the catalytic domain this protease contains a fibronectin type II repeat that is
typical, and diagnostic, of the gelatinase family of MMPs. MT1-MMP (54-64 kDadepending upon activation state) is a Membrane-type protease that contains a
transmembrane domain that functions in part to anchor the enzyme to the plasma
membrane.
Typically the prototypic, soluble MMP is expressed in a latent, zymogenic state
(non-active) into the extracellular compartment. Intracellular processing by furin represents
an alternate site for enzyme activation. These enzymes may be stored in the extracellular
environment in this state for variable intervals of time and then activated in response to an
environmental signal. Activation is regulated through the pro-domain, this portion of the
molecule acts as a physical constraint on the structure of the enzymatic domain. Within the
80 amino acid sequence of the pro-domain there is a conserved region, PRCG(V/N)PD,
that contains a cysteine residue that forms a coordination complex with the Zn+2 cation that
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resides within the catalytic domain. This bond confers latency to the enzyme and has given
rise to the concept of a “cysteine switch” 125. The nature of this bond makes these enzymes
susceptible to a host of chemical, mechanical, and physiologic events that can lead to
activation. A family of peptides, the Tissue Inhibitor(s) of Metalloprotienase (TIMP),
modulate the activation cascades that ultimately regulates the enzymatic activity of these
proteases. There are 4 described TIMPs, these small (~24 kDa MW) peptides bind to
various sites on the enzymes and act to suppress activation and/or localize specific MMPs
to different extracellular compartments.

The Gelatinases: MMP-2 and MMP-9
Representative of the Gelatinase family of MMPs are MMP-2 and MMP-9. These
proteases are of particular interest to this study as these enzymes are active in the
myocardium during embryonic growth and during episodes of ventricular wall remodeling
in adult life

126, 127

. These enzymes represent the primary MMPs expressed by the cardiac

fibroblast in the rodent

128

. Historically the nomenclature designating these enzymes has

been based on substrate specificity, molecular weight and/or the order of discovery. MMP2 has been variously identified as Gelatinase A and/or the 72 kDa type IV collagenase (and
MMP-2). MMP-9 has been known as Gelatinase B and/or the 92 kDa type IV collagenase
(and MMP-9). The designations of MMP-2 and MMP-9 for these gelatinases reflect a
naming convention that is based on the order of discovery and these terms are widely used
to describe these two proteases.
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For most MMPs, non-catalytic interactions with ECM proteins occur through the
C-terminal, hemopexin domain. However, unique to MMP-2 and MMP-9 are the
fibronectin Type II-like domain repeats that are present within the N-terminal catalytic
domain of these enzymes. These domains mediate the unique N-terminal binding
interactions of these proteases with collagenous components of the ECM 129. Note, MMP-2
and MMP-9 are both expressed and deposited into the ECM as inactive enzymes that are
subsequently activated in response to environmental signals. Essentially, the fibronectin
Type-II repeats function to tether these inactive enzymes to components of the 3D
scaffolding that surrounds the fibroblasts of the heart (and most other tissues).
Substrate specificity of the gelatinases is fairly broad. MMP-2 and MMP-9 both
have demonstrated activity against such diverse proteins as elastin, vitronectin, laminin,
SPARC, aggrecan, decorin, Link Protein and MBP 18. MMP-2 can cleave collagen Type I,
III, IV, VII, X and XI. MMP-2 also has unique activity against the non-collagenous
proteins, fibronectin and various laminins. MMP-9 has activity against the collagen Types
IV, V, XI, and XIV. Enzymatic activity of MMP-2 and MMP-9 against the target substrate
proteins has largely been defined in vitro, resulting in some degree of controversy, and
uncertainty, as to the targets that might be degraded in vivo by these proteases (defining
this type of activity in the complex in vivo environment is not a trivial task). Nevertheless,
MMP-2 binds and can cleave native type I collagen into fragments in a fashion typically
assigned to the interstitial collagenases

130, 131

. In contrast, MMP-9 exhibits only binding

activity against this ECM protein and does not appear to cleave Type I collagen 132.
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The activation of MMP-2 and MMP-9 is regulated at a number of different sites;
the uncontrolled activation of these proteases would clearly have deleterious consequences
on the structural integrity of the ECM 133. Under most circumstances MMP-2 is expressed
constitutively into the extracellular environment in the inactive, pro-form and stored as a
zymogen within the ECM. MMP-9 is more often expressed into the extracellular
environment in response to specific environmental signals. As with MMP-2, MMP-9 is
typically deposited into the ECM in the inactive, pro-form. The conversion of these proforms of these enzymes into the active state is subject to a multi-tiered pattern of
regulation.
The regulatory schemes controlling the activation state of MMP-2 and MMP-9 vary
to some degree. As noted, MMP-2 is usually expressed in a constitutive manner; however,
this does not mean that the enzyme is expressed in a haphazard, unregulated manner. The
over-expression (and dysregulation) of this protease occurs in some cancers and is
associated with enhanced cell migration and the spread of metastatic disease

134, 135

. The

principle pathway for the activation of pro-MMP-2 involves the cell surface bound MT1MMP and the regulatory peptide, TIMP-2 136, 137. When MMP-2 and TIMP-2 are present at
equimolar concentrations in the extracellular environment, the conversion of pro-MMP-2
to the active MMP-2 isoform is inhibited. As the concentration of TIMP-2 is increased, the
TIMP-2 molecule binds to MT1-MMP. When a critical concentration of TIMP-2 is
reached, TIMP-2 can be bound simultaneously to a pro-MMP-2 and to a MT1-MMP,
forming a ternary complex at the cell surface. This complex positions the pro-MMP-2 in
proximity to an adjacent “free” MT1-MMP leading to the proteolytic processing of the
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pro-MMP-2 molecule to the active MMP-2 state. If very high concentrations of TIMP-2
are present with respect to pro-MMP-2 and MT1-MMP these “enzymatic” compartments
become saturated; effectively blocking the formation of the ternary complex and
quenching the activation cascade. Alternate pathways leading to the formation of the MT1MMP:TIMP-2:MMP-2 complex and/or the activation of pro-MMP-2 are limited. The proMMP-2 enzyme is highly resistant to many endoproteases, which limits the activation
process through spurious cleavage events 138. However, pro-MMP-2 can undergo a process
of self cleavage and subsequent autoactivation under conditions in which the enzyme is
present in very high concentrations 139.
The regulation of MMP-9 is perhaps in some ways more elaborate as it is not
expressed constitutively 140. MMP-9 expression is regulated by growth factors, cytokines,
cell-cell interactions, and cell-ECM interactions and events that alter cell shape

141

. In a

model of cyclic stretch MMP-9 was detected only at moderate degrees of stretch whereas
MMP-2 was detected at baseline, moderate and high degrees of stretch 142. The proteolytic
activation cascade that regulates the processing of pro-MMP-9 to active MMP-9 is subject
to TIMP-dependant regulation in a pattern similar to MMP-2. TIMP-1 (a peptide related to
TIMP-2) and TIMP-2 can both bind and suppress the conversion of pro-MMP-9 to the
active state. The relative contributions of TIMP-1 and TIMP-2 in the regulatory cascade
remain ill-defined 143, although TIMP-1 dependant regulation of MMP-9 appears to be the
predominate regulatory pathway in the control of pro-MMP-9

144

. Adding additional

support to this conclusion, TIMP-1 and pro-MMP-9 are expressed in a highly coordinated
fashion. In an analogous axis of control that regulates the activation of pro-MMP-2, the
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activation of pro-MMP-9 is mediated by the disruption of the cysteine/ Zn+2 coordination
bond. TIMP-1: pro-MMP-9: MMP-3 (Stromelysin-1) form a ternary complex that results
in the formation of active MMP-9

145

. MMP-3 and a plasmin dependant pathway

effectively process the pro-peptide yielding the active MMP-9 146,147. Plasmin has two fold
effects on the activation cascade, first, this protease can directly active MMP-9, second
plasmin can increase MMP-3 mediated processing of MMP-9 148.

Functional Consequences of MMP-2 and MMP-9
Changes in MMP-2 and MMP-9 activity are closely associated with disease states
and developmental processes (events in which the balance of signals between the
intracellular and extracellular environments have been perturbed, leading to a change in the
steady state condition) and that lead to alterations in ECM architecture and function. The
role of these gelatinases in matrix remodeling is particularly striking in arthritis and in a
variety of cancers. For example, increased gelatinase activity parallels the onset of the
osteoid and rheumatoid types of arthritis

149,150

. Increased levels of Activated Protein C

process and cleave PAR-2 (protease activated receptor-2) in osteoarthritic cartilage; this
enzymatic activity leads to increased activation of MMP-2 and MMP-9

151

. This pathway

is not observed to be active in normal cartilage. Symptomatic of osteoarthritis is the
accumulation of high levels of collagen breakdown products, this diagnostic feature of the
disease can be blocked by treatment with broad spectrum MMP inhibitors

152

.

In

rheumatoid arthritis, the invasion of the cartilage matrix by migrating synovial fibroblast
occurs in a MT1-MMP dependent process that is susceptible to the application of TIMP-2
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(to block activation processes) and other pharmacologic agents that disrupt MMP-2
activation. The invasive process also can be blocked by the over expression of a dominant
negative MT1-MMP that is inactive and cannot activate MMP-2 153.
The dysregulation of gelatinases (and other MMPs) has devastating effects in the
progression of cancers. The breakdown of the basement membrane and the loss of
compartment integrity is often a prelude to the dissemination of cancer cells in tumor
invasion and metastases 134. For example, the loss of basement membrane type IV collagen
paralleled elevation in MMP-2 and MMP-9 activity in the progression of colorectal tumors
in human

154

. For migration and direct invasion of cancer cells, the native ECM forms a

barrier that is overcome by the proteolytic events that compromise its structural (and
functional) integrity. MMP-2 specific protease activity mediates the processing of ECM
proteins during the attachment and migration of ovarian tumor cells within the peritoneum
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. Critical to the growth of solid tumors is the process of angiogenesis, an event that can

be initiated by the migration, in the absence of proliferation, of the existing of endothelial
cells

156

. The gelatinases can drive the process of vessel formation by inducing the release

of VEGF 157. Alteration in the levels of MMP activity are associated with a poor outcome
in many cancer types. A representative but by no means comprehensive list highlights the
many cancer types that involve deregulated MMP.
-

The expression of MMP-2, MMP-9 and MT1-MMP was associated with
disseminated, advanced disease and correlated with shorter disease
specific survival in ovarian carcinoma 158.
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-

In prostate cancer a major problem diagnostically is the lack of markers
that delineate clearly the disease state. Traditionally PSA levels along
with clinical impression were the mainstay in this determination. In a
comparison of men with normal, benign hypertrophic, organ confined and
metastatic prostate adenocarcinoma the levels of plasma activity of
MMP-2 and-9 were highest in men with disseminated disease 159.

-

In a range of severity of astrocytic tumors MMP-2 and MMP-9
expression levels were not correlated with survival rates

160

. The lack of

difference in the survival rates is likely a reflection of the high degree of
infiltration of astrocyomas which is correlated with the level of MMP-2
activity 161.
-

Levels of gelatinases and TIMP were correlated with established
prognostic criteria in breast cancer it was seen that alteration on the
MMP-2/ TIMP-2 ratio was indicative disease that had spread and was
positive for nodal involvement.

-

MMP involvement is also a determinant in the growth of more “cellular”
tumors as Hodgkin’s lymphoma162. In CLL (chronic lymphocytic
leukemia) MMP-9 is involved in the invasion and migration of this B-cell
cancer 163.

The changes in MMP mediated proteolytic activity observed in parallel with the
growth of so many different types of transformed cells has lead to the increased interest
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and use of inhibitor based therapies that are designed to limit cell migration

164

. The

recurrent theme in the interplay between cancer and MMP is that MMP degrade ECM
components, which serve as a barrier to constrain cells. Additionally, MMP are responsible
for the release of cryptic site and for the processing and release of growth factors from the
ECM. In this context the ECM can be though of as 1) the substrate that provides structure
to tissue and 2) the series of tissue interfaces created by basement membranes that define
compartments. The breakdown of both of these components is evidenced in disseminated
diseases. In cancer invasion within the local tissue environment requires migration that is
dependant on the action of MMP. Differences in levels of TIMP-2 regulate the activation
of MMP-2 by MT1-MMP and underlie the invasive potential of melanoma

165

. Basement

membrane demarcates tissue compartments and is enriched in type IV collagen.
Gelatinases are relevant as type IV collagenases.

MMPs in the Heart in Development
During embryonic and fetal development in mammals the forming body and
individual organ systems undergo dramatic changes in topology (shape) and size. These
processes are mediated by events that take place on a local cellular scale that transpire in a
coordinated fashion, ultimately resulting in the formation of the adult body plan. Organs of
the gut, the lungs, the central nervous system, urogenital system are initially expressed in
one form during embyrogeneis and then during subsequent development are completely
remodeled to achieve the final adult form (and function). Synthetic and degradative
processes must be precisely regulated to achieve normal development.
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The changes in tissue architecture that mark normal development are clearly
apparent in cardiac development and growth. At the onset of organogenesis mesenchymal
stem cells emerge from the primitive streak, congregate, undergo differentiation and
establish the cardiogenic zones

166

.

As development precedes this cell population is

recruited to form the solid, paired cylindrical heart tubes parallel to the midline of the body
axis. The tubes condense to form a single hollow heart tube and that will undergo erosion
to form the internal lumen that will become portions of the ventricular and atrial chambers.
Initially the heart tube is nearly straight, as growth continues it elongates and this
primordial structure begins to loop to form the basis for the four chambered architecture of
the mammalian heart. At this point the developing heart is structurally simple with an outer
layer of differentiating myocytes, a proteoglycan rich connective tissue, cardiac jelly, and
the innermost layer of endocardium 167.
The biological events that drive formation of the four chambered mammalian heart
take place in a complex regulatory environment. Signals from multiple sources modulate
the looping process, although, hemodynamic signals do appear to play an absolutely
central role in the formation of the four chambered myocardium 168. In the rat, changes in
load alter the differentiation patterns of myocytes and selectively promote the maturation
of myofibrillar arrays in a regional pattern
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. These changes in cytoskeletal organization

may serve to limit the extensibility of the ventricular wall and thereby direct the looping
process by stiffening (strengthening) aspects of the muscle wall. In this model of
development, the less stiff domains undergo the looping process. Protease mediated events
also are critical to normal development. In the context of these events, the suppression of
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MMP-2 mediated proteolytic activity results in gross defects in cardiac looping and
varying degrees of cardia bifida

170

. Presumably, proteolytic events facilitate cardiac

looping by reducing the structural integrity of the ventricular ECM, thereby allowing the
gross movements in the ventricular wall that must take place during looping. The
embryonic period from E-12 to E-21 is dominated by MMP-2 mediated proteolytic
activity, with a peak of activity around E-16. In contrast, MMP-9 has much lower level of
activity during this window of development with a peak around E-16

126

. This interval of

development is associated with the formation of valvular structures.
A recurring theme in cardiac physiology is the notion that changes in hemodynamic
load promote the elaboration and accumulation of the ECM throughout the heart proper as
well as in the outflow tracks and valve structures

128

. Changes in MMP expression

typically track with the events that promote the accumulation of nascent ECM proteins
during these developmental processes. For example, MMP-2 activity is contemporaneous
with migration of mesenchymal cells and the expression of this enzyme parallels the
differentiation of cardiac valves

171

. The migration of non-resident, neural crest cells into

the developing heart during septation is spatially and functionally associated with changes
in MMP-2 expression; suppressing MMP mediated migration of neural crest cell results in
severe cardiac defects as persistent truncus arteriosus, double outlet right ventricle and the
tetrology of Fallot 172.

44

MMPs in the Heart in Adult Life
Sustained changes in mechanical loading in the adult heart initiate well documented
remodeling events

173

. Within the myocardial compartment elevated peripheral vascular

resistance results in increased mechanical load and the onset of hypertrophic cardiac
growth. During the compensatory stage of the disease the heart exhibits increased
contractility and improved performance (output). Overtime the heart begins to
decompensate as remodeling events alter the ECM composition and the myocardial
compartment begins to fail

174,175

. In long standing hypertension the progression into

congestive heart failure is hallmarked by left ventricular dilation. This transition involves a
thinning of the myocardial wall and a dilatation of the ventricular lumen. In rodent models
of hypertrophy expression of MMP-2 and MMP-9 are markedly elevated during when
compensation or decompensation
attenuate this process

127

. Moreover, inhibition of MMP activity can directly

176

. Experimentally induced expression of MMP-2 in the heart can,

independently of hemodynamic load, induce marked ventricular wall remodeling and the
onset of systolic dysfunction 177.
In experimental myocardial infarction the suppression of MMP mediated processes
acts to preserve ventricular architecture. Notably, Ramipril, an Angiotensin Converting
Enzyme (ACE) inhibitor, prevents left ventricular dilation following a coronary artery
occlusion induced infarct in the spontaneously hypertensive rat. This treatment is
associated with a depression in MMP-2 activity

178

. The positive effects of ACE inhibitor

treatment in lowering MMP-2 activity, in the A-V shunt (High output failure) model, were
detected with a reduction of the intendant cardiac hypertrophy that develops in untreated
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control animals

179

. Lower levels of MMP-2 activity decrease the remodeling of the

existing cardiac interstitium that is a prelude to the development of hypertrophy. Of
patients with controlled hypertension, only patients with left ventricular hypertrophy and
congestive heart failure had high serum levels of TIMP-1180. The high level of TIMP-1 was
related to the extent of left ventricular remodeling. These data are mentioned to reiterate
the importance of balance in the turnover of ECM components in the heart as being
effected by the not only the activity(amounts) of MMP, but also the regulatory peptides
that control activation of these proteases.

MMP Interactions with Integrins
In the classic view of MMP-2 and MMP-9 these proteases are found bound to
constituents of the extracellular matrix. The enzymes are then processed into an active state
and function to degrade elements of the surrounding environment. It is unclear how
enzymes that are bound to the ECM are transitioned into a more or less soluble state for
processing into the active protease. These processes are clearly regulated as enzyme
activity increases and decreases in response to various environmental signals.
Another factor in the biology of these systems concerns the extent to which the
positioning and the degree to which the actual enzymatic processing of target substrates is
regulated. Developing evidence has pointed to binding interactions between specific
integrin subtypes and selected MMP molecules. This type of interaction results in a
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complex on the cell surface that theoretically can target small, and highly relevant domains
(to the cell) for processing.
The association of pro-MMP-1 collagenase with the α2β1 integrin in keratinocytes
represents a profound, and elegant, example of the functional consequences of the
formation of this type of complex. In dermal burns (and other forms of full thickness
injuries to the dermis) the keratinocytes at the periphery of the wound site undergo a
phenotypic shift. At least 4 distinct sub-populations, based on various molecular markers,
can be described, including the differentiated, proliferative, motile and differentiating
phenotypes

181

. Each cell type appears to “evolve” from cells that existed in a previous

phenotypic state. Differentiated basal keratinocytes represent the cell population that
resides at the base of the epithelial layer in normal skin. Within hours of injury rates of cell
division increase, marking the appearance of proliferative keratinocytes. During this phase
of wound healing there increased expression of MMP-3182. The motile phenotype is
composed of the keratinocytes that migrate out over the provisional wound matrix to form
the epithelial tongue

183

. Differentiating keratinocytes appear as contiguous sheets of cells

form on the wound.
The migration process for the motile phenotype of keritinocytes on native collagen
is absolutely dependent upon the expression of functional α2β1 integrins and the MMP-1
protease

122, 184

. Demonstrating this association were a series of experiments that blocked

the function of MMP-1 with either pharmacological, physiological (TIMP-1),
immunological, also blocked the migration of keritinocytes on native collagen. Moreover,
keritinocyte migration was inhibited by collagenase resistant collagen. Specific blocking of
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α2β1 blocked migration on type 1 collagen and the expression of MMP-1. These functional
(observations) of keritinocyte migration suggests a physical association of proMMP-1 and
α2β1 integrin. This association was vetted by microscopic demonstration of the
colocalization of these proteins on the surface of migratory keritinocytes and the
coimmunoprecipitation these antigens. Disrupting the association by the exogenous
application of active MMP-1 or antibodies directed against the I-domain of the α2 chain
demonstrate the interaction to be constrained to the linker and hemopexin domain of
MMP-1 with the I- domain of the α2 chain. The specific interaction of the I-domain and
MMP-1 was delineated with a series of binding assays of purified α2 I-domain to native
and chimeric MMP-1

185

. This complex appears to direct proteolytic activity to domains

that must be remodeled in the ECM in order for migration to take place 184.
Several other examples of integrins linked to MMPs also exist. In angiogenic
blood vessels MMP-2 colocalizes with the αvβ3 integrin on the endothelium. This
interaction is mediated through the C-terminal domain of the MMP-2 molecule with the
αvβ3 integrin. It is thought that this interaction is based on homology of the C-domain with
the established αvβ3 integrin ligand vitronectin. In this topological arrangement the Nterminal catalytic domain of the MMP is free to mediate proteolysis

186

. The fibronectin

Type II like repeats of the MMP-2 molecule have also been implicated in linking this
protease to the cell surface. In this instance, a pericellular collagen peptide acts as a bridge
between the β1 integrin subunit and the MMP-2 protease

187

. One aspect of this particular

relationship that remains to be more fully explored concerns the observation that the
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MMP-2 recovered from this complex is resistant to cellular activation. It has been
theorized that this resistance may be a reflection of this pool of MMP-2 being positioned as
“reserve” of readily available latent gelatinase that can be secreted in the inactive pro-form
without intersecting the MT1-MMP activation pathway.
Several lines of evidence indicate that specific interactions between selected MMPs
and other cell surface molecules exist in a variety of systems. MMP proteases have been
detected in association with CD44, ICAM-1, and Caveolin-1

188

. The formation of these

complexes appears to allow the cell to specifically direct and control proteolytic activity
within its immediate vicinity. In the heart, changes in MMP expression and activation
occur during periods of active ventricular wall remodeling. Given this observation and the
emerging literature that MMPs are specifically tethered to the cell surface in many tissue
types this study was undertaken to test the hypothesis that MMP mediated proteolytic
activity is spatially regulated in the rat cardiac fibroblast by members of the integrin
family. The specific aims of this study were to:
1. Define the structural relationships that exist between specific integrin sub-types and
members of the MMP family of gelatinases.
2. Optimize the binding conditions necessary to achieve maximal adhesion of
neonatal rat cardiac fibroblasts to collagen, laminin and fibronectin using
conventional adhesion assays.
3. Define the strength of adhesion that develops as the cells attach to different ECM
substrates using centrifugal adhesion assays.
4.

Define the functional relationships that link extracellular protease activity with the
integrin mediated adhesion of cardiac fibroblasts to collagen, laminin and
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fibronectin.
The results of this study demonstrate that MMP-2, and not MMP-9, is linked
specifically to the α3β1 integrin in a complex that also contains TIMP-2. Evidence in
support of this conclusion is derived from co-immuno-precipitation experiments designed
to alternately pull down the α3, the β1, or the MMP-2 molecule from a cell extract isolated
from 3-5 day old neonatal rat cardiac fibroblasts. The recovered material was then assayed
for the presence of α3, the β1, MMP-2, MMP-9, TIMP-1 and TIMP-2. MMP-2 immunoreactivity was present in material recovered from immuno-precipitations against α3 and β1.
Assays of material recovered by immuno-precipitations directed against MMP-2 indicated
that these integrin subunits represented the predominate site of attachment. There was no
immuno-reactivity against α1 α2 or α5 integrin when MMP-2 was targeted for immunoprecipitation.

Quantitative scanning confocal microscopic observations were used to

confirm these results. Functionally, adhesion assays suggest that MMP mediated protease
activity promotes the attachment and or maturation of adhesion sites in cells plated onto
collagen and fibronectin, but not laminin or poly-l-lysine.
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CHAPTER VI.

Methods
Cell Culture
Cell Isolation. Cardiac fibroblasts were isolated from postnatal, three to five day
old (P3 to P5) Sprague-Dawley rat pups. (IUCAC 0204-3058) Pups were decapitated and
subjected to a mid-line thoracotomy. Skin was folded back from the thorax and the
pressure applied to the dorsum of the pup during this procedure causes the heart to move to
the anterior surface of the thorax and through the thoracotomy where it was clipped from
the attached vasculature. Hearts were collected and placed into PBS in a 50 ml centrifuge
tube. Any floating or suspended debris was decanted and discarded. Hearts were rinsed
with PBS until clear of blood. Hearts were transferred to a sterile 30 ml beaker (Pyrex No.
1000) and minced with iris scissors into 1 mm2 pieces. This preparation was rinsed in fresh
PBS until clear of blood.
Using a 30 ml syringe (BD Falcon) fitted with a #14 gauge x 6 in stainless steel
cannula (Popper), the minced heart tissue was transferred to a sterile 50 ml Erlenmeyer
flask (Pyrex No. 4980) for enzymatic dissociation. Liquid contents were aspirated and
discarded using the syringe and cannula. A 10 ml aliquot of collagenase solution was
introduced into the vessel. Collagenase was prepared fresh in PBS (Collagenase type I, 250
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u/mg, Worthington Biochemical Corporation; Lakewood, NJ), diluted to 120 units of
enzymatic activity/ml and filtered through a 0.2 µm syringe filter. The flask containing the
heart tissue and collagenase solution was placed into a shaking water bath set to agitate at
100 cycles/min at 37˚C (Precision; Winchester, VA) for 10 min. The supernatant was
aspirated and discarded. A fresh 10 ml aliquot of collagenase solution was added to the
tissue, followed by gentle cannulation (4x) to mechanically disrupt the tissue. The flask
was returned to the water bath for a 10-15 min digestion cycle. Supernatant was collected
and strained (100 µm cell strainer, BD Falcon) to remove large debris into a 50 ml
centrifuge tube. The addition of collagenase, the digestion incubation, and collection
procedure was repeated, without additional mechanical cannulation, until the tissue was
fully digested.
The pooled cell supernatant was pelleted by centrifugation at 800 x G for 8 min
(ALC International, Milano, Italy). The recovered cell pellet was suspended in 5 ml of
Complete Media (DMEM/F-12 supplemented with 5% Horse Serum, Sigma H1138, 2.5%
Fetal Bovine Serum, Heat Inactivated, Invitrogen 10437-028, 1.2% Sodium Bicarbonate,
Invitrogen 25080, and 1.2% Antibiotic/Antimycotic, Invitrogen 15240).
Differential adhesion was used to partially purify viable cardiac fibroblasts from
the crude digest. The suspended cell pellet was divided into three 150 mm2 tissue culture
flasks (Corning), each having a total final volume of 20 ml, for each litter of pups
(assuming 8-10 animals per litter). Flasks were incubated in a 5% CO2 incubator at 37˚C
for 5 hours. At the conclusion of this interval the media was decanted and the flask was
rinsed briefly with PBS. Complete Media was added to a final volume of 25 ml. At best, a
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nominal number of cardiac myocytes will adhere to tissue culture dishes under these
conditions. Any surviving myocytes are lost during subsequent cell passages.

Culture Maintenance. Cultures of neonatal rat cardiac fibroblasts were routinely
maintained in 150 mm2 culture flasks supplemented with 25 ml of Complete Media in a
5% CO2 incubator at 37˚C. Media was changed every 3-5 days. Cultures were assessed by
microscopic examination. When cultures were 90% confluent, the cells were split 1:2 into
fresh culture vessels. For cell passage, media was decanted, plates were rinsed with PBS
and supplemented with 10 ml of 0.25% Trypsin/EDTA (Invitrogen, 25200) prepared in
DMEM and incubated for 10 min at room temperature. The release of cells was visually
confirmed. Cells were collected in 50 ml centrifuge tubes, flasks were rinsed with 10 ml of
complete media which was collected and added to the 50 ml tube containing the released
cells. The number of 50 ml tubes needed for each passage was determined by the number
of culture flasks that were to be split; typically 3 flasks can be accommodated by one 50
centrifuge ml tube. Cells were brought to pellet by centrifugation (800 x G for 8 min). The
cell pellet was suspended in a small volume of complete media (~ 5-10 ml per flask) mixed
and then distributed into twice the number of starting flasks. Complete media was added as
needed to bring the total volume of media to 25 ml per flask. Fibroblasts were used for
experimentation after 3 and no more than 8 passages.
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Culture Media Formulation.

Media formulations that were used during these

experiments are as listed. All reagents from Gibco/Invitrogen unless noted. Formulations
included:
1) “Complete Media” as already described-used for routine culture
maintenance: DMEM F-12 supplemented with 5% Horse Serum (Heat
Inactivated: Sigma), 2.5% Fetal Bovine Serum (Heat Inactivated;
Sigma), 1.0% Sodium Bicarbonate, and 1.0% Anti-biotic/anti-mycotic
(penicillin G, streptomycin, and amphotericin).
2) “ITS Media”- DMEM F-12 supplemented with; 1.0% Insulin
Transferrin, Selenium (ITS+1; Sigma), 1.0% Sodium Bicarbonate, 1.0%
Anti-biotic/anti-mycotic (penicillin G, streptomycin, and amphotericin).
3) “Depleted Media”- used for selected experimentation: DMEM F-12
supplemented with 0.1% Gelatinase depleted FBS, 1.0% Insulin
Transferrin Selenium (ITS+1; Sigma), 1.0% Sodium Bicarbonate, 1.0%
Anti-biotic/anti-mycotic (penicillin G, streptomycin, and amphotericin).
Gelatinase depleted media was prepared by incubating FBS overnight at
4º C against a 1% Gelatin/ PBS slab polymerized in a 150 cm2 culture
flask (proteases of the MMP family that reside in serum adhere to the
gelatin slab). Following recovery, the depleted FBS was passed through
a 0.2 µm syringe filter. Depletion of endogenous gelatinase activity in
this media formulation was verified by 10% gelatin zymography. This
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media formulation was selected for use to minimize the effects of serum
proteases in the experimental paradigms.

Adhesion Assays
Conventional Adhesion assays. Conventional adhesion assays were conducted on
surfaces coated with different extracellular proteins. These experiments are designed to
examine the initial stages of cell adhesion. Conventional adhesion assays were
subsequently used in conjunction with various MMP inhibitors to investigate how this
family of enzymes might modulate initial adhesion.
In preliminary conventional adhesion experiments, 96 well flat bottom culture
plates (Immunolon HB2, ThermoForma) were coated with various concentrations (0, 1, 5,
10, 25, or 100 µg protein/ml of PBS in 250µl) of Type I collagen (Vitrogen 100, Palo Alto,
CA), laminin (EHS, Sigma), or fibronectin (Human Plasma, Sigma) or poly-l-lysine
(0.01% 70k-150k in 250µl, Sigma) overnight at 4˚C. The protein concentrations translate
into surface densities of 0.007 µg protein/mm2, 0.035µg/mm2, 0.07 µg/mm2, 0.21µg/mm2,
and 0.7µg/mm2, respectively. This range of extracellular protein concentrations (ECM)
was selected to produce 2D surfaces that exhibit an incremental increase in the number of
available ECM sites for specific adhesion. After coating all wells were blocked with 2%
BSA (1 hour) and rinsed with PBS prior to experimentation.
Trypsin released cells were counted and plated onto the different surfaces in 100µl
of depleted media or ITS media for varying time points from 30 min to 4 hours. Nonadhering or floating cells were removed by blotting the plate upside down on lint-free
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towels and a single gentle rinse with PBS. This rinse was done by tilting the dishes to
approximately 450 angle and allowing the rinse solution to flow slowly across the bottom
of the dishes. Adherent cells were stained and fixed with 100 µl of 0.5% (w/v) Methylene
Blue (Fisher Scientific) prepared in 50/50 ethanol/ water for 30 min at room temperature.
Excess stain was removed by 3x flooding with ddH2O and aspiration. The retained dye was
solubilized with 100 µl of 1% Sodium Dodecyl Sulphate prepared in ddH2O. Absorbance
at 620 nm was read after 1 hour in a Molecular Devices SpectramaxPlus
spectrophotometer 189.
In 30 minute adhesion assays the absolute cell number present on the dishes at the
conclusion of the experimental interval was determined by extrapolation against a standard
curve of cells seeded onto plates coated with 100 µg/ml Type I collagen. Data sets were
screened by one-way ANOVA, absolute cell numbers that were adherent to the different
surfaces were compared by pairwise multiple comparison using the Holm-Sidak method.
In 60 minute adhesion assays the numbers of cells present on each ECM substrate was
expressed as a percentage of cells present on poly-l-lysine. Once again these data sets were
screened by one-way ANOVA, the Holm-Sidak method was used for multiple pairwise
multiple comparisons.

Centrifugal adhesion assays. The strength of adhesion of CF to different surfaces
was tested using a centrifugal adhesion assay. In this assay cells are allowed to adhere to a
given surface for a defined interval of time and then subjected to a controlled centrifugal
force that is oriented perpendicular to the plating surface (i.e. the plates are centrifuged
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upside down).

See

189

for additional discussion. These assays were conducted in

Immunolon HB2 96 well plates (ThermoForma) that had been coated overnight at 4˚C with
10 µg/ml of Collagen type I (Vitrogen 100), Fibronectin (Human Plasma) (Sigma Aldrich),
EHS Laminin (Sigma Aldrich) or Poly-L-Lysine (Sigma Aldrich, 100 µl 0.01% 70k-150k)
prepared in PBS. The plates were rinsed with PBS and blocked for 1 hour at room
temperature with 1% BSA in PBS.
Cells were trypsinized with 0.25% Trypsin/EDTA (Invitrogen) from 150 mm2
tissue culture flasks. Complete Media was used to quench any residual trypsin activity.
Cells were recovered by centrifugation (800 x G for 8 min) for cell plating and suspended
in ITS media. The cells were counted and diluted to the target stock concentration desired
for a particular experimental protocol (1.0 x 106 or 5 x 104 cells/ml) using ITS media.
These stock concentrations were used to deliver 2,000 to 40,000 cells per tissue culture
well, depending upon the nature of the specific experiment or the concentration of cells
needed in the assay (e.g. sparse vs. dense cell cultures).
Statistical evaluation of the centrifugal adhesion assays was conducted in 2 steps.
At the conclusion of the initial 1 hour plating interval the number of cells present on each
surface was expressed as a percent present on poly-l-lysine. At this stage of the experiment
the data sets are equivalent to the data sets generated by a conventional 1 hour adhesion
assay. These data sets were screened by one-way ANOVA, the Holm-Sidak method was
used for multiple pairwise comparisons. The objective of the centrifugation paradigm is to
examine how the controlled force applied by centrifugation impacts cell adhesion as a
function of ECM substrate. Cell number at this juncture of the experiment was expressed
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as a percent of cells present on each matched substrate at the conclusion of the 1 hour
initial adhesion interval. For example, at the conclusion of the experiment the number of
cells present on collagen after centrifugation was expressed as a percentage of the number
of cells present on collagen after 1 hour of adhesion. Data sets were screened by one-way
ANOVA, the Holm-Sidak method of pairwise multiple comparison was used for multiple
pairwise comparisons.

Enzyme Inhibition.
The use of pharmacological inhibitors was employed to inhibit the activity of
extracellular proteases to test the hypothesis that enzymes of the MMP family play a role
in the processes that control the adhesion of CF to specific substrates. The broad spectrum
collagenase inhibitor GM6001 (Ilomastat; Chemicon, CC1010) 191,192,193 and the gelatinase
MMP specific inhibitor, SB-3CT (Chemicon, CC1500) were used in these experiments
194,195,196

. In cultured cells the typical working dosage of GM6001 is 10-25µM with

inhibition coverage for MMP-1 (Ki = 4 nM), MMP-2 (0.5 nM), MMP-3 (27 nM), MMP-8
(0.1nM) and MMP-9 (0.2nM)

197

. SB-3CT is more selective and inhibits the activity of

MMP-2 (Ki = 0.0139 +/- 0.0004 µM) and MMP-9 (Ki = 0.6 +/- 0.2 µM)

198

. Cells were

diluted for experimentation from a starting stock concentration of 5 x 104cells/ml.

GM-6001. For experiments using GM-6001, the stock concentration (2.5 mM) was
prepared to a working stock (100µM) in PBS and diluted as necessary to achieve the
desired working concentrations. Dilutions that were used during experimentation include;
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5, 10, 25 µM. Vehicle control (DMSO) was prepared following this same dilution format.
The preparation of sample groups is depicted in the table below.
GM-6001 (µM)

Cell Volume

Inhibitor/Vehicle

Media

Total Volume

0 µM

1600 µl

0

2.4 ml

4 ml

5 µM

1600 µl

200 µl

2.2 ml

4 ml

10 µM

1600 µl

400 µl

2.0 ml

4 ml

25 µM

1600 µl

1000 µl

1.4 ml

4 ml

SB-3CT. A stock solution of 20 mM was prepared and diluted 1:20 in Buffer R (50
mM HEPES pH 7.5, 150 mM NaCl, 5 mM CaCl2, 0.01% Brij-35, and 50% DMSO) to a
final concentration of 1 mM. This stock solution was then diluted to 200 µM in ITS media.
Vehicle control dilution was made based on this dilution. Final doses used in
experimentation included; 1, 5, 10, 25 µM. In table format, experiments conducted with
2000 cells per well on a 96 well plate in a well volume of 100 µl would have the following
culture tubes prepared for plating.

SB-3CT (µM)

Cell Volume

Inhibitor/Vehicle

Media

Total Volume

0 µM

1200 µl

0

µl

1.800 ml

3 ml

1 µM

1200 µl

15 µl

1.785 ml

3 ml

5 µM

1200 µl

75 µl

1.725 ml

3 ml

10 µM

1200 µl

150 µl

1.650 ml

3 ml

25 µM

1200 µl

375 µl

1.425 ml

3 ml
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Adhesion experimentation with protease inhibitors. The proper volume of cell
solution was added to the media/ inhibitor solution to generate the desired plating number.
This mixture was gently swirled to ensure an even distribution of cells with inhibitor and
was incubated with intermittent swirling for 30 min prior to plating onto different ECM
coated surfaces. During the protease inhibitor incubation, a standard curve of CF that had
been serially diluted over a five point range (A=4000 cells/well, B=2000 cells/well,
C=1500 cells/well, D=1000 cells/well, E=500 cells/well) were plated onto tissue culture
wells coated with 10 µg/ml type I collagen (Type I acid soluble collagen, Vitrogen).
Following the 30 min protease inhibitor incubation interval, 100 µl of cell
suspension was plated in triplicate on each of the substrates Collagen type I (0.07 µg
protein/mm2), Fibronectin (0.07 µg protein/mm2), Laminin (0.07 µg protein/mm2), and
Poly-l-Lysine (100 µl 0.01% 70k-150k) to be examined and incubated for 1-4 hour at
37˚C.

At the conclusion of the adhesion interval media was carefully aspirated and

replaced with 100 µl of media supplemented with of Calcein AM solution (2 µM in PBSD) and allowed to incubate for 15 min at room temperature. Following this interval, nonadhering cells were removed by blotting the plate upside down on lint-free towels. The
wells were filled with 200 µl of PBS-D (1x PBS, 1% Sodium Bicarbonate, 200 mM
Dextrose) and an initial fluorescence measurement was conducted at 485 nm
excitation/520 nm emission using a BMG Labtechnologies FLUOstar. This measurement
provides a baseline for comparison and standardization and represents the relative number
of cells that are retained on each substrate at the onset of centrifugation. The wells were
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then filled completely with PBS-D and sealed. The plate was placed upside down in a
custom plate carrier (ThermoForma, 5785) and centrifuged for 1 min at 51rcf in a
(ThermoForma 5682 GP8R) centrifuge. With the plate remaining upside down, the sealing
tape was removed and the contents blotted to remove any non-adhering cells. Wells were
filled with 200 µl of PBS-D and a final absorbance measurement was taken to determine
the relative number of cells remaining on the plates after centrifugation.
In preliminary experiments the timing of the Calcein AM labeling was varied to
test for possible global metabolic effects that protease inhibitors or carrier solvents might
induce on the cultures. If one or another of these agents were to adversely and or
selectively effect the uptake of the Calcein AM the relative number of cells present in a
culture may be under (or over) estimated due to a metabolic effect (poor uptake or
stimulated uptake of the Calcein AM). For these experiments freshly suspended cells were
allowed to recover from trypsin digest for 10-15 min and exposed to Calcein AM labeling.
Cells were rinsed by centrifugation (800 x G, 8 min) and processed with inhibitors as
described in the centrifugation adhesion experiments. This approach makes it possible to
ensure that all cells are exposed to the same pool of Calcein AM. However, this strategy
increases the length of time that a particular cell population is maintained in suspension, a
condition that appears to non-specifically reduce the absolute number of cells that will
adhere to the ECM substrates. In summary, the results of these experiments, in conjunction
with cell viability assays, indicate that there is no measurable impact of the enzyme
inhibitors or carrier solvents on the accumulation of the Calcein AM indicator. As a result
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of these preliminary observations, the experiments documented in this study were
conducted by labeling plated cells with Calcein AM.
Statistical analysis of the adhesion data generated from the centrifugal assays was
conducted in two separate steps. In the first analysis the number of cells present at the
conclusion of the initial plating interval (as estimated from Calcein AM labeling) was
expressed as a percent of the cells present on poly-l-lysine. A 2-way ANOVA was used to
screen data sets for the impact of substrate composition (Factor 1: collagen, laminin,
fibronectin or poly-l-lysine) and the impact of drug dose (Factor 2: drug dose) on cell
adhesion (Data). The Holm-Sidek method was used in multiple pairwise comparisons.
Second, after the centrifugation interval the number of cells present on each substrate was
expressed as a percent of the number of cells present on each specific substrate at the onset
of centrifugation. These data also screened by two-way ANOVA, where, once again Factor
1=substrate (collagen, laminin, fibronectin or poly-l-lysine) and Factor 2= (drug dose) and
the data was the percentage of cells present on each surface. The Holm-Sidek method was
used for multiple pairwise comparisons.
Viability assays. The use of viability assays occurred in parallel with the design and
in defining the parameters used in our adhesion assays. Assays were conducted to verify
that cell viability remains constant under the conditions used to define cell adhesion. The
selective loss of cells (for any reason) from this type of an assay manifests itself as a
reduction in total cell adhesion. As such, many of these assays were conducted on CF that
had been plated and allowed to adhere for a defined time interval prior to the cultures being
supplemented with drug or vehicle. These assays were designed to parallel the cell number
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used for plating in adhesion assays (2k and 40k/ per well/ 96 well plate.) Viability was
assessed by routine microscopy, and with two metabolic based measures; the WST-1 assay
and with Calcein AM. The WST-1 assay is typically used as an assay to measure cell
proliferation; in this study we utilize this assay to determine the potential toxicity of the
inhibitors (GM-6001 and SB-3CT) used in conventional and centrifugal adhesion assays.
This colorimetric assay relies on the conversion by mitochondrial dehydrogenases of the
WST-1 tetrazolium salt to formazan. The accumulated formazan can be measured at an
absorbance at ~450nm. Calcein AM is metabolically dependant as well; however, it is the
metabolic cleavage of this dye that 1) converts Calcein AM to Calcein, the fluorescently
active species of the dye, and 2) decreases the membrane permeability of the dye thereby
“trapping” the dye in the cell and providing a “direct” measure of cell number.
Accumulated Calcein was measured at 480ex/520em. As stated, theses assays were
conducted in concert with the process of determining the parameters; the type of inhibitor
(GM 6001 / SB-3CT), the concentration of that inhibitor, and the density at which CF were
plated. These assays function to validate the adhesion data and suggest a cell
number/density dependant response to treatment with MMP inhibitors. As the scope of
adhesion assays narrowed, viability testing became more focused and was tailored to
encompass the relevant inhibitor concentrations and cell density.
Viability was assessed on collagen, laminin, and fibronectin under the following
sets of conditions;
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Inhibitor

Assay

Cells
Per well

Dose/ Vehicle

Timing
dose

of Incubation
time

GM-6001

WST-1

40k

0, 10, 25µM

After 30min

SB-3CT

WST-1

40k

0,1,5,10,25µM At plating

4hr

SB-3CT

WST-1

40k

0,1,5,10,25µM At plating

24hr

SB-3CT

WST-1

2k

0,1,5,10,25µM At plating

24hrs

SB-3CT

CalceinAM

2k

0,1,5,10,25µM At plating

24hrs

SB-3CT

WST-2

2k

0,1,5,10,25µM At 24, 26, 6hr,4hr,2hr
28hr
post
plating

4hr

Data from viability assays on SB-3CT was expressed as the percent of activity
detected in the untreated, substrate matched control. Data from each plating substrate was
treated with one-way ANOVA (P=<0.001) and followed with pairwise multiple
comparison using the Holm-Sidak method with an overall significance level of 0.05.

Microscopy
Hoffmann Modulation Contrast. The morphology of live cardiac fibroblasts was
examined using a Nikon Eclipse TE 300 microscope equipped with Hoffman modulation
optics and Nikon DXM 1200 digital camera. Culture plates were coated with various ECM
substrates or poly-l-lysine as described at a rate of 0.07 µg protein/mm2 (optimized ECM
density that supports maximal adhesion for each of the surfaces assayed). Cells were
plated at a rate of approximately 55 cells per mm2, a density equivalent to that used in
adhesion assays. Cells were plated in depleted media and cultured for 4 hours. Non64

adherent cells were rinsed from the wells by PBS rinsing, and the cultures were re-fed with
depleted media. Imaging was conducted with a 40x objective at the 4 hour time point and
again at 24 hours post plating.
A similar approach was used to examine the effects of GM 6001 on cell
morphology. These experiments were run in parallel with the adhesion assays. Cells were
incubated with inhibitor (10 and 25 µM) and plated onto plates coated with 0.07 µg
protein/mm2 with collagen, laminin, fibronectin, or Poly-l-lysine (100 µl 0.01% 70k-150k).
Cells were imaged at the time of plating or following a 30 min and a 4 hour interval of
culture.
Given observations concerning the effects of gelatinase inhibition on cell adhesion,
the morphological impact of SB-3CT was documented by time lapse microphotography in
cultures plated onto different ECM substrates. CF were plated onto collagen, laminin,
fibronectin (all at 0.07 µg protein/mm2) or poly-l-lysine in the presence or absence of 10
µM SB-3CT or vehicle control (Buffer R) in ITS Media . Over the next 60 min images
were captured at 2 min intervals; data files (.TIFF) were compiled and converted to a
Windows Media File format. For presentation in this document selected time points (0, 10,
30, 40, 50, 60min) for each data set are presented in graphical format for side-by side
comparisons. In a similar set of experiments, CF were plated onto laminin in the presence
or absence of 25 µM SB-3CT. Times series were taken for the one hour interval following
plating, and for one hour following the addition of inhibitor to cells that had been plated
for 24 hours. This dose was abandoned due to overt toxicity issues.
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Colocalization experiments: Quantitative scanning confocal microscopy. To
document the spatial relationships between specific integrins, MMP-2 and MT-MMP1 colocalization experiments were conducted. Coverglass slides, #1.5 were acid etched (100%
Nitric acid) and rinsed extensively in PBS and distilled water and autoclaved. The glass
coverslips were allowed to air dry and coated at a rate of 0.07 µg protein/mm2 with
collagen, laminin, fibronectin or poly-l-lysine (100 µl 0.01% 70k-150k) overnight at 40C.
Surfaces were blocked for 1 hour with 1% BSA prepared in PBS; CF were then plated onto
each surface for 1 hour at 370C. At the conclusion of the plating interval cultures were
rinsed in PBS, fixed in 4% para-formaldehyde for 5 min rinsed 3x with fresh PBS and
blocked for 2 hours with 500 µl normal serum at 40C.
Members of the integrin family that were imaged in these experiments include the
β1 integrin (AB1952, Chemicon), the α1 chain (AB1934, Chemicon), the α2 chain
(AB1936, Chemicon), the α3 chain (AB1920, Chemicon) and the α5 chain (AB1952,
Chemicon) all in rabbit polyclonal format. Based on previous work these represent the
principle integrins expressed by the rat neonatal cardiac fibroblast (Kanekar, 1998). A
monoclonal mouse anti-MMP-2 was used to image this protease (IM51, Calbiochem). A
monoclonal rabbit isolate was used to detect MMP-MT1 (Ab51074, Abcam). DAPI was
routinely used to image the nuclei of the cells. Secondary antibodies used for detection
included goat anti-rabbit 488 (A11034, Invitrogen), and goat anti-mouse Texas Red (T862,
Invitrogen.)
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Images for co-localization analysis were captured on a Leica DMIRE2 confocal
microscope using a 63x oil immersion lens with a N.A. of 1.4, x-y resolution of 0.1394
µm, x-z resolution of 0.2358 µm. Images were captured at 400Hz with a line average
setting of 4 and formatted at 1024 x 1024 pixel dimensions. With this optical setup and
pixel dimensions a minimum zoom of 3.37X is necessary to achieve Nyquist sampling
parameters and a voxel size of 69.03nm x 69.03nm. PMT settings were set within the
dynamic range of the collectors and maintained constant during the capture of images from
different slides. Sequential scanning was used to collect all data in the “between lines”
mode for image capture. Three separate PMTs were used; the first PMT was set up for
interference reflection to direct and verify the plane of focus was at the cell-coverslip
interface, the second PMT was set to capture a narrow bandwidth in the vicinity of 520
nm, and the third PMT was set to capture wavelengths in the vicinity of 615 nm. During
the initial set up for each experiment all instrumentation settings were optimized to
eliminate chromophore bleed through between PMTs 1-3.
JACoP (Just Another Colocalization Plugin) in the NIH Image J software package
(http://rsb.info.nih.gov/ij/) was used for image analysis. Data generated from this software
include; 1) Pearson’s Correlation Coefficient, 2) the Overlap coefficient and, 3) Mander’s
coefficient.
Pearson’s Correlation Coefficient looks at the overall relationship between two
channels. This analysis effectively determines the “strength” of the relationship that might
exist between images. This method determines the correlation of fluorochrome association
given by linear regression. For example, the position of each antigen site in 1 channel is
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plotted against the position of each antigen site in channel 2 in a scatterplot. When these
values are most coincident, a single straight line with positive slope is generated. If this
line is positive in slope there is (+1) perfect colocalization; however, if this line is negative
in slope (-1) there is perfect inverse correlation. A slope of (0) represents that the channels
are not correlated. The tighter the distribution of points in channel 1 are with the points in
channel 2, the closer to (1) is the correlation between these channels. Partial correlation
occurs when not all of the molecules imaged in channel 1 are coincident with the
molecules imaged in channel 2. The plotting of the point to point position of channel 1
with channel 2 then deviates from perfect correlation and a single straight line, and
graphically has a wider distribution.
In Overlap analysis, the correlation coefficient ranges in value from 0 to 1 and
provides an indication of the overlap that exists between two channels of interest without
sensitivity to variations in signal intensity. The relative insensitivity to variations in signal
intensity originates in the calculation of the Overlap coefficient. In the equation for
calculating the overlap coefficient, the mean pixel intensities for each channel are not
subtracted from the original pixel intensities. This is the primary difference between
Overlap and Pearson’s Coefficient an analysis where the mean channel intensity is
subtracted. By not subtracting the mean channel intensity the result is a correlation
coefficient that reflects the “raw” overlap between channel 1 and channel 2. Addressing the
issue of differences in intensity of the channels are the component coefficients, k(1) and
k(2). Briefly, k(1) is dependant on the values of intensity of Channel 2 whereas k(2) is
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dependant on the values of intensity in Channel 1, and the product of these component
coefficients is equal to the square of the Overlap. When there is greater variation in the
intensity of Channel 1 as compared to Channel 2, the value of k(2) will be higher than the
value of k(1).
Mander’s coefficients indicate the percentage of each antigen that is present in one
channel that is co-incident with another molecule present in the second channel. For
example, given M1, this data represents the percentage of the molecules present in channel
1 that are participating in overlap with a molecule imaged in channel 2. The data might
look at 100 sites of M1 and ask how many of these sites are coincident with M2. Then the
analysis takes the converse circumstances and asks the question “for 100 M2 molecules
present in channel 2 how many of these are coincident with M1 in channel 1?” It follows
from this discussion that it is possible for 100% of the molecules in channel 1 to be
coincident with molecules present in channel 2. However, if the molecules present in
channel 2 far out number the molecules present in channel 1 the converse circumstances
will not be true. Substantially less than 100 of the molecules in channel 2 may be
associated with molecules in channel 1 under these circumstances. This condition was
detected in the analysis of Mander’s coefficient for the association of MMP-2 (“channel 1
in this example”) with the α2 integrin (“channel 2”).

Interference Reflection Microscopy.(IRM) In this imaging mode the focal plane at
the cell/ substratum interface produces a maximal amount of reflection off the sample (i.e.
the image background is dark when the imaged focal plane is not at the cell-substratum
69

interface and becomes progressively brighter as the interface is approached). At the cell
substratum interface the sites where cell processes are most tightly linked (closest) to the
underlying substratum appear dark, sites of contact just distal to the actual contact sites
appear grayer in the final image
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. IRM approach unambiguously identifies the sites

where cells and the surface of the coverslip are in contact with one another.
Interference reflection microscopy was used to characterize focal adhesion
structure with respect to protein markers of these structures. Number 1.5, 22 mm x 60 mm
cover slips (Fisher) were etched with nitric acid for 15 min, neutralized with PBS, rinsed
with ddH2O and autoclaved prior to substrate coating. Coverslips were coated with
collagen, laminin, fibronectin (0.07 µg protein/mm2), or poly-l-lysine (100 µl 0.01% 70k150k) overnight at 40C, rinsed with PBS, and blocked with 1% BSA for 1 hour. Cells were
plated for varying lengths of time depending upon the nature of experimentation. All
cultures were rinsed gently with PBS and fixed in 3% paraformaldhyde for 10 minutes.
Cultures were permeabilized with 0.1% Triton X-100 prepared in PBS, rinsed in PBS and
blocked (3% BSA, 10% Normal Goat Serum, 0.1% Tween 20 in PBS or as otherwise
noted in specific experiments using interference reflection microscopy as a method to
identify the cell substratum interface) for 30 min at room temperature.
Mouse monoclonal anti-talin (T3287, Sigma) antibodies were applied at 1:40
overnight at 4ºC. Samples were counter stained with Texas Red goat anti-mouse (1:200,
Invitrogen) and with 2 units fluorescein phallodin for 1 hour at room temperature. Selected
cultures were stained with DAPI to detect nuclei. Coverslips were mounted with anti-fade
mounting media (Vector) and sealed with nail polish. Confocal images were taken with a
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63x objective using a 6x zoom setting with a Leica DRE2 scanning laser scanning confocal
microscope.

Gelatinase Labeling
To conduct localization and competition experiments in live cells MMP-2/ MMP-9
gelatinase zymography standards (Chemicon, gelatinase standard, CC073) were labeled
with rhodamine. Briefly, the EZ-Label Rhodamine Protein labeling kit (Pierce 53002) was
used according to the manufactures protocol for the labeling of gelatinase standard. In this
reaction, 50 µl of stock gelatinase standard (Chemicon) was labeled with 1 µl of NHSRhodamine. Labeled MMP was dialyzed against PBS to remove un-incorporated
rhodamine. The rhodamine labeled gelatinase (RLG) standard was frozen at -70˚C in 5 µl
aliquots. RLP was run separated by SDS gel electrophoresis and processed for gelatin
zymography to verify that the labeling procedure did not overtly alter protein structure or
cause the formation of multimeric complexes.

Titration of Gelatinase label. Experiments utilizing confocal microscopy were
conducted to determine the localization of exogenously applied RLG protein as well as to
optimize the amount of labeled gelatinase needed for use in future experimentation. CF
were incubated in suspension (20k cells/ml) in ITS media supplemented with a 1000 fold
range of RLG. Serial dilutions were made as follows:
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A) 5 µl of RLG stock solution to 20 ml ITS media (solution A)
B) 1 ml of solution A added to 9 ml ITS media (Solution B=10X dilution of A)
C) 1 ml of solution B added to 9 ml ITS media (Solution C= 100X dilution of A)
D) 1 ml of solution C added to 9 ml ITS media (Solution D=1000X dilution of A)
Cardiac Fibroblast were incubated in RLG formulations for 30 minutes and centrifuged
for 8 min at 800 x G, media was decanted and cells were suspended in 10 ml of fresh ITS
media. Cells were pipetted into 4-well Lab-Tek II Chambered slides that were coated at a
rate of 0.07 µg Type I collagen/mm2 and allowed to adhere for 1 hour at 370C. Chamber
wells were rinsed with PBS and then fixed with 3% paraformaldhyde for 15 min. Cultures
were rinsed 3x with PBS and permeablizied with the addition of 500 µl of 0.01% Triton
X-100 prepared in PBS for 5 min. Cultures were rinsed 3x with PBS. In the final rinse, 2
units of fluorescein phallodin were added to each well for the visualization of F-actin.
After 15 min, the samples were rinsed with PBS, and mounted in anti-fade media (Vector
Laboratories). Samples were imaged by laser scanning confocal microscopy as described.
Results from preliminary dilution experiments using various concentrations of the
RLG indicated that dilution “D” described in the previous discussion provides more than
adequate signal for the detection of surface associated gelatinase. Next, unlabelled “cold”
gelatinase (ULG) was added to the experimental paradigm over the 1000 fold range used in
the initial RLG experiments. The objective of this approach was to determine if it is
possible to chase off the labeled gelatinase in manner analogous to a radio immune assay.
In these experiments varying concentrations of ULG were added to a constant
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concentration of RLG and mixed. Control (ITS supplemented with 10 µg/ml BSA) and ITS
media containing no additional gelatinase were used to determine the non-specific effects
of adding protein or fresh media to the cultured cells. Each media formulation was added
to an equal density of cells and gently mixed. Replicate cultures were incubated at 40C
(cold) or at 370C (warm) for 1 hour in solution. At the conclusion of this incubation
interval the suspended cells were pelleted by centrifugation (800 x G for 10 min), resuspended in 200 µl of PBS and plated by centrifugation (51rcf x 5 min) onto coverslips
coated with collagen (0.07 µg/mm2). This plating procedure was used to minimize the
potential impact that adhesion processes might have on the distribution of surface
associated MMPs. Cultures were fixed with 3% paraformaldhyde for 15 min, rinsed with
PBS 3x, and stained with fluorescein phallodin.

Evaluation of SB-3CT effects on cell surface associated MMPs. Experiments were
conducted to determine if the distribution of cell surface associated MMP-2 gelatinase in
the living state is effected by the SB-3CT inhibitor. These experiments, while largely
unsuccessful (in the sense that the inhibitor did not displace the MMP-2 molecule),
provided indirect evidence that the integrin MMP-2 complex is structurally stable in the
face of challenge by protease inhibition. A series of 4-well Lab-Tek II Chambered (#1.5
Borosilicate Coverglass; NalgeNunc) were coated at a rate of 0.07 µg protein/mm2 with
collagen type I (adhesion is sensitive to MMP inhibition) or with EHS Laminin (adhesion
to this surface is not sensitive to MMP inhibition) overnight at 40C and then blocked for 1
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hr with 1% BSA prepared in PBS. Cells in suspension were treated to one of the following
interventions:

1) Exogenous RLG (5 ul/20ml ITS media)
2) Exogenous RLG (5 ul/20ml ITS media) + SB-3CT
3) Exogenous RLG and vehicle (DMSO)
4) Baseline controls, no treatment.
Cells were incubated for 30 min in each of the conditions as described. Cells were
then plated at 55 cell mm2 as per conventional adhesion experiments for 1 hour and then
rinsed 3x with 500 µl of PBS. Cultures were fixed in 3% para-formaldehyde for 10 min,
rinsed 3x with fresh PBS and blocked for 2 hours with 500 µl Normal Goat serum at 40C.
Primary monoclonal mouse-anti MMP-2 antibody (Ab-4, Oncogene) was applied at a rate
of 5 µl per well in 200 µl of blocking buffer for 1 hour at room temperature. In this
application, blocking buffer is formulated in PBS supplemented with 3% BSA, 10%
Normal Goat Serum, and 0.1% Tween 20. Chambers were rinsed 3x for 15 min with
blocking buffer on a rotating table at room temperature. Primary antibodies were imaged
with a Texas Red conjugated goat anti-mouse antibody (Molecular Probes, Eugene OR,
1:200) diluted into blocking buffer for 1 hour at room temperature. The chambers were
then rinsed 3x with PBS + 0.1% Tween 20 for 15 min intervals. These antibody complexes
were then fixed with 3% paraformaldhyde and rinsed 3x for 15 min with PBS + Tween 20.
The chambers were then incubated overnight at 40C with 500 µl of blocking buffer.
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For β1 integrin staining, 250 µl of Rabbit anti-β1 (1:500, Chemicon, AB1952) was
prepared in blocking buffer and added to each well for 1 hour at room temperature.
Cultures were incubated with blocking buffer 3x for 15 min. Alexa 488 conjugated goat
anti-rabbit antibody (Molecular Probes) was used for detection at a dilution of 1:200 in
blocking buffer. The secondary antibody solutions were supplemented with 2 µl of DAPI
for the detection of DNA. Chambers were rinsed 3x with PBS + 0.01% Tween 20. A final
brief rinse with ddH20 was used to reduce salt contamination. One drop of medium set
anti-fade mounting media (Vector Laboratories) was delivered to each well. Images were
captured using a Leica DMIRE2 scanning laser confocal microscope.

Immunoprecipitation
A variety of different immunoprecipitation (IP) strategies were used to characterize
the structural relationships that exist between members of the integrin family and MMP-2.
This section will describe the methods used to immunoprecipitate antigens from cell
lysates. Experiments in which immunoprecipitation was used to evaluate specific events
will be described in sub-sections that are experiment specific.

Routine immunoprecipitation. Cells were plated on 100 mm x 15 mm Falcon Petri
dishes for 1 hour at 370C, media was decanted and the plates were rinsed 3 X with 10 ml
sterile PBS. Cultures extracted in 1 ml ice-cold, modified RIPA buffer (50 mM Tris-HCl,
150 mM NaCl, 1% Triton X-100, pH 7.4). In selected experiments this buffer was
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supplemented with protease inhibitors (Roche, 11 836 145 001). On ice, cells were
removed from the plate with a cell scraper (Falcon), the lysate was quantitatively recovered
and transferred to a 1.5 ml microcentrifuge tube. Cell lysates were placed on ice for 30 min
with occasional mixing and centrifuged at 10 G for 15 min at 40C (Eppendorf, 5804 R).
Supernatant was decanted, without disturbing the pellet, and transferred to a clean 1.5 ml
centrifuge tube.
Cell lysates were pre-cleared using normal serum appropriate to the primary
antibody used in the IP. A 20 µl aliquot of normal serum (2 mg/ml normal serum; Rabbit
or Mouse, Pierce Immunopure) was added to each lysate sample and allowed to incubate at
40C for 30 min on a shaker. Next, 50 µl of protein A/G agarose beads (Santa Cruz, SC2003) was added to each solution, samples were incubated for 60 min on ice and
centrifuged at 10 x G for 10 min at 40C. Supernatant was decanted, without disturbing
beads and transferred into a clean centrifuge tube (if beads were disturbed, samples were
spun again and transferred to a new tube). Each pre-cleared cell lysate was supplemented
with 5 µl of the primary (precipitating) antibody and incubated on ice for 2-8 hour at 40C
on a shaker. Following this interval, 50 µl of protein A/G agarose beads was added and
incubated at 40C on a shaker for 60 min. Tubes were then spun at 10 x G for 1 min at 40C.
Without disturbing the pellet, the supernatant was decanted, and the beads were washed
with 500 µl of ice-cold, modified RIPA buffer. The wash, centrifugation cycle, and
aspiration cycle was repeated 3-5 times. Following the final wash, 80 µl of 1x Laemmli
buffer (Bio-Rad, Cat # 161-0737) was added to the bead pellet. Samples were placed in a
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pre-heated (950C) dri-bath for 3-5 min (Thermolyne, Type 16500 Dri-Bath). Samples were
once again centrifuged at 10G for 5 min and the supernatant was recovered for analysis.
Antibodies used in these experiments include:
•

Anti β1 integrin, Chemicon

•

Anti MMP-2, IM51 Calbiochem

•

Anti MMP-9, IM73 Oncogene

Samples were immediately separated by SDS-PAGE (25 µl per sample) or gelatin
zymography. Selected material recovered by IP was frozen until needed at -20˚C.

Crosslinking of cell surface Except were noted, the bulk of the experimentation
presented in this document was conducted with cells with a “native” plasma membrane.
However, during early experimentation cell surface associated proteins were crosslinked to
stabilize protein-protein interactions using DTSSP (21578, Pierce). This reagent has an
effective cross linking distance of 12 Å. In these experiments CF were plated out onto
poly-l-lysine coated 6 well dishes in ITS media. Following one hour of plating, cultures
were rinsed 2x with PBS, cultures were then supplemented to a final concentration of
crosslinker at 1 mM in PBS and allowed to incubate for 30 min at room temperature. The
reaction was quenched with the addition of sufficient Tris (stock solution 1 M, pH 7.5) to
bring the final Tris concentration to 15 mM for 15 minute incubation. At this point cultures
were treated with cell lysis buffer in preparation for SDS-PAGE. Parallel cultures without
the use of crosslinker were processed for SDS-PAGE.
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Seize IP. By definition conventional IP experimentation recovers the primary
antibodies used to identify (capture) an antigen of interest. When this type of material is
processed for Western blot analysis the primary antibodies can be dislodged from the
protein A/G agarose beads used to initially recover the antigen complex. Subsequently,
these primary antibodies can and clearly do appear as a component element in the analysis
of the antigen complex. This condition can introduce artifacts into the analysis of the
recovered material; this is especially a consideration when Western blot analysis is
conducted. The primary or secondary antibodies used to probe the recovered antigens may
react with the contaminating precipitating antibodies that have been dislodged from the
agarose beads.

The presence of this contaminating antibody restricts the species of

antibodies that can be used to probe the blot, can cause interference and ambiguity if the
molecular weight of the antigen of interest overlaps with the contaminating antibody, and
or limits the selection of antibodies that can be used in the Western blot analysis (due to
cross-reactivity and or poor specificity of the secondary detection antibodies).
To validate the conventional IP experiments, IPs were also routinely conducted
with primary antibodies cross-linked to the surface of agarose beads using a Seize primary
IP kit (Pierce, 45335). Cross-linking the primary antibody of interest to the agarose beads
negates the need for the protein A/G interaction for the capture of the antibody/antigen
complex and eliminates the risk of antibody contamination in the eluted antigen fraction.
This method is identical in the preparation of cell lysate as described above under “routine
immunoprecipitation.” The seize IP method was used in experiments designed to test the
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the interaction of β1 integrin and MMP-2, to identify the α integrin chain(s) involved, and
to determine the interaction of TIMP-1 and TIMP-2 with the α3β1: mmp-2 complex.
Primary antibodies of interest were coupled to agarose beads supplied by the
manufacturer as per AminoLink Plus Coupling Gel recommendations. The process of
coupling the antibody to the beads involved “activation” (using the buffers supplied by the
kit) of the beads, over-night incubation at 4˚C with mixing, and a series of rinsing and
washing steps to remove any uncoupled antibody present on the beads. The reactions using
this kit take place in a spin cup placed in the top of a 2 ml centrifuge tube which allows for
ease of rinsing and elimination of possible bead contamination during the elution of
antigen. In brief, approximately 2 million cells were prepared as cell lysate either from
suspension or following one hour of plating in ITS media in 1 ml of modified RIPA buffer
by a 30 minute 4˚C extraction with agitation. Lysate was then centrifuged for 30 minutes
4˚C at 14 K rpm to remove debris. Prepared lysate (333uL) was added to the antibody
conjugated beads or frozen at -20˚C for future analysis. Conjugated beads and lysate were
incubated with end-over-end mixing overnight at 4˚C. Column was then spun to remove
flow through and washed (3X) to clear any nonspecifically bound material on the beads.
Antigen complexes were eluted in a series of three repetitive elution steps by lowering the
pH with the supplied elution buffer. The fractions were kept separate for analysis by
Western blot. For Western blotting, eluted material was mixed at a ratio of 20ul:5 ul of 5X
sample buffer, heated to 65˚C for 5 min, allowed to cool, and loaded at a rate of 25 ul per
gel well for 10% SDS-PAGE. When reduction of sample was necessary, samples were
prepared to a final concentration of 5% 2-mercaptoethanol, and heated to 95˚C for 5
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minutes. The Seize IP format was used for the pull down of antigen complexes recognized
by the following antibodies (coupled to beads) and these antibodies were used in antigen
detection as primary antibodies in Western blotting.

Primary antibodies used in these assays include:
•

Anti- α1 integrin, Rbt polyclonal (AB1934, Chemicon)

•

Anti- α2 integrin, Rbt polyclonal (AB1936, Chemicon)

•

Anti- α3 integrin, Rbt polyclonal (AB1920, Chemicon)

•

Anti- α5 integrin , Rbt polyclonal (AB1946, Chemicon)

•

Anti- β1 integrin, Rbt polyclonal (AB1952, Chemicon)

•

Anti- TIMP-2, Rbt polyclonal (ab38973, Abcam)

•

Anti-TIMP-1, Rbt polyclonal (AB800), Chemicon)

•

Anti- MMP-2, Ms Monoclonal (IM51, Calbiochem)

•

Normal Mouse IgG, (12-371, Upstate)

Secondary Antibodies;
•

HRP labeled Anti- Rabbit, Goat (H+L)(PI-1000, Vector)

•

HRP labeled Anti- Mouse, Horse (H+L)(PI-2000, Vector)

Immunoprecipitation and gelatin zymography. Gelatin zymography was conducted on
samples recovered by IP against β1 Integrin. Material recovered by IP was first separated
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by conventional SDS gel electrophoresis on a 10% slab gel and transferred to PVDF for
Western blot analysis against β1 and/or MMP-2 (AB1952, Chemicon; IM51, Calbiochem,
respectively.) Representative fractions of the IPs were then subjected to gelatin
zymography.

Zymography. Equal volumes of whole cell lysate or protein fractions purified by IP
were mixed with Laemmli buffer and separated on a SDS 10% polyacrylamide gel
supplemented with 1.0% gelatin. Gelatinase standards (Chemicon) were loaded (20 µl of
stock solutions that had been diluted 1:200) were used as positive controls to identify
MMP-9 and MMP-2 enzymatic activity. In experiments that focused on MMP-2, proMMP-2 (Calbiochem, PF037) was used as the positive control (20 µl of a 1:200 dilution of
the stock solution). Following electrophoretic separation at 120V (constant voltage), gels
were incubated in renaturation buffer (BioRad) for 1 hour and then transferred into
development buffer (Bio-Rad) for 18 hour at 37ºC. Gels were fixed (20% Methanol, 10%
Glacial Acetic Acid, 70% distilled de-ionized H2O) and stained with Coomassie Blue, G250 (Bio-Rad). De-stained gels were imaged (Gel Doc 2000, BioRad) and analyzed by
densitometry (Quantity One, BioRad) to characterize gelatinolytic activity.
Following development and documentation, the gelatin zymograms were
transferred to PVDF for Western Blot analysis against MMP-2. The preparation of these
samples was done in the absence of exogenous protease inhibitors (to allow protease
activity associated with IP material to function and degrade the gelatin present in the
zymograms).

Lanes were loaded with a whole cell lysate prepared from a CF cell
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suspension, an IP to β1 (AB1952, Chemicon), or recombinant human MMP-2 pro-enzyme
standard (PF037, Calbiochem). The anti-MMP-2 antibody used in these experiments
recognizes the 72 kDa latent and 66 kDa active species of MMP-2.

Western Blotting.

Following protein separation by SDS-PAGE, gels were

incubated in Towbin buffer (Tris-Glycine, 20% MeOH) for 30 min to equilibrate and
remove residual SDS. Simultaneously, PVDF Membranes (BioRad) was activated by a
brief incubation in 100% methanol and then equilibrated in Towbin Buffer. Transfer
cassettes were loaded and placed into a Criterion Blotting chamber (Biorad) for the transfer
of proteins from gels to PVDF membranes, transfer was effected at 125 mA for a total of
1250 mA/hour at 40C. Following the transfer interval, the appearance of the molecular
weight standard on the PVDF was used to visually verify the transfer process. PVDF was
blocked in 5% Non-Fat Dry Milk prepared in PBS/0.01% Tween-20 for a minimum of 30
min. To reduce “spotting” artifacts blocking buffer was made at least 1-2 hour prior to use
to ensure the milk was fully dissolved when applied to the PVDF membranes. Primary
antibodies were applied overnight at 40C or for 1 hour at room temperature with constant
agitation. Antibodies were applied to the blots in 10 ml of Blocking buffer per 7 cm x 8.4
cm sheet of PVDF. Specific dilutions included:
•

Rb anti-α1 1:1000 (Chemicon, AB1934),

•

Rb anti-α2 1:1000 (Chemicon, AB1936),

•

Rb anti-α5 1:500 (Chemicon, AB1949),

•

Rb anti-β1 1:1000 (Chemicon, AB1952),
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•

Rb anti-TIMP-2 1:1000 (Abcam, ab38973)

•

Ms anti-MMP2 1:5000 (EMD, IM51),

•

Ms anti-MMP-9 1:5000 (EMD, IM73).

Following incubation with primary antibodies the PVDF membranes were rinsed
extensively with PBS-0.1% Tween 20 (5 rinses for 15 min/ rinse) under constant agitation.
Prior to the application of secondary horse radish peroxidase labeled antibodies, blots were
placed in blocking buffer for additional 30 min incubation. This step was found to further
reduce non-specific background staining. Again, 10 ml of antibody solution was used per
sheet with secondary antibody concentrations of 1:20,000, in blocking buffer, of either
Goat anti-Rabbit (Vector, PI-1000) or Horse anti-Mouse (Vector, PI-2000) as appropriate
for a 1 hour incubation at room temp. PVDF was rinsed, as previously described, and then
treated for 5 min with ECL Plus Western Blot detection reagent (GE Healthcare, RPN
2132). Excess chemiluminescence solution was wicked from the PVDF, the PVDF
membranes were wrapped in plastic and then secured in an 8 x 10 inch Spectroline
radiographic cassette (Spectronics Corporation, Westbury, New York.). In the dark,
radiographic film (Kodak BioMax MR, Rochester, New York) was placed for detection of
Chemiluminescence signal. Film was developed on an automatic processor (Futura 2000K,
Fischer Industries Inc, Geneva, IL). Exposure time was adjusted to optimize the signal
intensity over a linear range. Developed film was then returned to the cassette and
molecular weight ladder indication and blot orientation was made with indelible ink.
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To verify the specificity of primary and secondary antibodies used in conventional
IP and seize IP based experiments, sera were separated by SDS and transferred to PVDF as
described. To test the specificity of secondary rabbit antibodies blots were stained with
Goat anti-rabbit or Horse anti-mouse antibodies. If these blots remained devoid of staining
the samples were stripped (100mM 2-mercaptoethanol, 2% SDS, 62.5mM Tris-HCL pH
6.7) and restained with Horse anti-mouse or Goat anti-rabbit to verify the presence of the
primary antibodies on the blot and verify the specificity of the matched primary and
secondary antibody interaction.
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CHAPTER VII.

Identification of a MMP-2/Integrin/TIMP-2 Complex in the Cultured
Neonatal Cardiac Fibroblast.

INTRODUCTION
In this chapter the structural association of MMP-2 and the α3β1 integrin is
documented in pull down assays. These experiments were conducted with freshly prepared
suspensions of neonatal cardiac fibroblasts isolated from 3-5 day old pups and cultured for
2-3 passages. In several sites in the following chapters supportive evidence for various
observations or experimental techniques are referenced to Appended materials. This
approach was used to provide the reader with additional information with minimal
interruption to the primary data presented in this chapter (which has been designed to be
submitted as a manuscript in support of this thesis).
RESULTS
Immunoprecipitation from cell suspensions. The gelatinases MMP-2 and MMP-9
are expressed at elevated levels during ventricular wall remodeling in development 128 and
at the onset of cardiac hypertrophy in the adult
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127

. Given the association of selected

integrins with selected members of the broader MMP family, pull down assays were
conducted to evaluate the possible structural relationships that might exist between these
receptors and MMP-2 and MMP-9 in the rat neonatal cardiac fibroblast. Beginning with a
suspension of cells in ITS Media, β1 integrin or MMP-2 was first recovered by
immunoprecipitation (IP) using Seize IP kits (ThermoScientific). The enriched material
recovered by IP was eluted in 3 separate fractions from the antibody columns; each
fraction was then separated by SDS gel electrophoresis under non-reducing conditions and
probed by Western blot for β1 integrin, MMP-2, or MMP-9. The Seize IP kits were used in
these experiments to avoid cross-contamination/cross-reactivity of the primary antibodies
with antibodies used in the Western Blot analysis (see also Appendix 1, for examples).
Western blot analysis of an IP against β1 integrin for β1 integrin reveals 3-5
prominent bands, depending upon the elution fraction, running at 210-220 kDa, 180 kDa,
110-120 kDa, 60 kDa and 40 kDa (Figure 1A, lanes 1-3). The lower molecular weight β1
immunoreactivity represents intracellular domain containing fragments

113

. Blotting this

same isolate for MMP-2 revealed a single band in each of the 3 fractions recovered from
the antibody columns running at 210-220 kDa (1A, lanes 4-6). Immuno-reactive MMP-9
was not detectable in this same assay or in a raw cell pellet fraction of cardiac fibroblasts
plated for 1 hour in ITS Media. However, MMP-9 was detectable by zymography in the
soluble media fraction recovered from CF plated for 1hour (see also Appendix 2 for this
data).
In the converse series of experiments, Western blot analysis of an IP against MMP2 for MMP-2 detected 2-3 bands (again, depending on the elution fraction examined).
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Elution fraction 1 exhibited a single prominent band running at 210 kDa. Elution fractions
2 and 3 exhibited 3 bands, running at 220 kDa, 210 kDa and 180 kDa (Figure 1B, lanes 13). Blotting material recovered by an IP against MMP-2 for β1 integrin revealed a single
distinct band running at 210-220 kDa (Figure 1B, lanes 4-6).
Given these results, zymographic analysis was conducted to confirm the presence
of gelatinolytic activity in material recovered by an IP against the β1 integrin subunit. In
these experiments, protease activity was only detected in IPs directed against β1 that were
recovered in the presence of the gelatinase specific inhibitor SB-3CT (Figure 1C). This
protease activity was present on the gels in association with a 200+kDa protein that
appears to correspond to the complex detected by the initial IP experiments. This result is
somewhat counterintuitive; however, it is possible that MMP-2 protease activity is at such
a high concentration in material recovered by IP that the enzyme is subject to some degree
of auto-proteolytic degradation during processing under baseline conditions 139. Consistent
with this conclusion gelatinase activity was present near the base of each gel lane; this low
molecular weight material was present even in samples treated with SB-3CT gelatinase
inhibitor. The gelatinolytic activity present in lanes treated with SB-3CT is probably a
reflection of the method used to assay gelatinase activity; this drug does not completely
suppress all MMP-2 proteolytic activity in this type of analysis (see Appendix 3, Figure 1).
As judged by zymography, SB-3CT suppresses approximately 50% of the MMP-2
associated gelatinase activity present in this type of analysis.
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FIGURE 1
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Figure 1. Immunoprecipitation (IP) experiments; Identification of a complex of β1
integrin and MMP-2. Panel (A) represents various fractions recovered from cardiac
fibroblasts subjected to immunoblotting (IB). IP against β1 integrin blotted for β1 reveals
proteins running at 210-220 kDa, 180 kDa, 110-120 kDa, 60 kDa and 40 kDa (A, lanes 13). MMP-2 immunoreactivity is present in association with the 210-220 kDa protein band
(A, lanes 4-6). Panel (B) represents the analysis of an IP against MMP-2. Western blot
analysis of this IP against MMP-2 reveals 3 bands running at 220, 210 and 180 kDa (B,
lanes 1-3). β1 integrin immunoreactivity is present in association with the 210 kDa band
(B, lanes 4-6). Panel (C) represents zymographic analysis of IP to β1 integrin with
Gelatinase inhibition. Lanes 1 and 2 represent raw lysate from cells in suspension treated
with 10µM SB-3CT or vehicle. Eluted fractions (Lanes 3-5) from IP to β1 with 10µM SB3CT or fractions (Lanes 6-8) from IP to β1 with vehicle were processed for zymography.
Zymographic analysis of an IP against β1 integrin in the presence of SB-3CT revealed
distinct bands of gelatinolytic activity (Panel C, Lane 3) at 210-220 kDa, 148 kDa and 94
kDa, representative of the intact complex, dimeric MMP-2, and pro-MMP-2 with TIMP-2,
respectively. To verify the identity of the material recovered by IP selected samples were
processed for zymography and then transferred for Western blot analysis and the detection
of MMP-2 (see Appendix 4).( See also Appendix 2 , Figure 1 for documentation of SB3CT inhibitory effects on MMP-2 activity).
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To determine if MMP-2 is associated with a specific integrin complex an IP against
MMP-2 was conducted and then probed by Western blot for β1, or α1, α2, α3, or α5, the
principle α integrin chains present in the neonatal rat cardiac fibroblast

59

. In this pull

down assay, only the α3 integrin chain was detectable in the recovered material (Figure 2).
From these experiments it is clear that α3β1 integrin and MMP-2 are present in a complex
that runs at 210-220 kDa.
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FIGURE 2
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Figure 2. Alpha integrin subunit analysis, composite image (all data from non-reduced
gels). MMP-2 was recovered by IP from 2 X 106 cells; this material was then subjected to
Western blot analysis for specific integrin subtypes. Panel (A): Lanes 1 and 2 Western blot
of β1, Lanes 3 and 4=α1, Lanes 5 and 6=α2, Lanes 7 and 8=α5 integrin. In this series of
experiments we were able to detect the β1, α1, and α5 integrin in the whole cell lysate
(lanes 1, 3, 5, and 7). The β1 chain was the only integrin subunit present in the fractions
recovered by IP to MMP-2 (Lane 2). Panel (B) represents a detailed analysis of the α3
subunit. Lane 1= Western blot against α3 in a whole cell lysate. Lanes 2 and 3 represent the
detection of the α3 subunit in enriched material recovered by IP to MMP-2, Lanes 4 and 5
represent the detection of the MMP-2 molecule in a pull down assay against the α3
integrin.
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In vivo, MMP-2 and MMP-9 present in the ECM are bound to a TIMP molecule;
these small inhibitory peptides play a role in regulating the activation state of these
enzymes

199,143

. To determine if TIMP-1 or TIMP-2 are component elements of the

integrin:MMP-2 complex an IP against β1 or α3 integrin was recovered from a suspension
of cells. This material was then run under non-reducing or reducing conditions and probed
for TIMP-1 and TIMP-2. Immunoreactive TIMP-1 was not detected in this assay (See
Appendix 5, for representative Western blot of TIMP-1 analysis). Immunoreactive TIMP-2
was present in the recovered material. In an IP against β1 integrin that was separated for
Western blot analysis under non-reducing conditions, 2 bands of TIMP-2 positive staining
were present, one prominent band at 220 kDa and a minor band at 56 kDa (Figure 3, A).
When these same samples were run under reducing conditions the 220 kDa band was lost
and bands running at 65, 50, 45 and 41 kDa were observed (Figure 3B). TIMP-2 has a
molecular weight of 24kDa; we assume that these higher molecular weight bands detected
under reducing conditions might represent complexes or multimers. In the analysis of an
IP to α3 integrin no reactivity was detected against TIMP-2 in the non-reduced format
(Figure 3, C). However, when these samples were run under reducing conditions, TIMP-2
was detected in the IP from α3 (Figure 3, D). Non-reduced samples of IPs directed against
α3 (Figure 3, E) and β1 integrin (Figure 3, F) from these experiments were blotted against
MMP-2 to confirm the existence of the putative complex. MMP-2 immunoreactivity was
present in both samples at a MW of 220 kDa.
Using a starting IP against the α3 integrin and then probing for TIMP molecules
produced similar, albeit not identical results when an IP against β1 integrin was used as the
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starting material. Under non-reducing conditions no TIMP-2 was detectable in the
recovered material. However, when this same sample was separated under reducing
conditions, protein bands running at 86, 55 and 50 kDa were detected. These data would
suggest that the antigenic site for the TIMP-2 peptide is sequestered when the complex is
isolated by an IP against α3 integrin and separated under non-reducing conditions. This
sequestration may occur because this aspect of the peptide represents the linkage site to the
α3 integrin 200.
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FIGURE 3
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Figure 3. Identification of TIMP-2 as a component of theα3β1 integrin / MMP-2
complex. Cells (2 X 106) were suspended and then incubated in the presence or absence of
10 µM SB-3CT or Vehicle for 30 minutes, immunoprecipitated and separated under nonreducing or reducing conditions. Panel (A) represents the detection of TIMP-2 from a β1
directed IP under non-reducing conditions: lane 1 with SB-3CT, lane 2 without SB-3CT.
Panel (B) represents the detection of TIMP-2 from a β1 directed IP under reducing
conditions: lane 1 with SB-3CT, lane 2 without SB-3CT. Panel (C) represents the detection
of TIMP-2 from an α3 directed IP under non-reducing conditions: lane 1 with SB-3CT,
lane 2 without SB-3CT. Note the absence of staining. Panel (D) represents the detection of
TIMP-2 from an α3 directed IP under reducing conditions: lane 1 with SB-3CT, lane 2
without SB-3CT. Panel (E) and Panel (F) represent blotting against MMP-2 as nonreduced samples from IP to α3 or to β1, respectively; lane 1 with SB-3CT, lane 2 without
SB-3CT.
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To address the possibility that MMP-2 might become secondarily associated with
the α3β1 integrin complex when the cell lysates are prepared for IP pull down analysis, live
cardiac fibroblasts were treated with the cross-linking agent DTSSP (Pierce). In these
experiments the cross-linking reagent links peptides that are within 12 Angstrom of one
another. Live, surface cross-linked cells were then processed for Western blot analysis. In
these experiments MMP-2 was present in association with a 200-210 kDa complex. These
results indirectly suggest that MMP-2 is bound to the α3β1 integrin prior to the IP process
and is not secondarily associated with this receptor as a consequence of the extraction
procedures (for documentation of these results see Appendix 6).

Summary. These experiments indicate that MMP-2 and TIMP-2 exist in a complex
with the α3β1 integrin of the neonatal cardiac fibroblast. This complex is stable enough to
withstand the processes used to recover IP isolated material for Western blot analysis
under non-reducing conditions. One aspect of these results that is difficult to fully
reconcile concerns the total MW of the isolated complex.
If the β1 represents the predominate binding site for MMP-2, it would be expected
that the α3 subunit would run at a substantially lower MW (120-130 kDa vs. 210-220 kDa).
The converse argument also holds true. If the α3 subunit was the exclusive binding partner
for MMP-2, the β1 subunit should run at approximately (110-120 kDa vs. 210-220 kDa).
However, regardless of the starting material used to recover MMP-2 in these pull down
assays, immunoreactive β1 and α3 are present in association with MMP-2 in a complex that
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has an estimated MW of 200-2120 kDa. There are several possibilities to explain these
results. For example, it is possible that under non-reducing conditions that the complex
runs at an aberrant MW due to its overall topography. However, it is also possible that the
MMP-2 molecule is linked to both integrin subunits.
When the MMP-2:TIMP-2:α3β1 complex is separated by SDS gel electrophoresis
the 2 integrin chains may separate from one another but the linkages that the anchor MMP2 to β1 and MMP-2 to α3 may be more stable, resulting in the appearance of the “common”
210-220 kDa complex that is observed. One may be composed of MMP-2, β1 and TIMP-2
and one may be composed of MMP-2, α3 and TIMP-2. In one case, the MMP-2 may be
bound to the β1 through the hemopexin domain 201or the collagen binding domain 187 and to
the α3 through TIMP-2

200

. Additional molecular experimentation will be necessary to

define the exact nature of the complex.
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CHAPTER VIII

Functional Implications of MMP-mediated Protease Activity
In Cell Adhesion Processes in the Cultured Neonatal Cardiac Fibroblast.

INTRODUCTION
The association of MMP-2 with the α3β1 integrin suggests this protease plays a role
in the process of cell adhesion and/or migration. To explore this putative aspect of MMPs
function in the neonatal cardiac fibroblast conventional 30 minute adhesion assays were
conducted with plates coated with various amounts of collagen, laminin, or fibronectin.
From these experiments, the optimized density of each ECM substrate that was necessary
to support maximal cell adhesion was determined. Centrifugal adhesion assays were then
used to characterize the relative strength of adhesion to each surface. These experiments
were all conducted in the presence and absence of protease inhibitors designed to block
MMP associated enzymatic activity. To limit the potential of untoward of serum elements
these assays were conducted in ITS supplemented media. These experiments suggest a role
for MMP in the maturation of adhesion in the Cardiac Fibroblast.
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RESULTS
Conventional Adhesion Assays. In 30 min conventional adhesion assays maximal
cell adhesion occurred at surface coating densities of 0.07 µg collagen/mm2, 0.035 µg
laminin/mm2 and 0.07 µg fibronectin /mm2 (Figure 4A). On plates coated with 0.07 µg
ECM/mm2, the minimal amount of each protein necessary to support maximal cell
adhesion for each type of surface, collagen, laminin and fibronectin all supported more
adhesion than tissue culture plastic or BSA (P<0.001). Further, at this same coating
density, collagen and laminin supported more adhesion than fibronectin (P<0.001). When
the plating interval was extended to 60 minutes under these same coating conditions,
collagen, laminin and fibronectin supported similar rates of adhesion (Figure 4B). Based
on these results all other experiments were conducted at an optimized surface coating
density of 0.07 µg ECM protein /mm2.

100

FIGURE 4
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Figure 4. Optimization of conventional adhesion assays: Panel (A) 30 minute incubation
and Panel (B) 60 minute incubation. The adhesion of cardiac fibroblasts to different ECM
substrates increases as a function of the coating density used to prepare the plates (A).
When equal numbers of cells were applied to collagen, laminin or fibronectin for 30 min
maximal adhesion occurred when the plating surfaces were coated with at least 0.07
µg/mm2 ECM protein (P<0.001). Each of these ECM substrates supported similar rates of
adhesion at this threshold value of coating density when the plating interval was extended
to 60 min (B). Each data point +/- S.E. N=3 of 3 replicates.
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Pharmacological inhibition of MMP function with the inhibitor SB-3CT did not
alter cell adhesion in conventional adhesion assays conducted over a 60 min incubation
interval (see Appendix 3 for characterization of SB-3CT effects on MMP function). SB3CT is a potent and highly specific inhibitor of gelatinases198 Rates of adhesion to
collagen, laminin, fibronectin, and poly-l-lysine were similar in the presence and absence
of this inhibitor (Figure 5). Experiments conducted with the more general and broader
spectrum, and less potent197 MMP proteinase inhibitor, GM6001, yielded similar results
(Figure 6).
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FIGURE 5
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Figure 5. SB-3CT does not alter initial adhesion. Cells were plated for 60 min onto
collagen, laminin or fibronectin (plates coated at 0.07 µg ECM protein/mm2) in presence or
absence of SB-3CT or vehicle. MMP inhibition with this reagent had little effect in this
assay. Cultures plated onto fibronectin in the presence of this inhibitor exhibited a modest
increase in adhesion with respect to vehicle treated cultures (P<0.006), but not to the naïve
controls. Each data point +/- S.E. N=3 of 3 replicates.
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FIGURE 6
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Figure 6. GM6001 does not alter initial adhesion. Cells were plated for 60 min onto
collagen, laminin or fibronectin (plates coated at 0.07 µg ECM protein/mm2) in presence or
absence of GM6001 or vehicle. MMP inhibition with this reagent had little effect in this
assay. An increase in the number of adherent cells was detected in cultures plated onto
fibronectin in the presence of 25µm GM6001 as compared to vehicle treated cultures(
P=0.005) but not to the naïve controls. Each data point +/- S.E. N=3 of 3 replicates.
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Centrifugal Adhesion Assays. To characterize the strength of adhesion that was
achieved over a 1 hour plating interval centrifugal adhesion assays were conducted. For
these experiments, culture plates were coated with collagen, laminin or fibronectin using
the optimized conditions established in the conventional adhesion assays. After the initial 1
hour plating interval the plates were inverted and decanted as if they were to be processed
for a conventional adhesion assay. The plates were rinsed and a determination of the total
cell number that was present was made, the plates were then centrifuged upside down to
subject the cells to a calibrated force. In the centrifugal assays neonatal cardiac fibroblasts
plated onto collagen and fibronectin were more strongly adherent (i.e. resistant to
detachment by centrifugation) than cells plated on laminin or poly-l-lysine (P<0.001,
Figure 7).
Incubating cultures with SB-3CT selectively reduced adhesion strength in cultures
plated onto collagen and fibronectin with respect to non-treated controls and vehicle
controls (P<0.003, Figure 8). This inhibitor had no effect on adhesion in cultures plated
onto laminin or poly-l-lysine. Treatment with GM6001 did not impact adhesion strength in
this assay (Figure 9).

108

FIGURE 7
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Figure 7. Baseline Centrifugal adhesion assays. Panel (A) illustrates the relative number
of cells adherent to culture dishes coated with 0.07 µg/mm2 ECM protein after a 60 min
plating interval. Rates of adhesion to collagen, laminin and fibronectin were similar and all
3 supported more adhesion than poly-l-lysine (P<0.001). These cultures were then turned
upside down and centrifuged at a calibrated force. Adhesion data in this panel is expressed
as a percent cells adherent to poly-l-lysine. Panel (B) illustrates the relative number of cells
adherent at the conclusion of centrifugation. Data is expressed as the per cent cells
remaining adherent with respect to the number of cells present at the onset of
centrifugation. Each data point +/- S.E. N=3 of 3 replicates.
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FIGURE 8
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Figure 8. SB-3CT impacts the strength of cell adhesion. Cells were plated for 60 min onto
collagen, laminin or fibronectin (plates coated at 0.07 µg ECM protein/mm2) in presence or
absence of SB-3CT or vehicle and subjected to a calibrated centrifugal force. Cells plated
onto collagen and fibronectin (P<0.003) were preferentially displaced from these ECM
substrates when treated with SB-3CT (A,C). Adhesion to laminin and poly-l-lysine was
un-effected by this drug treatment. Each data point +/- S.E. N=3 of 3 replicates.
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FIGURE 9
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Figure 9. GM6001 does not impact the strength of cell adhesion. Cells were plated Cells
were plated for 60 min onto collagen, laminin or fibronectin (plates coated at 0.07 µg ECM
protein/mm2) in presence or absence of GM6001 or vehicle and subjected to a calibrated
centrifugal force. No significant change in the adhesion of CF was attributable to the
application of this inhibitor. The reason for the differences in the effects of SB-3CT and
GM6001 in the adhesion of CF may be a reflection of the differences in specificity of these
inhibitors. N=3 of 3 replicates.
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Cell Viability in the face of protease inhibition. There is a technical limitation to
the adhesion based viability assays used in this study. These assays assume that any
intervention that reduces the number of cells present at the conclusion of the assay will be
reported as a reduction in cell adhesion. Unfortunately, any intervention that reduces cell
viability also will be reported by these assays as a reduction in cell number. A 10% loss of
cells due to cell death will be reported as a 10% loss of cells from the assay. A further
complication arises when a particular intervention is used to study the process of cell
adhesion, a variety of cell types will undergo apoptosis when adhesion is blocked or lost
202

.

To verify that protease inhibition reduces cell number in the adhesion assays used
in this study occurs as a consequence of impacting the adhesion process, cell viability
assays were conducted under a variety of conditions (See also Appendix 7). These
experiments indicate that SB-3CT has nominal effects on cell viability over the time
intervals used in the assays described in this chapter (Figure 10). As per the discussion in
the preceding paragraph, conducting an assay for cell viability in which the agents to be
tested have an effect on cell adhesion implies inherent limitations in the design of these
assays (interventions that kill cells reduce cells in the adhesion assay, interventions that
reduce adhesion reduce cells in the viability assays). To address the major concern that
cells will not attach if plated in the presence of inhibitors, viability was first assessed on
cells that had been plated for 24 hours. In these assays there was no detectable change in
metabolic activity in cultures treated with 1µM, 5µM SB3-CT or vehicle with 2, 4, and 6
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hours of treatment. However, within 2 hours of treatment at the 10µM dose of SB3-CT the
cultures plated on collagen and laminin exhibited approximately a 20% decrease in
metabolic activity as compared to naïve and vehicle controls (P=<0.001). Under these
same conditions CF plated on fibronectin were similar to naïve and vehicle controls.
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FIGURE 10
A.
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Figure 10. Time component of cell viability. Cultures were plated out onto collagen (A),
laminin (B), and fibronectin (C) for a total of 30hours. At time points 2, 4, and 6 hours
prior to assessing metabolic activity, media was aspirated and replaced with media
supplemented with 1, 5, and 10um or vehicle control. No change in metabolic activity was
detected at the 1 and 5uM doses in CF plated on these surfaces. At 10uM the inhibitor
appeared to impact the metabolic activity of CF in a time dependant manner. In cultures
plated on collagen (A) and laminin(B) there was a decrease in metabolic activity following
2hours of exposure to 10uM SB-3CT as compared to vehicle and untreated, naïve controls
(P=<0.001)( with overall significance level of 0.05 for multiple comparisons). We note that
initial cell adhesion was similar when CF were plated in the presence of inhibitors as
compared to vehicle and naïve controls in 1hr adhesion assays. N=3
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Summary. Overall the results of the conventional adhesion assays and the
centrifugal adhesion assays demonstrate that cardiac fibroblasts adhere relatively slowly to
fibronectin (this surface supported the least adhesion in conventional adhesion assays
conducted over a 30 minute interval). However, the cells that do attach to this ECM
protein are more strongly anchored than cells plated onto laminin or poly-l-lysine (more
cells are retained on this surface in the centrifugal adhesion assays). The strength of
adhesion of cells to collagen and fibronectin was similar in the centrifugal assays.
Treatment with SB-3CT selectively reduced cell adhesion when cells were plated
onto collagen and fibronectin. GM6001 did not impact cell adhesion in these assays.
Together, the cell adhesion assays and cell viability assays suggest that SB3-CT alters the
total number of cells present in the adhesion assays by perturbing the processes that lead to
the maturation of adhesion sites. Perhaps the most compelling series of experiments that
support this conclusion are the results of the centrifugal adhesion assays. First, at the initial
1 hour time point SB3-CT does not alter the total number of cells present in the assay on
any of the surfaces examined. Second, in the centrifugal portion of this same assay (which
is conducted and concluded within 10 minutes of taking the initial cell number reading)
SB3-CT selectively reduced cell number on collagen and fibronectin but not laminin or
poly-l-lysine.
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CHAPTER IX

In Situ Structural Relationships between MMP-2, Specific Integrin Subunits
and MT-1 MMP in the Cultured Neonatal Cardiac Fibroblast.

INTRODUCTION
Pull down assays have detected a complex composed of the α3β1 Integrin, MMP-2
and TIMP-2. Adhesion assays have implicated MMP mediated activity in the regulation of
cell adhesion to collagen and fibronectin, but not laminin or poly-l-lysine. In this series of
experiments the spatial relationships of specific integrin sub-units with respect to MMP-2
is examined using high resolution scanning confocal microscopy. The spatial relationship
of MMP-2 and MT1-MMP is also evaluated with this approach. Observations made in this
study were constrained to the ventral surfaces of the cells as defined by Interference
Reflection Microscopy.
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RESULTS

Qualitative

Scanning

Confocal

Microscopy.

To

investigate

the

spatial

relationships that exist in situ between β1 integrin, specific integrin α chains, and MMP-2
qualitative and quantitative, scanning confocal microscopy was used to examine cultures of
fibroblasts plated onto collagen, laminin, fibronectin or poly-l-lysine for 1 hour. These
experiments suggest that the distribution and relative overlap of the integrins and MMP-2
with respect to one another is subject to regulation by the identity of the surrounding ECM.
At the light microscopic level a gross examination of the cultures revealed that fibroblasts
plated for 1 hour onto each of these surfaces exhibited, on average, a rounded-cell shape.
Cell processes extended from the central rounded domain of the cells out over the coated
surfaces in a concentric pattern. Other cells within the cultures appeared less symmetrical
in shape; however, the general staining pattern described for the rounded cells was still
present in cells that displayed this phenotype.
A qualitative survey of cells plated onto collagen revealed that staining for β1
integrin was scattered over the basal surface of the cells in a punctate pattern (Figure 11A).
Staining for MMP-2 was present in a prominent band that was localized along the distal
boarders of the spreading fibroblasts (Figure 11Ab). β1 integrin and MMP-2 were coincident with one another at low density and in small clusters along these distal domains
(Figure 11Ae). The central regions of the rounded cells exhibited punctate staining for β1
integrin but were largely devoid of MMP-2.
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On laminin, staining for β1 integrin appeared in two distinct patterns (Figure 11B).
First, this receptor subunit was present in the punctate pattern along the basal surfaces that
was reminiscent of cells plated onto collagen (Figure 11Bb). Second, staining for β1
integrin was concentrated in a prominent, concentric band along the edges of the forming
cell processes. MMP-2 was concentrated in these distal domains and was co-incident with
the larger aggregates of β1 (Figure 11Be). On fibronectin, staining for both β1 integrin and
MMP-2 appeared in a population of small scattered spots (Figure 11C). These antigens
were co-incident with one another in restricted domains, many cells exhibited a poorly
defined band of β1 integrin and MMP-2 staining that appeared just proximal to the distal
boarders of the cells (Figure 11Ce). Finally, on poly-l-lysine β1 integrin and MMP-2 were
scattered over the basal surfaces of the cells, as with cells plated onto fibronectin there was
a degree of overlap in specific sub-domains (Figure 11D).
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FIGURE 11- Qualitative imaging of MMP-2 and β1
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Figure 11. Scanning confocal images of cells plated for 1 hour on various ECM substrates.
Panel (a) in each set of images represents a typical survey image taken at low
magnification (63X) of cells plated onto collagen, laminin, fibronectin or poly-l-lysine
stained for β1 integrin (green) and MMP-2 (red). Panel (b) for each image represents data
sets captured in zoomed section of the cell periphery. Note in Ab (collagen) the MMP-2
associated signal nearly overwhelms any β1 integrin staining. Panel (c) (green: β1 integrin)
and (d) (red: MMP-2) for each data set represent projection of the individual channels.
Panel (c) in each image set represents a subtraction analysis; the green projection depicts
the sites of β1 integrin and MMP-2 that are co-localized. The grey pixels in this image
represent the population of β1 integrin that exists independent of MMP-2 staining.
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Quantitative Scanning Confocal Microscopy. Next, the distribution of α1, α2, α3,
α5, and β1 with respect to MMP-2 and the overlap of MMP-2 with respect to MT1-MMP
were evaluated by quantitative methods. For these experiments data was captured at the
interface of the ventral surfaces of the cultured cells and the substratum as defined by
interference reflection microscopy. This approach makes it possible to concentrate on
domains within the cell that are actively undergoing remodeling during cell spreading
(example, domains similar to those depicted in Figure 11 panel e). As with the adhesion
assays the cells were plated for 1 hour onto each of the different substrates and then
processed for microscopic analysis. Representative images depicting the interference
reflection, the distribution of each antigen that was assayed, an overlay of the IRM with the
antigens, and an overlap image of the antigens are provided in Figures 12-16.
The overlap image (panel 5) in this type of analysis represents the distribution of
the relevant integrin chain (in grey) with regions of overlap with MMP-2 (in green). In
Figures 12-15, MMP-2 is represented in red and the integrin chains are represented in
green. In Figure 16, staining for MMP-2 was captured in the red channel (panel 2), staining
for MT1-MMP was captured in green channel (panel 3). In the overlap image (panel 5) the
green represents domains where staining for MMP-2 is co-incident with MT1-MMP (in
grey). For quantitative analysis the following parameters were maintained during image
collection; 1) Channels were scanned sequentially with a line average setting of 4, 2)
Images (1024 X 1024) were collected at the same voxel dimension of 69 nm x 69 nm to
obtain Nyquist limits, 3) PMT settings were set and maintained at levels that reflect the
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dynamic range, 4) PMT settings were adjusted for image capture to insure no bleed
through from one channel to the other could occur. A similar treatment of images was used
during post imaging analysis with JaCoP (Just another Colocalization Plugin) within Image
J. Overlap images presented within figures 11-17 were generated with Colocalization
Finder within Image J.
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Representative Image Panels Used in Overlap Analysis: Integrin α chains/MMP-2

The following series of confocal images depict the distribution of integrin chains of the
cardiac fibroblast with MMP-2. Figure legends are not provided as this information is
integrated within the results section preceding these images. In each image series, Panel 1
represents the Interference Reflection, Panel 2 represents MMP-2 (red), Panel 3 represents
the specific integrin alpha chain, Panel 4 is the overlay of these images, and Panel 5 is an
overlap image with the integrin chain distribution shown in grey and the areas coincident
with MMP-2 in green.
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Figure 12: Distribution of α1 integrin subunit with respect to MMP-2.
Interference reflection images of cells plated onto collagen reveals a series of contact sites
along the distal boarders of the spreading membrane processes that are arranged into a
series of concentric rings (Figure 12A, Collagen Panel 1). MMP-2 (Collagen Panel 2) is
scattered over this domain and appears as a broad band of staining that is distributed into a
concentric pattern that appears like a hollow ring encircling the middle of the cell. A subset
of this staining appears to lie within domains in contact with the underlying substratum as
defined by interference reflection microscopy (see Collagen Panel 4). Staining for the α1
subunit on these ventral cell surfaces is generally distributed as punctate spots. Examining
the images depicted in Collagen figure 12, panels 2 and 3 reveals that staining for MMP-2
occurs more prominently along the outer edges of the cells while staining for α1 is mainly
concentrated in the more central domains of the rounded cells. This central concentration
of α1 staining is approximately encircled by the concentric rings of focal adhesions as
defined by interference reflection microscopy. It is along the edges of this central area that
the most overlap between MMP-2 appears to occur (green, Collagen Panel 5). A similar
staining and overlap pattern was observed in cells plated onto laminin (Figure 12B,
Laminin).
No attempt has been made to conduct overlap analysis for the relative distribution
of α1 (or other integrin subunits or MMP-2) with respect to the focal adhesions as defined
by interference reflection. While technically possible, processing samples for immunofluorescence microscopy will cause the cells to collapse to an uncertain degree. This does
not obviate the usefulness of this technique for defining the focal plane at which the cell is
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in contact with the substratum. However, this can increase the total surface contact area to
some degree, thereby reducing the accuracy of the technique with respect to defining
individual contact sites.
Cells plated onto fibronectin did not display the pronounced concentric distribution
of contact sites defined by interference reflection microscopy that cells plated onto
collagen and laminin exhibited (Figure 12C, Fibronectin Panel 1). Instead, these cells
developed a series of small triangular adhesion sites along the distal boarders of the
spreading membranes (Fibronectin Panels 1 and 3). The concentric ring-like staining
pattern for MMP-2 that was observed in cells plated onto collagen and laminin was some
what less pronounced in cells that were plated onto fibronectin (Fibronectin Panel 2). This
pattern was present, just not as clearly delineated. The α1 chain was distributed as fine
punctate dots over the entire basal surface, but there was evidence that this integrin subunit
was present in somewhat higher abundance in the central domains (Fibronectin Panel 3).
Overlap analysis indicates that most of the co-localization appears to be of low level across
the surface of the cells (Fibronectin Panel 5).
Cells plated onto poly-l-lysine were not in full contact with the substratum. Focal
contacts were scattered over the basal surfaces that were in contact with the underlying
surface. Staining for MMP-2 and α1 integrin appeared to be scattered over the ventral
surfaces, the concentric (MMP-2) and circular patterns (α1) observed in the other cells
were largely absent in these cultures (Figure 12, Poly-l-Lysine).
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FIGURE 12- Distribution of a1 integrin with MMP-2
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Figure 13: Distribution of α2 integrin subunit with respect to MMP-2. Not
surprisingly, and as expected, the distribution of MMP-2 is clearly similar in the
experiments and data sets collected to evaluate the distribution of this protease with respect
to the α2 integrin. Of some note, as before, staining for MMP-2 appeared in concentric
pattern in cells plated onto collagen and laminin, and somewhat less so on fibronectin
(Figure 13). This result was very consistent and characteristic throughout these
experiments. From the distribution of MMP-2 and the morphology of plated cells at 1 hour
localize the protease within a region of transition. At this time point in the adhesion of cells
the central region of the cell is rounded with the edges spreading out giving “fried-egg”
morphology to the cell. The typical concentric distribution and concentration of MMP-2
within the region of transition between the central and peripheral regions of the cell
suggests that this protease may be functioning in the process of adhesion. Once again,
MMP-2 was more widely and uniformly distributed over the basal surfaces of cells plated
onto poly-l-lysine (Figure 13D, Panel 2).
While the staining for the α2 integrin subunit was also similar to the pattern
observed for the α1 subunit there were some minor differences. The bulk (e.g. not all) of
staining for this integrin was roughly encircled by the outer concentric focal adhesions as
defined by interference reflection microscopy. On collagen, this integrin subunit was more
evenly distributed across the basal surfaces of the cells (Figure 13A, Collagen Panel 3)
than the α1 subunit. The localization overlap image for α2 and MMP-2 indicates these
antigens were co-incident within the central domains of the cells (Figure 13 Collagen Panel
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5). There was not extensive staining (e.g. low “copy number”) but there appeared to be
very little MMP-2 staining that was co-incident with this integrin chain.
On laminin the α2 subunit appeared to be mainly concentrated in the central
domains of the spreading cells (Figure 13B, Laminin Panel 3). This integrin was largely
excluded from areas of close contact as judged by interference reflection microscopy
(Figure 13B Panel 4). The overlap analysis indicated that there was a moderate association
between the α2 integrin and MMP-2 protease (Figure 13B, Laminin Panel 5). The data
image clearly indicates considerable MMP-2 staining that is co-incident with the α2
integrin.
On fibronectin, the staining patterns for MMP-2 and the α2 integrin were very
similar to that observed for MMP-2 and the α1 integrin on this ECM substrate. One minor
difference, the α2 integrin appeared to be somewhat more widely distributed and not so
nearly confined to the central domains of the spreading cells (Figure 13C, Fibronectin
Panel 3). Overlap analysis indicated a very low frequency of co-localization (Figure 13C
Panel 5).
On poly-l-lysine the α2 integrin was sparsely distributed and appeared to be
aggregated into small clumps within the central domains of the cultured cells (Figure 13,
Poly-l-lysine Panel 3). These structures appeared to be independent of close contacts as
defined by interference reflection microscopy (Figure 13D, Panels 3 and 4). Overlap
analysis indicated very little co-localization between MMP-2 and the α2 integrin occurs on
this non-specific surface (Figure 13D, Panel 5).
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FIGURE 13- Distribution of α2 integrin subunit with respect to MMP-2.
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Figure 14: Distribution of α3 integrin subunit with MMP-2. Staining for MMP-2
on collagen, laminin, fibronectin and poly-l-lysine was again consistent with the other
experiments conducted to define the distribution of this protease with the α1 and α2
integrins (Figures 12 and 13). Cells in this particular data set are representative of the cells
that exhibit a less-well defined rounded cell shape (see Figure 14B and 14C).
The α3 integrin was widely distributed across the basal surfaces of the cells on all
of the surfaces assayed. The overall staining intensity for this integrin subunit was much
higher than either the α1 or α2 integrin (This increased signal intensity can result from a
difference in antibody affinities or from absolute differences in the amount of integrin. The
IP experiments would suggest that there is more α3 integrin). On collagen the α3 integrin
was nearly evenly distributed over the entire basal surfaces of the cells (Figure 15
Collagen, Panel 3). However, staining for the cell surface receptor did appear to be
excluded from the very distal boarders of the cells. The overlap image indicates that colocalization between MMP-2 and the α3 subunit occurs predominately in the peripheral
domains of the spreading cells (Figure 14A, Panel 5).
On laminin the α3 subunit appeared in a distribution that was essentially identical to
that observed on collagen (Figure 14B, Laminin Panel 3 and 4). The overlap analysis
images were also very similar to that observed in cell cultured on collagen. Co-localization
was predominately along the edges of the central domains of the cells (Figure 14B, Panel
5).
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Cells cultured on fibronectin exhibited distribution of the α3 subunit on the basal
cell surfaces that was very similar to that observed on collagen and laminin (Figure 14C,
Fibronectin Panel 3 and 4). The overlap images indicated that co-localization also occurred
in the central cell domains (Figure 14C, Panel 5). Qualitatively the overlap images
suggested that there was more MMP-2 that was co-incident with the α3 subunit on this
ECM surface (Figure 14C, Panel 5) than on collagen or laminin.
On poly-l-lysine, MMP-2 and the α3 subunit were scattered over the basal surfaces
of the cells (Figure 14D, Poly-l-lysine Panels 2-4). Overlap between these 2 antigens
occurred mainly along the periphery, there appeared to be far less MMP-2 on the surface of
these cells (Figure 14D, Panel 5).
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FIGURE 14- Distribution of α3 integrin subunit with MMP-2
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Figure 15: Distribution of α5 integrin subunit with MMP-2. On collagen and
laminin the α5 integrin was distributed as punctate spots that were mainly concentrated in
the central domains of the spreading cells. Again, the bulk of this staining appeared to be
encircled by the focal contact structures (Figure 15A and B, Panels 3 and 4). Overlap
analysis indicated the was co-localization of MMP-2 and α5 integrin in the more central
domains of the spreading cells; however, there was considerable integrin chain that was
independent of MMP-2 (Figure 15A and B, Panel 5).
On fibronectin staining for MMP-2 was, as before, present in a less well defined
concentric pattern (as compared to collagen and laminin) on the ventral surfaces (Figure
15C Fibronectin Panel 2). The α5 integrin was concentrated in triangular focal contacts
that were scattered over the surfaces of the cells. Interference reflection microscopy
confirmed that these structures corresponded to focal contact sites (Figure 15, Panel 4). In
overlap images MMP-2 and α5 integrin were concentrated and co-localized in these
domains (Figure 15C, Panel 5).
On poly-l-lysine MMP-2 appeared in a poorly defined concentric pattern that
encircled the central domains of the spreading cells (Figure 15D, Poly-l-lysine Panel 2).
Staining for the α5 integrin appeared within the central “doughnut” pattern of the MMP-2
labeling (Figure 15D, Panel 3). Qualitatively, there was less overall α5 integrin positive
staining in these cells. Overlap analysis indicated that co-localization was predominately
present around the outer portions of the α5 positive spots and on the inner ring of the
concentric staining pattern that characterized MMP-2 staining (Figure 15D, Panel 5).
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FIGURE 15 Distribution of α5 integrin subunit with MMP-2.
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Representative Image Panels Used in Overlap Analysis: Integrin β1 chain/MMP-2
The following series of confocal images depicts the distribution of integrin chains of the
cardiac fibroblast with MMP-2. A Figure legend is not provided as this information is
integrated within the results section preceding these images. Panel 1 represents the
Interference Reflection, Panel 2 represents MMP-2 (red), Panel 3 represents β1 chain
(green), Panel 4 is the overlay of these images, and Panel 5 is an overlap image with the β1
integrin chain distribution shown in grey and the areas coincident with MMP-2 in green.
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Figure 16. Distribution of β1 integrin with MMP-2. In many ways the distribution
of the β1 integrin can be expected to exhibit an average/aggregate distribution that
resembles the distribution of individual α chains (because it is the binding partner to each
of the α chains described in this study). On collagen (Figure 16A Collagen, Panel 3) and
laminin (Figure 16B, Laminin Panel 3) β1 integrin appears in small aggregates of staining
in the central domains of the spreading cells. On fibronectin, β1 appeared in a less well
defined circular pattern on many cells (e.g. see Figure 16C, Fibronectin Panel 3). In the
illustrated sample a roughly circular pattern of staining is evident. Within this domain there
appears to be a broader, more continuous region of staining that corresponds with contact
sites (Figure 16C, Panels 3 and 4). The clearly defined triangular focal adhesions that were
delineated by α5 staining were not obviously present (see Figure 15C, Panel 5).
Undoubtedly, these structures are present but not visible because the β1 partners with all of
the other α chains (e.g. not able to see the trees {focal adhesions} because of the forest
{extensive β1 staining in association with other α chains}). Moreover, similar shaped focal
adhesions were detected in cells plated on fibronectin as depicted by interference reflection
microscopy.
In the overlap analysis for MMP-2 and β1 integrin the co-localization of these
antigens occurred primarily within the central domains of the cultured cells. The extent of
co-localization varied across the different substrates. For example on collagen, the overlap
analysis suggested that there was far less co-localization and there was considerable MMP2 staining that appeared to be separate and distinct from the β1 integrin (Figure 16A,
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Collagen Panel 5). On laminin, this analysis indicated that there was extensive colocalization between MMP-2 and β1 integrin within the central domains of the cells
(Figure 16B Laminin, Panel 5). Very little β1 integrin staining appeared to be independent
of MMP-2 on this particular surface. Qualitatively, cells plated onto fibronectin (Figure
16C, Fibronectin Panel 5) exhibited overlap images that were similar to cells plated onto
laminin. There were clear examples of overlap, and clear examples of β1 chain that was
independent of MMP-2. On poly-l-lysine (Figure 16 Poly-l-lysine, Panel 5) the overlap
images were intermediate to the staining patterns observed on laminin and fibronectin.
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FIGURE 16- Distribution of β1 integrin with MMP-2
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Representative Image Panels Used in Overlap Analysis: MT-1 MMP and MMP-2
The following series of confocal images depict the distribution of MT1-MMP and MMP-2
on the cardiac fibroblast. A Figure legend is not provided as this information is integrated
within the results section preceding these images. Panel 1 represents the Interference
Reflection, Panel 2 represents MMP-2 (red), Panel 3 represents MT1-MMP (green), Panel
4 is the overlay of these images, and Panel 5 is an overlap image with the distribution of
MT1-MMP shown in grey and the areas coincident with MMP-2 in green.
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Figure 17: Distribution of MT1-MMP and MMP-2. These experiments were
conducted to characterize the distribution of MMP-2 with respect to a known binding
partner. The activation of proMMP-2 to the active isoform is mediated at the cell surface
by MT1-MMP. As with all of the other conditions assayed in this study, staining for MMP2 appeared in a concentric circular pattern around the “central core” of the cells. This
pattern was evident regardless of cell shape in cells cultured for 1 hour. Staining for MT1MMP was scattered over the ventral surfaces of the cells in a nearly uniform pattern
(Figure 17A-D Panel 3). There did not appear to be any preferential localization of this
protease in any particular subcellular domain. This pattern was evident in cells plated onto
collagen, laminin, and fibronectin.
In the overlap analysis areas depicted in green (Panel 5) represent colocalization of
MMP-2 on MT1-MMP whereas areas depicted in grey represent MT1-MMP independent
of MMP-2. On collagen (Figure 17, Collagen Panel 5) and laminin (Figure 17, Laminin
Panel 5) the overlap analysis indicated that perhaps half of the MT1-MMP and MMP-2 are
associated with one another. Cells on these surfaces exhibited distinct spots of MT1-MMP
that were co-incident with MMP-2, but nearly an equal number of MT1-MMP positive
sites were independent of staining for this antigen. On fibronectin (Figure 17 Fibronectin
Panel 5) and poly-l-lysine (Figure 17 Poly-l-lysine Panel 5) the relative amount of sites
that were positive (co-incident) for both MT1-MMP and MMP-2 was visibly increased
with respect to cells plated onto collagen and laminin. While MMP-2 appeared in the
characteristic concentric staining pattern, the overlap analysis on collagen, laminin and
fibronectin did not recapitulate this pattern. Co-localization analysis suggested that MT1144

MMP and MMP-2 appeared to be present in association with one another in a nearly
uniform pattern on the cultured cells (i.e. scattered over the basal surfaces). This is in
contrast to cells plated onto poly-l-lysine. On this non-specific surface there was an
obvious zone of co-localization between MT1-MMP and MMP-2. The overlap images
reveal a concentric staining pattern similar to that observed to MMP-2 (Figure 17 Poly-llysine Panel 5).
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FIGURE 17- Distribution of MT1-MMP and MMP-2.

146

Overlap analysis:
Scanning confocal microscopy indicates that MMP-2 is co-incident to varying
degrees with specific integrin α chains; co-localization appears to vary as a function of the
plating substrate. The visual analysis of these images is highly subjective, even if the
methods used to collect the data are quantitative in nature. Overlap analysis generates a
numerical representation of the raw overlap between signals present in different channels
in a microscopic data image. This process essentially distills the visual image into a far less
subjective form. The term “raw” overlap is a qualifier that denotes that this analysis
occurred without each channel being divided by the average intensity value of the
representative channel. This type of manipulation essentially represents a smoothing of the
data and sets a threshold at which signals from different channels will be accepted as data.
No such filtering is used in raw overlap analysis. The resulting graphical representation of
the overlap images represents an approximation of the coincidence of the two antigens
without regard to differences in signal intensity that can exist between the two channels.
This approach was used in this analysis to detect the relative differences in the overlap of
MMP-2 with specific integrin chains, or with MT1-MMP and the degree to which this
relationship is affected by ECM composition.

Figure 18: Overlap analysis. The overlap coefficient for each of the specific
integrin subunits with respect to MMP-2 varied as a function of ECM composition. For
example, for cells plated onto collagen and laminin (Figure 18), on a scale of 0 (no
overlap) to + 1.0 (complete overlap), the coefficient of overlap for α1 integrin and MMP-2
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was approximately 0.27-0.29, on fibronectin the overlap value was 0.15 for this integrin
subunit. On poly-l-lysine the overlap coefficient was approximately 0.31. Values for the α2
integrin ranged from about 0.18 on collagen to approximately 0.35 on laminin and
fibronectin. The α3 integrin and MMP-2 exhibited the highest coefficient of overlap on
all of the surfaces evaluated. The overlap coefficient for these two antigens was also
greater than the coefficient of overlap for MT1-MMP and MMP-2 on all surfaces. On
collagen the overlap coefficient between α3 and MMP-2 was 0.4, and on laminin,
fibronectin and poly-l-lysine it was approximately 0.5. Analysis of the α5 integrin and
MMP-2 generated overlap coefficients of 0.26 on collagen, 0.35 on laminin, 0.3 on
fibronectin and 0.37 on poly-l-lysine.

For the β1 integrin and MMP-2 the overlap

coefficient was 0.3 on collagen, approximately 0.42 on laminin, and 0.3 on fibronectin and
poly-l-lysine.
As a comparison, the association of MMP-2 with MT1-MMP generated values of
0.26 on collagen, 0.29 on laminin and approximately 0.38 on fibronectin and poly-l-lysine.
(Horizontal dashed line Figure 18 represents overlap of MMP-2 and MT1-MMP).
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FIGURE 18
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Figure 18. Overlap analysis of specific integrin subunits and MMP-2. The extent of
overlap varied as a function of the ECM substrate used to plate the cells. The overlap
coefficient was highest between α3 and MMP-2; this relationship existed on each of the
substrates examined. The dashed line in each panel represents the average overlap value
generated from an analysis of MT1-MMP and MMP-2 for each ECM substrate.
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Mander’s Coefficient
Mander’s analysis takes overlap analysis one step further and determines the
percentage of an antigen that is involved in the overlap with a second antigen. The output
of this analysis determines the fractional population of one antigen that is co-localized with
a second antigen. The analysis then reverses this process and determines the percentage of
the second antigen that is co-localized with the first antigen. Values are expressed on a
scale of 0 (no overlap) to +1.0 (total overlap). Data considered for Mander’s analysis was
thresholded automatically within the JACoPlugin within Image J. This manipulation
eliminates from the analysis data points that are on the low end of the intensity scale (grey
pixel intensity from 0- 256) (potential noise). Data from the upper end of the intensity
scale are not clipped in this filter. This thresholding tightens the data by eliminating low
intensity signal present in each channel that potentially could dilute the relationships of
these antigens.

Figure 19: Mander’s Coefficient. Once again the relative fraction of each antigen
that was associated with the putative companion molecule varied as a function of the
plating conditions. For all surfaces assayed, Mander’s coefficient was highest for the
association of MMP-2 with the α3 subunit (Figure 19). In the converse analysis of this
relationship the relative fraction of α3 integrin that was localized in association with MMP2 was substantially less. For example, on collagen, Mander’s coefficient for the association
of MMP-2 with the α3 integrin was about 0.35. However, for the converse circumstance
the association of the α3 integrin with MMP-2 generated a value of 0.14. This data
151

indicates that a considerable amount of the MMP-2 molecule is present in association with
the α3 integrin. The low value generated for the association of α3 integrin with MMP-2
indicates that there is a much higher copy number of this integrin subunit on the cell
surface than MMP-2. (More α3 integrin is without MMP-2 than α3 integrin that is with
MMP-2) Mander’s coefficient for MMP-2 with β1 integrin was similar on all surfaces and
ranged from 0.2 to 0.3. Finally, Mander’s coefficient for MT1-MMP and MMP-2 ranged
from about 0.1 on collagen to 0.2 on fibronectin, values that are substantially less (by
nearly 2 fold) than that reported for the association of MMP-2 and the α3 integrin.
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FIGURE 19
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Figure 19. Mander’s coefficient of co-localization analysis for specific integrin subunits
and MMP-2. For all substrates, Mander’s coefficient was highest for the association of
MMP-2 with α3 integrin. However, this analysis indicates that the bulk of the α3 subunit
exists independent of the MMP-2 molecule. The fractional co-localization for the other
integrin subunits, including β1 integrin, and MMP-2 were more similar on all substrates.
The converse analysis yielded similar results. Mander’s coefficients for the association of
MMP-2 and MT1-MMP-2 were consistently less than the coefficients calculated for the
association of MMP-2 with the α3 integrin subunit.
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Summary
Data presented in this document demonstrates the association of MMP-2 with the
β1 integrin in an interaction that specifically involves the integrin alpha chain α3.
Pharmacologically blocking MMP protease activity with SB-3CT decreases the strength of
cells adherent on collagen and fibronectin. Both qualitative and quantitative confocal
microscopy was implemented to define the in situ relationship of MMP-2 with the primary
integrins of the neonatal cardiac fibroblast plated on to specific ECM components for 1
hour. Similar analysis was conducted with MMP-2 and MT1-MMP, a known cell surface
binding partner and activator of MMP-2
Overlap analysis demonstrates the highest association of MMP-2 occurs with the α3
integrin chain. This result is in agreement with biochemical data of the reciprocal
interaction of this integrin alpha chain with MMP-2. Pull down assays did not demonstrate
this relationship with the other alpha integrin chains addressed in these assays, namely the
α1, α2, α5 integrin chains. These alpha chains, however, demonstrate some degree of
overlap with MMP-2. It is unclear as to why these alpha integrin chains demonstrate a
level (albeit low) of overlap with MMP-2 with microscopy, but did not demonstrate a
physical connection with this protease in our pull down assays. One possibility is related to
the α3 integrin being promiscuous in both substrate specificity203 and in participating with
heterogeneous integrins in forming adhesions 73. Perhaps the overlap of MMP-2 with α1,
α2, α5 that is detected is actually MMP-2 bound to α3 integrin intermingled in close
proximity with these integrin chains.
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Overlap of MMP-2 with the β1 integrin chain reflects a lower level of association
than was detected with the α3 chain. This result is expected as the β1 chain partners with a
number of integrin alpha chains. The overlap present between the α1, α2, α5 integrin chain
with MMP-2 was low in comparison to the overlap present between α3 and MMP-2 on all
substrates. As a consequence of β1 integrin having multiple alpha chain binding partners
the degree of overlap that is present between MMP-2 and β1 integrin reflects the average of
the association of MMP-2 with all of the alpha chains that are present with β1

integrin.

This averaging provides indirect evidence to the specificity of the interaction of MMP-2
with the α3β1 integrin.
Evident from the images of cells plated for 1 hour was a typical distribution pattern
of MMP-2 as a clearly discernable ring shape at the region of transition between the central
rounded region and the flattened edges that are spreading outward. This is of note as this
location places this protease at the base of spreading adhesion structures. More elaborate
techniques may delineate how this implication relates to the changes in adhesion
maturation that occur with protease inhibition in cells plated on collagen and fibronectin.
The substrate specific response likely represents a combination of factors both intrinsic and
extrinsic to the cell; the integrin profile, the identity of the substrate, and the role of this
protease.
In adhesion experiments, blocking MMP associated protease activity alters the
strength of adhesion fibronectin and collagen. It is tempting to connect the separate results
of adhesion and the distribution of MMP-2 with integrins on specific surfaces; however,
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these connections would be largely speculative. One clear interpretation is the overlap of
MMP-2 with the α3β1 integrin is present on cells following 1 hour of adhesion and this
overlap is predominate and of a greater degree that the association of MMP-2 and MT1MMP. Moreover, this interaction was defined to the cell surface interface by interference
refection microscopy. This evidence supports our isolation of a complex of MMP-2: α3β1
from the surface of cardiac fibroblast.
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Chapter X.
Discussion
Biochemistry of the MMP-2 integrin complex. This study has demonstrated 2
distinct results. First, MMP-2 is present in a complex that contains the α3β1 integrin and
TIMP-2. Second, pharmacological inhibition of MMP activity disrupts the maturation of
cell attachment sites in an ECM specific manner. Circumstantial evidence links these two
observations and suggests that MMP-2 bound at the cell surface modulates the maturation
of adhesion sites in the cultured cardiac neonatal fibroblast. Biochemical assays (IP,
Western blot assays, cell culture experiments, and pharmacological inhibition assays) and
scanning confocal microscopic examination (distribution of MMP-2 with respect to
integrin receptors) of cultured cells indicates that MMP-2 present at the cell surface
mediates this process.
IP pull down experiments conducted on cell-suspensions reveal that MMP-2 is
physically, and preferentially, associated with the α3β1 integrin complex. Conducting a pull
down assay directed against either the α3 or β1 integrin chains recovered immunoreactive
MMP-2 (as judged by Western blot analysis and zymographic analysis of material
recovered by IP). Conversely, IP experiments conducted against MMP-2 recovered α3 and
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β1 integrin. The complex recovered in these conventional IP pull down assays is stable
enough to withstand the elution buffers used to recover the complex and subsequent SDS
treatments during rinses, although running these samples on SDS gels under reducing
conditions will break down the MMP-2:integrin complex. On one hand these data suggest
the complex is very stable. However, an alternative explanation, and clearly one potential
criticism of these experiments, comes from the standpoint that the extraction procedures
used to put the antigens of interest into solution during the initial stages of the IP could
lead to the secondary association of the MMP-2 with the α3β1 integrin. During extraction
the association of MMP-2 with the different integrin subunits could occur through nonphysiological means as a consequence of the assay conditions. Under these circumstances
the non-specific association of the MMP with the integrin complex could appear to be very
stable-if the proteins of interest are literally entangled and denatured with one another.
Several lines of evidence argue against this explanation.
First, in selected experiments cells were processed with the cross-linker DTSSP in
the living state prior to Western blot analysis. This particular cross-linker functions at the
cell surface and will chemically cross-link proteins together that are within 12 Å (See
Appendix 6). An analysis of cells that have been processed in this manner for the detection
of MMP-2 reveals an immunoreactive protein running at a MW of 200-210 kDa (See
Appendix 6). This experiment provides compelling evidence that MMP-2 is in, at least,
close proximity to the integrin complex in the living cell. Similar experiments conducted to
assay for the presence of MMP-9 failed to detect this closely related (both structurally and
functionally) protease. These results, in conjunction with pull down assays directed against
159

MMP-2 that failed to detect interactions between MMP-2 and any other α chains, provides
additional (albeit indirect) evidence that the MMP-2: α3β1 integrin interaction exhibits a
considerable degree of specificity.
Second, scanning confocal microscopic observations of cultured cells were
conducted under circumstances that make it possible to assess the extent to which different
antigens are co-localized with one another within a spatial resolution of 0.1394µm in the xy dimension, 0.2358µm in the x-z with the 63x objective. These experiments demonstrated
that the association of MMP-2 with the α3 integrin was the highest under all circumstances
that were assayed. In fact, Mander’s coefficient of co-localization for MMP-2 and the α3
chain was higher than Mander’s coefficient of co-localization for MMP-2 and the MT1MMP protease (a well known and well characterized binding partner for MMP-2).
The results of these different types of experiments are consistent with a complex
composed of MMP-2: α3β1 integrin. However, there is at least one discrepancy in the
analysis of the present results that remains to be fully resolved. The MW of the complex
detected in this study can not easily be reconciled with existing literature. Given the caveat
that it can be dangerous to estimate the MW of a protein complex that has been separated
on a SDS gel run under non-reducing conditions (the tertiary structure of a multi-molecular
complex that has been run in a non-reduced state can result in the calculation of a highly
anomalous MW), the 210 kDa complex is still exhibits a very unusual mass. Using a
median estimate of mass and adding the reported MWs of β1 (115-130 kDa, non-reduced)
204, 59, 61

, α3 integrin (120-130 kDa non-reduced )204, MMP-2 (72 kDa for the pro-isoform

and 64 kDa for the active isoform) TIMP-2 (20 kDa non-reduced) generates a complex that
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would have a nominal total MW of approximately 340 kDa (β1 @ 123 + α3 @ 125 + MMP2 @ 70 kDa + TIMP-2 @ 20 kDa = 338 kDa). While changes in the Stokes radius can
greatly alter the movement of proteins within the electric field of the gels this mass is
considerably higher than the mass observed for the complex defined in this study.
The MW of the various integrin subunits have been defined in different cell types
(isolated from various stages of rat development) and rat hepatocytes by chemically
labeling their surfaces by iodination. This approach places a radioactive marker on, just,
the surface associated molecules

61, 113

. The labeled material was then extracted and

subjected to an IP against different integrin subunits. The incorporated radioactivity was
used to detect the recovered antigens. IPs against the β1 chain have been conducted against
rat cardiac fibroblasts 59, 205, cardiac myocytes 113 and hepatocytes 61 using this cell surface
labeling technique. When the recovered material was separated by SDS under nonreducing conditions the β1 integrin generated an estimated MW of approximately 115-130
kDa, substantially lower than the mass of the complex described in this study 59, 61, 113 .
In addition, when cell surface radio-labeled β1 chain is recovered under nonreducing conditions all of the α chains that are associated with that β1 chain on the cell
surface are also labeled. When a pull down directed against β1 is used to recover the α3
chain it exhibits an apparent MW of approximately 120-130 kDa, again much smaller in
mass than was detected in this study. The published gels and the written discussion in these
studies do not disclose any evidence of a high MW band that could correspond to the
complex detected by this study. In addition to these observations, there is yet one more
complicating factor. In Western blot analysis conducted in this study of whole cell extracts
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the estimated MWs of α3 and β1 more closely approximated the expected MWs of these
antigens (see Figure 2). Together, these observations generate two questions: Why are the
α and β chains that are recovered by IP in this study remaining as a very high MW
complex? Second: Why does this complex exhibit a low MW compared to the reported
MWs of the individual proteins detected in the complex. Unfortunately, there is no clear
answer to these questions.
If the samples processed in this study by IP responded as has been described in the
literature it may have been possible to make more definitive conclusions about how the
recovered complex might be structurally organized. For example, if this precondition had
been met and the β1 represented the predominate binding site for MMP-2 in the complex;
it would be expected that the α3 subunit would run at a substantially lower MW the SDS
gels (closer to 120-130 kDa vs. 210-220 kDa). Recovering the complex with an IP against
β1 or MMP-2 would bring down the α chain(s) that were present in the putative complex.
Once the sample was run on the gels the α and β chains should dissociate and separate.
Assuming the MMP was linked to the β chain, these two proteins would run together while
the α chain would separate and run at its expected, and substantially, lower MW. The
converse argument also holds true. If the α3 integrin represented the exclusive binding
partner for MMP-2, the β1 integrin should have been dissociated from the “complex” and
run at approximately (110-120 kDa vs. the observed 210-220 kDa).
Still recognizing that it is an inexact science to predict an exact molecular weight of
a protein complex that has been separated under non-reducing conditions, the existing
literature and the present data can be used to argue that MMP-2 is linked to both integrin
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subunits. Western blot analysis of the complex recovered in this study has indicated that
TIMP-2 is present in association MMP-2 and the α3β1 integrin in the neonatal cardiac
fibroblast. In these experiments, a pull down assay was conducted against β1 integrin and
the recovered material was probed by Western blot for TIMP-1 and TIMP-2. This
approach was used because an IP against MMP-2 would ordinarily be expected to bring
down one or both of the TIMP peptides (the normal binding partners for MMP-2). An IP
against the β1 should represent a fairly stringent approach in determining if the TIMP
molecule(s) represent component elements of the complex. The TIMP-1 molecule was
present in the whole cell lysates but was not clearly associated with the 210-220 kDa
MMP-2:α3β1 complex. TIMP-2 was clearly present in the complex and a Western blot
analysis of this type of an IP confirms that both α3 and MMP-2 are present in the recovered
material and running at the 210-220 kDa mass (Figure 2 and Figure 3).
There is at least one scenario that can be used to defend model that MMP-2 actually
interacts with both the α3 and the β1 chains of the integrin complex. It is possible that when
the recovered complex is separated by SDS gel electrophoresis that the 2 integrin chains
separate from one another but the linkages that the anchor MMP-2 to β1 and MMP-2 to α3
may be more stable, resulting in the appearance of the “common” 210-220 kDa complex
that we have observed. One maybe composed of β1 MMP-2 and TIMP-2 (β1 @ 115-130
kDa + MMP-2 @ 68-72 kDa = 183 kDa to 202 kDa). One other complex could be
composed of α3, MMP-2, and TIMP-2 (α3 @ 120-130 kDa + MMP-2 @ 68-72 kDa +
TIMP-2 @ 20 kDa = 208 kDa to 222 kDa). Under these conditions a Western blot
analysis would detect a complex composed of α3β1 integrin, MMP-2 and TIMP-2 running
163

at a “common” MW of 210-220 kDa. This result would occur because IP against α3 or β1
integrin or MMP-2 will bring down the entire complex; the complex then partially breaks
down in the gel run into the composite structures described. Analysis by Western blot of
the individual components would then detect all of component elements running at a MW
of 210-220 kDa.
In order to unambiguously define the exact nature of the interactions that mediate
the interaction between MMP-2 and the α3β1 integrin it will be necessary to specifically
design and conduct experiments to explore the structural properties of this complex.
Various proteases of the MMP family exhibit interactions with different integrins.
Somewhat surprisingly the nature of the MMP integrin interaction varies considerably
across cell type. For example, in human gingival fibroblasts MMP-2 is indirectly linked to
β1 integrin through a collagen peptide fragment

187

. In this system one domain of the

collagen peptide appears to be bound to the active site in the integrin, while the MMP,
which recognizes and binds to native collagen 132 , is bound by the collagen fragment. The
association of MMP-1 (collagenase) with the α2β1 integrin is primarily defined by
structural motifs that are present in the α2 chain 184,185 . The binding events that anchor the
C-terminal hemopexin domain of the MMP-2 molecule to the αvβ3 integrin remain ill
defined

186

. However, this interaction is specific to this integrin. In the gel shift assays

described in this latter study mixing MMP-2 with the αvβ3 integrin results in an increase in
MW. Conducting this same experiment with the α5β1 integrin and MMP-2 resulted in no
apparent shift in MW in the samples in the gel analysis. Given these observations the
MMP-2 in cardiac myocytes may be could be bound to the β1 through the hemopexin
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domain

201

or the collagen binding domain

187

and to the α3 through TIMP-2 mediated

events 200. A specific binding site for TIMP-2 on α3 has been detected 200.
Experiments conducted to examine the association of TIMP-2 with the integrin
complex provide some insights into how this interaction might be mediated. In this series
of IPs were conducted against the α3 and β1 integrin. Material from these isolations were
then run under non-reducing and reducing conditions and blotted for TIMP-2. (Figure 3).
Interestingly material that was pulled down with α3 and run under non-reducing conditions
did not show reactivity to TIMP-2. This is not an artifact of the antibody used to detect
TIMP-2 as this antibody recognized this antigen in non-reducing conditions in isolates of a
β1 integrin pull down. Under reducing conditions, however, TIMP-2 is detected in the α3
pull down. Blotting for MMP-2 in the isolates from the α3 pulldown confirm that the
differences in the detection of TIMP-2 in the non-reduced and reduced conditions were not
resultant from an ineffective pull down of the complex of MMP-2: α3β1:TIMP-2. One
likely explanation for the differences in detection of TIMP-2 in α3 isolates is that in the
non-reduced condition the binding of TIMP-2 to the α3 integrin chain conceals the epitope
recognized by the antibody used in this study. The immunogen or target for this antibody
directs this antibody to the N-terminal, loop-1 domain of TIMP-2. The structure of TIMP
is maintained as a series of 5-6 loops by disulfide bonds. Presumably, in the non-reduced
condition this epitope is concealed in the binding to the α3 integrin chain. With reduction
TIMP-2 was detected. Defining the exact site of interaction is beyond the scope of these
studies; however, the interaction of TIMP-2 with α3 likely mediated by the N-terminal
domains of TIMP-2. Additionally TIMP-2 was detected from IP to the β1 chain under non165

reducing and reducing conditions implying that the interaction sites of

TIMP-2 with α3

and β1 are different200.
In summary, experimental evidence suggests that MMP-2, α3β1 and TIMP-2 exist
as a complex on the surface of the cardiac fibroblast. It remains unclear how this complex
is organized and selecting one model over another to explain the present results is difficult
at best. Alternative models to explain the composition of the 210-220 kDa complex that
was identified in this study include:

•

A much higher mass complex that runs at an “anomalously low” MW of
210-220 kDa as a consequence of the running conditions used to separate
the proteins for analysis. In this model the tertiary structure of the intact
complex causes it to run at a low MW in the SDS gels under non-reducing
conditions.

•

A high MW complex in which the MMP-2 is linked to both the α and
β chains. The 210-220 kDa complex is generated when the intact complex
is broken down into 2 separate complexes composed of β1 @ 115-130 kDa
+ MMP-2 @ 68-72 kDa and then α3 @ 120-130 kDa + MMP-2 @ 68-72
kDa + TIMP-2 @ 20 kDa.

Of the two alternatives presented the first may be the most tenable for two reasons. First,
the buffers used to isolate and recover the IP material for analysis appear to be relatively
gentle, allowing the integrin chains to remain intact with one another. When conventional
IPs were processed by boiling in SDS to recover the antigens the chains would occasional
remain intact other times they would breakdown. This result appeared to be very variable
and dependent upon the length of time (or temperature?) the samples were processed (very
166

small changes resulted in very inconsistent results which is one reason the Seize IP kits
were used). Second, the test tube and gel shift assays conducted with MMP-2 and αvβ3 and
α5β1 would appear to indicate that MMP-2 alone will not bind to the α5β1 (this
circumstance may be changed if the TIMP-2 molecule alters the structure of the MMP-2
molecule in such a way that MMP-2 would now bind the α5β1 integrin).

Functional implications of the MMP-2 integrin complex. The

association

of

MMP-2 with the α3β1 integrin is particularly interesting when one considers the
promiscuous nature of the substrate specificity of this integrin. Collagen, laminin and
fibronectin are all surfaces engaged by the α3β1 integrin. The MMP-2 protease exhibits
activity against each of these surfaces 18,130,131
Adhesion assays conducted in this study provide evidence that the MMP-2:TIMP2:α3β1 complex plays a role in the maturation of cell adhesion sites in an ECM specific
fashion. Pharmacological inhibition of MMP function with SB-3CT did not alter cell
adhesion in conventional cell adhesion experiments (30 or 60 minute incubation intervals).
This is perhaps not surprising; these early events of adhesion are relatively non-specific in
nature and are largely driven by electrostatic interactions

106

. When these same cultures

were plated for 60 min and then challenged with a calibrated centrifugal force treatment
with SB-3CT selectively reduced the adhesion of the neonatal cardiac fibroblast to
collagen and fibronectin, but not laminin or poly-l-lysine. It seems unlikely that this
substrate specific effect on adhesion represents a reflection of the intrinsic proteolytic
properties of MMP-2. This protease can degrade a broad spectrum of ECM proteins,
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including laminin

18

. The proteolytic processing of collagen and fibronectin can uncover

RGD binding sites that are not ordinarily accessible in these ECM proteins by the integrins
of the cardiac fibroblast

206,207

. Proteolytic processing of laminin exposes this very same

type of binding site; however, the cardiac fibroblast typically exhibits low expression of
the integrin that mediates adhesion to these (now uncovered) cryptic sites208,209.
It is not possible to entirely discount the role that the MT1-MMP:MMP-2 complex
might play in the adhesion studies 136. Our co-localization experiments clearly demonstrate
this complex is present, and presumably active, in cells that have been plated for 1 hour.
However, at this time point the coefficient of colocalization for MMP-2 with the α3
integrin is far larger than the coefficient of colocalization of this enzyme with β1 or its
more classic binding partner, MT1-MMP. The low values generated by the co-localization
analysis for the MT1-MMP and MMP-2 suggest that very little MMP-2 is associated with
this binding partner during this early stage of culture. Nor can we detect active MMP-2 (or
MMP-9) in the supernatant of the cultures at this time interval (Figure 2, Appendix 3).
Given these results it seems likely that our inhibition experiments are impacting MMP-2
activity on a very local scale 210. We have been unable to “rescue” cell adhesion in cultures
treated with inhibitors by first pre-treating the ECM coated culture dishes with exogenous
proteases. This result also suggests the impact of SB-3CT is a very local event specific to
the cell surface. By implication and the shear volume (number) of MMP-2 molecules
associated with the α3 integrin this seems like the most likely site at which protease
inhibition effects the cells.
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In confocal localization experiments MMP-2 exhibited a low background of
association with the other integrin α chains. If there this association is “real” it occurs at a
very low level, if an IP is conducted from a known number of cells only the α3 and β1
chains are detectable in the final isolate. The low “background” of association of MMP-2
with the other α chains could be reflection of the relatively promiscuous nature of the α3β1
integrin. This particular integrin complex can bind to a variety of ECM substrates and cooperates with other integrins in the maturation and formation of adhesion sites 73. During
adhesion the α3β1 integrin does not necessarily participate in the very earliest stages of cell
attachment, rather it appears to play a more distal role in the process. The α3β1 integrin
accumulates in developing adhesions and is an integral component of the formation of
heterogeneous adhesion sites (sites composed of multiple integrin subtypes).
The constraints placed on the co-localization analysis by the inherent limits of
optical resolution of confocal microscopy (63X objective, x-y resolution 0.1394µm; x-z
resolution 0.2358µm) makes it impossible to determine if the overlap represents an
association of the α3β1: MMP-2 complex with other integrins, the association MMP-2 with
a common β1 chain, or the true association of the MMP-2 molecule with other α subunits.
Together the data suggests that MMP-2 is selectively associated with the α3β1 integrin, the
integrin most closely associated with the maturation of adhesion sites.
Whenever a study involves the application of pharmacologic agents a common
concern is that these agents will adversely impact cell viability. Any loss of cells from the
adhesion assays as a result of death would be reported as a reduction in cell adhesion.
Conversely, any loss of cells from a viability assay due to changes in cell adhesion will be
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reported by the viability assay as a reduction in cell viability. These characteristics
represent a major limitation in conducting and interpreting the data presented in this study.
In attempts to mitigate and circumvent these technical limitations necessitates
conducting the viability assays on full attached cells. This assumes that once the cells are
attached that protease inhibition over a short interval of time will not greatly impact
adhesion. Several observations form the basis for the argument that cell viability was not
adversely affected over the 1 hour plating interval used during the adhesion assays in this
study. Evidence supporting this conclusion is first provided by the conventional adhesion
assays in which indicated equal initial adhesion in cells treated with inhibitors. The
preliminary stages of the centrifugal adhesion assays support this result. A vital dye is
added to the cultures immediately prior to centrifugation (essentially a conventional
adhesion assay at this point). In these experiments all cultures exhibited similar numbers of
cells. Perhaps the most convincing evidence that viability was not adversely affected by
protease inhibition (or the vehicle carrier) during the 1 hour culture interval used in the
adhesion assays is that the adhesion strength was selectively reduced on collagen and
fibronectin, and not on laminin or poly-l-lysine. While this line of reasoning is not a
“direct” line of evidence, it may be more accurate than the metabolite based assay in
assessing viability. The reality is that metabolic assays are inherently limited in
determining cell number. It is possible for these types of assays to represent similarly a
low number of cells with high activity with a high number of cells with low activity.
One result in the viability assays of note concerns the observation that changes in
metabolic activity in response to SB-3CT were dependant on the density at which cells
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were initially plated. Cells plated at high density for 24 hours have elevated rates of
metabolism compared to cells plated for the same interval at low density (see Figure 3 and
Figure 4 Appendix 7). In cultures plated at low density (2k) for 24 hours and then
supplemented with inhibitor a depression in metabolic rates was evident within 2 hours of
treatment.(Figure 10) A broad interpretation of these results would suggest that they are
consistent in some ways with the presented model that MMP-2 mediated activity is
necessary for focal adhesion maturation. In cells that have reached adhesion equilibrium
the inhibition of protease activity can be expected to impair the ability of the cells to
routinely turn over existing adhesions and express nascent sites. At low density cells are
much more mobile and in contact with the underlying substrate. In this type of culture the
turnover and expression of nascent focal adhesions would be relatively robust.
Interventions that effect adhesion may cause the displacement and loss of cells from this
type of culture. In contrast at high density cells are more stationary and contact with one
another. Under these conditions focal adhesion turnover and contact with the substratum
may be relatively unimportant. Muscle cells express very prominent focal adhesions when
maintained at low cell density and extremely rudimentary focal adhesions when cultured at
very high density 211.
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Figure 20 Schematic of Adhesion Maturation
MMP-2 bound to of α3β1.
During initial adhesion, the native ECM
component fibronectin has available a number of sites for adhesion. For example,
the binding site for the α5β1 is present in the on the surface of this glycoprotein.

A

MMP-2 bound to α3β1 integrin is positioned to
cleave ECM constituents. Proteolysis of fibronectin
exposes additional RGD binding sites that are unavailable
in the native peptide. Additional binding sites increase the number
of potential sites for integrin binding. Moreover, these sites can
be bound by integrin such as α3β1 in addition to the α5β1 thereby increasing not only the
number of binding sites but also the complement of integrin that bind to a unique ECM
protein. Conventional adhesion assays at 30 minutes and 1hour support the maturation of
adhesion during this time interval Proteolytic events may contribute to this maturation
process.

B

Treating cells with a specific protease inhibitor against
MMP-2, blocks this proteolysis and as a consequence
there is a decrease in the strength, maturation of
adhesion. Theoretically, the increase in the number of binding sites
would not occur. Under these circumstances the absolute or
potential number of binding sites in the ECM is reduced and as a
consequence there are fewer sites for attachment. Secondarily, the
complement and number of receptors participating in adhesion are reduced. However,
there are adequate binding sites on the native fibronectin substrate that support equal levels
of initial adhesion and spreading as compared cells plated Taken together these
considerations suggest MMP-2 and potentially the complex of MMP-2 and α3β1 are
involved in the maturation of adhesion in cells plated on fibronectin (and collagen but not
on laminin or poly-l-lysine).

C.

Inhibitor

α3
MMP-2
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α5

β1

Physiological implications. The integrin MMP-2 complex identified in this study
brings together both the receptors that mediate adhesion to the ECM, integrins, with the
main class of enzymes responsible for the proteolysis of ECM components, the MMPs.
Relevant to this discussion is the role of the cardiac fibroblast in development and disease.
This cell type represents the major nexus responsible for the deposition, turnover,
maintenance, and remodeling of the cardiac ECM. In the postnatal period rapid changes in
hemodynamic load are associated with the turnover of existing matrix constituents and the
elaboration of a robust cardiac ECM. A complex composed of MMP-2 and the α3β1
integrin may represent a self-contained mechano-sensitive site that can detect changes in
load while mediating aspects of the proteolytic processing of the local microenvironment
to facilitate cell migration and the shedding of integrins 212
Early in the progression of cardiac hypertrophy the myocardium adapts and
increases performance to meet peripheral demand. However, the onset of changes in the
composition (myocardial compliance) of the ECM parallels the transition to
decompensation and failure of the myocardium174,
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. As in cardiac development, the

deposition of nascent matrix components requires the remodeling or degradation of the
preexisting ECM. Similarly, changes in the hemodynamic load initiate the elaboration and
accumulation of these components.

MMP-2 is expressed in concert, temporally and

spatially during the developmental period171,

172

. Likewise, in the adult changes in

hemodynamic stress trigger a similar sequence of events and are a prelude to remodeling of
the ventricular wall127.

The developmental mechanisms and relationships between

mechanical stretch, the expression of proteases, and elaboration of ECM components are
173

carried over and relevant to the adult. In the adult heart changes in the compliance
(composition) of the ventricular wall and systolic dysfunction can be induced by the overexpression of MMP-2

177

; whereas, deleterious remodeling can be attenuated by

pharmacologically interventions that decrease the levels of this protease178, 179.
Treatment paradigms for hypertension, a complex disease entity of multiple
etiologies, are focused on reducing the mechanical load on the heart. This treatment
strategy delays the progression toward and the transition of compensated heart disease to
decompensated heart disease. If this complex represents a mechanosensitive site for the
detection of mechanical load on the cardiac interstitium and at the same time is a site for
effecting both changes in fibroblast cell adhesion and matrix turnover, interventions
targeting this complex could augment current treatment paradigms. These strategies may
decrease the migration of cardiac fibroblast and attenuate maladaptive changes in the
cardiac interstitium. However, the extent that these in vitro observations carry over into
the in vivo situation is unclear. The complex of MMP-2 and α3β1 integrin represents a site
on the surface of the cultured cardiac fibroblast that combines mechano-sensitive and
proteolytic elements that may mediate substrate specific maturation of adhesion.

174

References

175

References
1. Dard N, Breuer M, Maro B, Louvet-Vallée S. Morphogenesis of the mammalian
blastocyst. Mol Cell Endocrinol. 2008 Jan 30;282(1-2):70-7.
2. Steinberg MS. Differential adhesion in morphogenesis: a modern view. Curr Opin
Genet Dev. 2007 Aug;17(4):281-6.
3. Edelman GM. Cell adhesion molecules in the regulation of animal form and tissue
pattern. Annu Rev Cell Biol. 1986;2:81-116.
4. Lu P, Werb Z.Patterning mechanisms of branched organs. Science. 2008 Dec
5;322(5907):1506-9.
5. De Arcangelis A, Mark M, Kreidberg J, Sorokin L, Georges-Labouesse E
Synergistic activities of alpha3 and alpha6 integrins are required during apical
ectodermal ridge formation and organogenesis in the mouse. Development. 1999
Sep;126(17):3957-68.
6. Legouis R, Hardelin JP, Levilliers J, Claverie JM, Compain S, Wunderle V,
Millasseau P, Le Paslier D, Cohen D, Caterina D, et al. The candidate gene for the
X-linked Kallmann syndrome encodes a protein related to adhesion molecules.
Cell. 1991
Oct 18;67(2):423-35.
7. Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by α4 integrins
are essential in placental and cardiac development. Development. 1995 (121): 549560.
8. Baudino TA, McFadden A, Fix C, Hastings J, Price R, Borg TK. Cell patterning:
interaction of cardiac myocytes and fibroblasts in three-dimensional culture.
Microsc Microanal. 2008 Apr;14(2):117-25.
9. Meng L, Bian Z, Torensma R, Von den Hoff JW. Biological mechanisms in
palatogenesis and cleft palate. J Dent Res. 2009 Jan;88(1):22-33.
10. Shimizu T, Yabe T, Muraoka O, Yonemura S, Aramaki S, Hatta K, Bae YK,
Nojima H, Hibi M. E-cadherin is required for gastrulation cell movements in
zebrafish. Mech Dev. 2005 Jun;122(6):747-63.

176

11. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, Rayburn H, Crowley D, UllmanCulleré M, Ross FP, Coller BS, Teitelbaum S, Hynes RO. Beta3-integrin-deficient
mice are a model for Glanzmann thrombasthenia showing placental defects and
reduced survival. J Clin Invest. 1999 Jan;103(2):229-38.
12. Springer, TA. Adhesion receptors of the immune system. Nature. 1990 Aug 2; 346:
425-434.
13. Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M, Wobus AM. Potential of
embryonic and adult stem cells in vitro. Biol Chem. 2003 Oct-Nov;384(1011):1391-409.
14. Grzesiak JJ, Bouvet M. Activation of the alpha2beta1 integrin-mediated malignant
phenotype on type I collagen in pancreatic cancer cells by shifts in the
concentrations of extracellular Mg2+ and Ca2+.Int J Cancer. 2008 May
15;122(10):2199-209.
15. Watanabe K, Takahashi H, Habu Y, Kamiya-Kubushiro N, Kamiya S, Nakamura
H, Yajima H, Ishii T, Katayama T, Miyazaki K, Fukai F.Interaction with heparin
and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of
fibronectin. Biochemistry. 2000 Jun 20;39(24):7138-44.
16. Harburger DS, Calderwood DA. Integrin signalling at a glance. J Cell Sci. 2009 Jan
15;122(Pt 2):159-63.
17. Telemeco, Todd A.(2004) Regulation of Gelatinases in neonatal cardiac fibroblast:
the interaction between substrate and strain specific signals. Doctoral Thesis,
Virginia Commonwealth University. Richmond, VA
18. Telemeco T, Ellis R, Bowman JR, Bowlin GL and DG Simpson. “Matrix
Metalloproteinases in Bioengineering Interventions”. In Wnek GE, and Bowlin GL,
editors. Encyclopedia of Biomaterials and Biomedical Engineering. New York:
Marcel Dekker. 2004.
19. Shirayoshi Y, Hatta K, Hosoda M, Tsunasawa S, Sakiyama F, Takeichi M.
Cadherin cell adhesion molecules with distinct binding specificities share a
common structure. EMBO J. 1986 Oct;5(10):2485-8.
20. Vaughn DE, Bjorkman PJ.The (Greek) key to structures of neural adhesion
molecules. Neuron. 1996 Feb;16(2):261-73.
21. Lasky LA. Selectins: interpreters of cell-specific carbohydrate information during
inflammation. Science. 6 November 1992: Vol. 258. no. 5084, pp. 964 – 969.
177

22. Rubin K, Gullberg D, Borg TK, Obrink B. Hepatocyte adhesion to collagen.
Isolation of membrane glycoproteins involved in adhesion to collagen. Exp Cell
Res. 1986 May;164(1):127-38.
23. Takeichi, M. The cadherins: cell-cell adhesion molecules controlling animal
morphogenesis. Development. 1988(102) 639-655.
24. Yagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization,
and neurologic diversity. Genes Dev. 2000 May 15;14(10):1169-80.
25. Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M, Nagai Y.p60v-src
causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell
adhesion system.EMBO J. 1993 Jan;12(1):307-14.
26. McCrea PD, Brieher WM, Gumbiner BM. Induction of a secondary body axis in
Xenopus by antibodies to beta-catenin.J Cell Biol. 1993 Oct;123(2):477-84.
27. Nakagawa S, Takeichi M. Neural crest cell-cell adhesion controlled by sequential
and subpopulation-specific expression of novel cadherins.Development. 1995
May;121(5):1321-32.
28. Yokoyama H, Tamura K, Ide H. Anteroposterior axis formation in Xenopus limb
bud recombinants: a model of pattern formation during limb regeneration.
Developmental Dynamics. 2002(255) 277-288.
29. Yajima H, Yonei-Tamura S, Watanabe N, Tamura K, Ide H. Role of N-Cadherin in
the sorting-out of mesenchymal cells and in the positional identity along the
proximodistal axis of the chick limb bud. Developmental Dynamics. 1999( 216)
274-284
30. Knudsen KA, Myers L, McElwee SA.A role for the Ca2(+)-dependent adhesion
molecule, N-cadherin, in myoblast interaction during myogenesis. Exp Cell Res.
1990 Jun;188(2):175-84.
31. Letourneau PC, Roche FK, Shattuck TA, Lemmon V, Takeichi M. Interactions of
Schwann cells with neurites and with other Schwann cells involve the calciumdependent adhesion molecule, N-cadherin. J Neurobiol. 1991 Oct;22(7):707-20.
32. Müller EJ, Williamson L, Kolly C, Suter MM. Outside-in signaling through
integrins and cadherins: a central mechanism to control epidermal growth and
differentiation? J Invest Dermatol. 2008 Mar;128(3):501-16.

178

33. Cunningham BA, Hemperly JJ, Murray BA, Prediger EA, Brackenbury R, Edelman
GM.Neural cell adhesion molecule: structure, immunoglobulin-like domains, cell
surface modulation, and alternative RNA splicing. Science. 1987 May
15;236(4803):799-806.
34. Schmid RS, Maness PF.L1 and NCAM adhesion molecules as signaling
coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol.
2008 Jun;18(3):245-50.
35. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME and Springer TA. The
integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biology.
1995. March, 1. Vol 128, 1243-1253.
36. Takai Y, Ikeda W, Ogita H, Rikitake Y. The immunoglobulin-like cell adhesion
molecule nectin and its associated protein afadin. Annu.Rev.Cell Dev Bio. 2008.
(24): 309-342.
37. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B.Endothelial leukocyte
adhesion molecule 1: an inducible receptor for neutrophils related to complement
regulatory proteins and lectins. Science. 1989 Mar 3;243(4895):1160-5.
38. Springer TA, Lasky LA.Cell adhesion. Sticky sugars for selectins. Nature. 1991 Jan
17;349(6306):196-7.
39. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow
rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991
May 31;65(5):859-73.
40. Alon R, Ley K.Cells on the run: shear-regulated integrin activation in leukocyte
rolling and arrest on endothelial cells. Curr Opin Cell Biol. 2008 Oct;20(5):525-32.
41. Carver W, Price RL, Raso DS, Terracio L, Borg TK. Distribution of β-1 Integrin in
the developing rat heart. J Histochem Cytochem 1994 42:167-175.
42. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin
receptor function with monoclonal antibodies: roles in cell adhesion, migration,
matrix assembly, and cytoskeletal organization. J Cell Biol. 1989 Aug;109(2):86375.
43. Montgomery AM, Reisfeld RA, Cheresh DA. Integrin alpha v beta 3 rescues
melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl
Acad Sci U S A. 1994 Sep 13;91(19):8856-60.

179

44. Simpson, DG. Integrins. In Wnek GE, and Bowlin GL, editors. Encyclopedia of
Biomaterials and Biomedical Engineering. New York: Marcel Dekker. (2005).
45. Tadokoro S, Shattil SJ, Eto K, Tai V, Liddington RC, de Pereda JM, Ginsberg MH,
Calderwood DA. Talin binding to integrin beta tails: a final common step in
integrin activation. Science. 2003 Oct 3;302(5642):103-6.
46. Moser M, Nieswant B, Ussar S, Pozgajova M, Fassler R. Kindlin-3 is essential for
integrin activation and platelet aggregation. Nature Medicine. 2008 Mar;
14(3):325-330.
47. Mulrooney J, Foley K, Vineberg S, Barreuther M, Grabel L. Phosphorylation of
the beta1 integrin cytoplasmic domain: toward an understanding of function and
mechanism. Exp Cell Res. 2000 Aug 1;258(2):332-41.
48. Briesewitz R, Kern A, Marcantonio EE.Assembly and function of integrin
receptors is dependent on opposing alpha and beta cytoplasmic domains. Mol Biol
Cell. 1995 Aug;6(8):997-1010.
49. Litvinov RI, Vilaire G, Li W, DeGrado WF, Weisel JW, Bennett JS Activation of
individual alphaIIbbeta3 integrin molecules by disruption of transmembrane
domain interactions in the absence of clustering. Biochemistry. 2006 Apr
18;45(15):4957-64.
50. Humphies MJ. Integrin structure. Biochemical Society Transactions. 2000 (28:4)
311-339.
51. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL, Arnaout MA.
Extracellular segment of integrin αvβ3 in complex with an arg-gly-asp ligand.
Science. 2002 Apr 5 (296); 151-155.
52. Takagi J, Petre BM, Walz T, Springer TA.Global conformational rearrangements in
integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002 Sep
6;110(5):599-11.
53. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and
signaling. Annu Rev Immunol. 2007;25:619-47.
54. Olsen IM, Ffrench-Constant C.Dynamic regulation of integrin activation by
intracellular and extracellular signals controls oligodendrocyte morphology. BMC
Biol. 2005 Nov 12;3:25.

180

55. Goksoy E, Ma YQ, Wang X, Kong X, Perera D, Plow EF, Qin J Structural basis for
the autoinhibition of talin in regulating integrin activation. Mol Cell. 2008 Jul
11;31(1):124-33.
56. Lee HS, Lim CJ, Puzon-McLaughlin W, Shattil SJ, Ginsberg MH. RIAM activates
integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol
Chem. 2009 Feb 20;284(8):5119-27.
57. Critchley DR. Smurf1 zaps the talin head. Nat Cell Biol. 2009 May;11(5):538-40.
58. del Rio A, Perez-Jimenez R, Liu R, Roca-Cusachs P, Fernandez JM, Sheetz MP.
Stretching Single Talin Rod Molecules Activates Vinculin Binding. Science. 30
January 2009: 638-641.
59. Kanekar S, Hirozanne T, Terracio L, Borg TK. Cardiac fibroblast: form and
function. Cardiovascular Pathology. 6 May 1998; 7(3): 127-133.
60. Burgess ML, Terracio L, Hirozane T, Borg TK. Differential integrin expression by
cardiac fibroblasts from hypertensive and exercise-trained rat hearts. Cardiovasc
Pathol. 2002 Mar-Apr;11(2):78-87.
61. Gullberg D, Terracio L, Borg TK, Rubin K.Identification of integrin-like matrix
receptors with affinity for interstitial collagens. J Biol Chem. 1989 Jul
25;264(21):12686-94.
62. Tomaselli KJ, Damsky CH, Reichardt LF.Purification and characterization of
mammalian integrins expressed by a rat neuronal cell line (PC12): evidence that
they function as alpha/beta heterodimeric receptors for laminin and type IV
collagen.J Cell Biol. 1988 Sep;107(3):1241-52.
63. Languino LR, Gehlsen KR, Wayner E, Carter WG, Engvall E, Ruoslahti E.
Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J Cell Biol.
1989 Nov;109(5):2455-62.
64. Gullberg D, Gehlsen KR, Turner DC, Ahlén K, Zijenah LS, Barnes MJ, Rubin
K.Analysis of alpha 1 beta 1, alpha 2 beta 1 and alpha 3 beta 1 integrins in cell-collagen interactions: identification of conformation dependent alpha 1 beta 1
binding sites in collagen type I.EMBO J. 1992 Nov;11(11):3865-73.
65. Calderwood DA, Tuckwell DS, Eble J, Kühn K, Humphries MJ.The integrin
alpha1 A-domain is a ligand binding site for collagens and laminin.J Biol Chem.
1997 May 9;272(19):12311-7.

181

66. Reyes CD, Garcia AJ. Engineering integrin specific surfaces with a triple-helical
collagen mimetic peptide. Journal of biomedical materials research. 2003, May 13
(65:4) 511-523.
67. Herr AB, Farndale RW.Structural insights into the interactions between platelet
receptors and fibrillar collagen. J Biol Chem. 2009 Apr 28.
68. Knight CG, Morton LF, Onley DJ, Peachey AR, Messent AJ, Smethurst PA,
Tuckwell DS, Farndale RW, Barnes MJ.Identification in collagen type I of an
integrin alpha2 beta1-binding site containing an essential GER sequence.J Biol
Chem. 1998 Dec 11;273(50):33287-94.
69. Forsberg E, Paulsson M, Timpl R, Johansson S. Characterization of a laminin
receptor on rat hepatocytes. J Biol Chem. 1990 Apr 15;265(11):6376-81.
70. Tulla M, Lahti M, Puranen JS, Brandt AM, Käpylä J, Domogatskaya A, Salminen
TA, Tryggvason K, Johnson MS, Heino J. Effects of conformational activation of
Integrin alpha 1I and alpha 2I domains on selective recognition of laminin and
collagen subtypes. Exp Cell Res. 2008 May 1;314(8):1734-43.
71. Elices MJ, Urry LA, Hemler ME. Receptor functions for the integrin VLA-3:
fibronectin, collagen, and laminin binding are differentially influenced by Arg-GlyAsp peptide and by divalent cations. J Cell Biol. 1991 Jan;112(1):169-81.
72. Wu C, Chung AE, McDonald JA. A novel role for alpha 3 beta 1 integrins in
extracellular matrix assembly J Cell Sci. 1995 Jun;108 ( Pt 6):2511-23.
73. Di Persio CM, Shah S, Hynes RO. Alpha 3A beta 1 integrin localizes to focal
contacts in response to diverse extracellular matrix proteins. J Cell Sci.1995 108 (
Pt 6):2321-36.
74. Conforti G, Zanetti A, Colella S, Abbadini M, Marchisio PC, Pytela R, Giancotti F,
Tarone G, Languino LR, Dejana E.Interaction of fibronectin with cultured human
endothelial cells: characterization of the specific receptor Blood. 1989 May
1;73(6):1576-85.
75. Wu C, Bauer JS, Juliano RL and McDonald JA The alpha 5 beta 1 integrin
fibronectin receptor, but not the alpha 5 cytoplasmic domain, functions in an early
and essential step in fibronectin matrix assembly J. Biol. Chem., Vol. 268, Issue 29,
21883-21888, Oct, 1993

182

76. Zhong C, Chrzanowska-Wodnicka M, Brown J, Shaub A, Belkin AM, Burridge K.
Rho-mediated contractility exposes a cryptic site in fibronectin and induces
fibronectin matrix assembly.J Cell Biol. 1998 Apr 20;141(2):539-51.
77. Sekiguchi K, Hakomori S. Functional domain structure of fibronectin. Proc Natl
Acad Sci U S A. 1980 May;77(5):2661-5.
78. Smith ML, Gourdon D, Little WC, Kubow KE, Eguiluz RA, Luna-Morris S, Vogel
V. Force-induced unfolding of fibronectin in the extracellular matrix of living
cells. PLoS Biol. 2007 Oct 2;5(10):e268.
79. Fukai F, Ohtaki M, Fujii N, Yajima H, Ishii T, Nishizawa Y, Miyazaki K,
Katayama T. Release of biological activities from quiescent fibronectin by a
conformational change and limited proteolysis by matrix metalloproteinases.
Biochemistry. 1995 Sep 12;34(36):11453-9.
80. Nobes CD, Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of
multimolecular focal complexes associated with actin stress fibers, lamellipodia,
and filopodia. Cell. 7;81(1):53-62. (1995).
81. Lotz MM, Burdsal CA, Erickson HP, McClay DR. Cell adhesion to fibronectin and
tenascin: quantitative measurements of initial binding and subsequent strengthening
response. J Cell Biol. 109(4 Pt 1):1795-805 (1989).
82. Dejana E, Colella S, Conforti G, Abbadini M, Gaboli M, Marchisio PC.
Fibronectin and vitronectin regulate the organization of their respective Arg-GlyAsp adhesion receptors in cultured human endothelial cells. J Cell Biol. 1988
Sep;107(3):1215-23.
83. Cairo CW, Mirchev R, Golan DE. Cytoskeletal regulation couples LFA-1
conformational changes to receptor lateral mobility and clustering. Immunity. 2006
Aug;25(2):297-308
84. Machesky LM, Hall A. LiRole of actin polymerization and adhesion to
extracellular matrix in Rac- and Rho-induced cytoskeletal reorganization. J Cell
Biol. 1997 Aug 25;138(4):913-26.
85. Riveline D, Zamir E, Balaban NQ, Schwarz US, Ishizaki T, Narumiya S, Kam Z,
Geiger B, Bershadsky AD. Focal contacts as mechanosensors: externally applied
local mechanical force induces growth of focal contacts by an mDia1-dependent
and ROCK-independent mechanism. J Cell Biol. 153(6):1175-86. (2001).

183

86. Balaban NQ, Schwarz US, Riveline D, Goichberg P, Tzur G, Sabanay I, Mahalu D,
Safran S, Bershadsky A, Addadi L, Geiger B. Force and focal adhesion assembly: a
close relationship studied using elastic micropatterned substrates. Nat Cell Biol.
2001 May;3(5):466-72.
87. Kawakami K, Tatsumi H, Sokabe M. Dynamics of integrin clustering at focal
contacts of endothelial cells studied by multimode imaging microscopy.J Cell Sci.
2001 Sep;114(Pt 17):3125-35.
88. Geiger B. The association of rhodamine - labelled alpha-actinin with actin bundles
in demembranated cells.Cell Biol Int Rep. 1981 Jun;5(6):627-34.
89. Hilenski LL, Terracio L, Borg TK.Myofibrillar and cytoskeletal assembly in
neonatal rat cardiac myocytes cultured on laminin and collagen. Cell Tissue Res.
1991 Jun;264(3):577-87.
90. Li F, Zhang Y, Wu C. Integrin-linked kinase is localized to cell-matrix focal
adhesions but not cell-cell adhesion sites and the focal adhesion localization of
integrin-linked kinase is regulated by the PINCH-binding ANK repeats. J Cell Sci.
1999 Dec;112 ( Pt 24):4589-99.
91. Shen Y, Schaller MD. Focal adhesion targeting: the critical determinant of FAK
regulation and substrate phosphorylation. Mol Biol Cell. 1999 Aug;10(8):2507-18.
92. Sun Z, Martinez-Lemus LA, Trache A, Trzeciakowski JP, Davis GE, Pohl U,
Meininger GA.Mechanical properties of the interaction between fibronectin and
alpha5beta1-integrin on vascular smooth muscle cells studied using atomic force
microscopy. Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2526-35.
93. Nobes CD, Hall A.Rho GTPases control polarity, protrusion, and adhesion during
cell movement. J Cell Biol. 1999 Mar 22;144(6):1235-44.
94. Chrzanowska-Wodnicka M, Burridge K.Rho-stimulated contractility drives the
formation of stress fibers and focal adhesions. J Cell Biol. 1996 Jun;133(6):140315.
95. Leung T, Chen XQ, Manser E and Lim L. The p160 RhoA-binding kinase ROK
alpha is a member of a kinase family and is involved in the reorganization of the
cytoskeleton Mol. Cell. Biol., Oct 1996, 5313-5327, Vol 16, No. 10
96. Chen W.-T., Mechanism of retraction of the trailing edge during fibroblast
movement. J. Cell Biol. 90 (1981), pp. 187–200.

184

97. Ezratty EJ, Partridge MA, Gundersen GG.Microtubule-induced focal adhesion
disassembly is mediated by dynamin and focal adhesion kinase. Nat Cell Biol.
2005 Jun;7(6):581-90.
98. Bretscher MS. Endocytosis and recycling of the fibronectin receptor in CHO cells.
EMBO J. 1989 May;8(5):1341-8.
99. Geiger B, Bershadsky A.Assembly and mechanosensory function of focal
contacts.Curr Opin Cell Biol. 2001 Oct;13(5):584-92.
100. Chao WT, Kunz J. Focal adhesion disassembly requires clathrin-dependent
endocytosis of integrins. FEBS Lett. 2009 Apr 17;583(8):1337-43.
101. Burridge K, Chrzanowska-Wodnicka M. Focal adhesions, contractility, and
signaling. Annu Rev Cell Dev Biol. 1996;12:463-518.
102. Fox MA, Colello RJ, Macklin WB, Fuss B.Phosphodiesterase-Ialpha/autotaxin: a
counteradhesive protein expressed by oligodendrocytes during onset of
myelination.Mol Cell Neurosci. 2003 Jul;23(3):507-19.
103. Ylänne J, Chen Y, O'Toole TE, Loftus JC, Takada Y, Ginsberg MH.
Distinct functions of integrin alpha and beta subunit cytoplasmic domains
in cell spreading and formation of focal adhesions. J Cell Biol. 1993
Jul;122(1):223-33.
104. Noiri E, Gailit J, Sheth D, Magazine H, Gurrath M, Muller G, Kessler H,
Goligorsky MS. Cyclic RGD peptides ameliorate ischemic acute renal failure in
rats.Kidney Int. 1994 Oct;46(4):1050-8.
105. MacKenna DA, Dolfi F, Vuori K, Ruoslahti E. Extracellular signal-regulated
kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrindependent and matrix-specific in rat cardiac fibroblasts. J Clin Invest. 1998 Jan
15;101(2):301-10.
106. Wegener J, Kesse CR, Giaever I. Electric Cell–Substrate Impedance Sensing
(ECIS) as a Noninvasive Means to Monitor the Kinetics of Cell Spreading to
Artificial Surfaces. Experimental Cell Research. Volume 259, Issue 1, 25 August
2000, Pages 158-166
107. Sharma KV, Koenigsberger C, Brimijoin S, Bigbee JW.Direct evidence for an
adhesive function in the noncholinergic role of acetylcholinesterase in neurite
outgrowth.J Neurosci Res. 2001 Jan 15;63(2):165-75.

185

108. Lehenkari PP, Horton MA. Single integrin molecule adhesion forces in intact cells
measured by atomic force microscopy.Biochem Biophys Res Commun. 1999 Jun
16;259(3):645-50.
109. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and
through the cytoskeleton. Science. 1993 May 21;260(5111):1124-7.
110. Hilenski LL, Ma XH, Vinson N, Terracio L, Borg TK. The role of beta 1 integrin in
spreading and myofibrillogenesis in neonatal rat cardiomyocytes in vitro. Cell
Motil Cytoskeleton. 1992;21(2):87-100.
111. Bell PB Jr, Lindroth M, Fredriksson BA.Use of sputter coating to prepare whole
mounts of cytoskeletons for transmission and high-resolution scanning and
scanning transmission electron microscopy. J Electron Microsc Tech. 1987
Nov;7(3):149- 59.
112. Hilenski LL, Terracio L, Sawyer R, Borg TK.Effects of extracellular matrix on
cytoskeletal and myofibrillar organization in vitro. Scanning Microsc. 1989
Jun;3(2):535-48.
113. Sharp WW, Simpson DG, Borg TK, Samarel AM, Terracio L. Mechanical forces
regulate focal adhesion and costamere assembly in cardiac myocytes. Am J
Physiol. 1997 Aug;273(2 Pt 2):H546-56.
114. Mallavarapu A, Mitchison T. Regulated actin cytoskeleton assembly at filopodium
tips controls their extension and retraction. J Cell Biol. 1999 Sep 6;146(5):1097106.
115. Vikstrom KL, Lim SS, Goldman RD, Borisy GG.Steady state dynamics of
intermediate filament networks. J Cell Biol. 1992 Jul;118(1):121-9.
116. Booz GW, Baker KMMolecular signalling mechanisms controlling growth and
function of cardiac fibroblasts.Cardiovasc Res. 1995 Oct;30(4):537-43.
117. Husse B, Briest W, Homagk L, Isenberg G, Gekle M Cyclical mechanical stretch
modulates expression of collagen I and collagen III by PKC and tyrosine kinase in
cardiac fibroblasts.Am J Physiol Regul Integr Comp Physiol. 2007
Nov;293(5):R1898-907.
118. Sadoshima J, Izumo S.The cellular and molecular response of cardiac myocytes to
mechanical stress.Annu Rev Physiol. 1997;59:551-71.

186

119. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks
PC. Proteolytic exposure of a cryptic site within collagen type IV is required for
angiogenesis and tumor growth in vivo. J Cell Biol. 2001 Sep 3;154(5):1069-79.
120. Cook H, Davies KJ, Harding KG, Thomas DW. Defective extracellular matrix
reorganization by chronic wound fibroblasts is associated with alterations in TIMP1, TIMP-2, and MMP-2 activity. J Invest Dermatol. 2000 Aug;115(2):225-33.
121. Davis GE. Affinity of integrins for damaged extracellular matrix: alpha v beta 3
binds to denatured collagen type I through RGD sites. Biochem Biophys Res
Commun. 1992 Feb 14;182(3):1025-31.
122. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC.The
activity of collagenase-1 is required for keratinocyte migration on a type I collagen
matrix. J Cell Biol. 1997 Jun 16;137(6):1445-57.
123. Sakakura Y, Hosokawa Y, Tsuruga E, Irie K, Yajima T. In situ localization of
gelatinolytic activity during development and resorption of Meckel's cartilage in
mice. Eur J Oral Sci. 2007 Jun;115(3):212-23.
124. VanSaun MN, Matrisian LM. Matrix metalloproteinases and cellular motility in
development and disease. Birth Defects Res C Embryo Today. 2006 Mar;78(1):6979.
125. Van Wart H E and Birkedal-Hansen H. The cysteine switch: a principle of
regulation of metalloproteinase activity with potential applicability to the entire
matrix metalloproteinase gene family. Proc Natl Acad Sci U S A. 1990 July;
87(14): 5578–5582.
126. Ratajska A, Cleutjens JP. Embryogenesis of the rat heart: the expression of
collagenases. Basic Res Cardiol. 2002 May;97(3):189-97.
127. Spinale FG, Coker ML, Thomas CV, Walker JD, Mukherjee R, Hebbar L.Timedependent changes in matrix metalloproteinase activity and expression during the
progression of congestive heart failure: relation to ventricular and myocyte
function. Circ Res. 1998 Mar 9;82(4):482-95.
128. Nakagawa M, Terracio L, Carver W, Birkedal-Hansen H, Borg TK. Expression of
collagenase and IL-1 alpha in developing rat hearts. Dev Dyn. 1992 Oct;195(2):8799

187

129. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G. Binding
of gelatinases A and B to type-I collagen and other matrix components. Biochem J.
1995 Jul 1;309 ( Pt 1):299-306.
130. Aimes R.T., Quigley J.P. Matrix metalloproteinase-2 is an interstitial collagenase.
Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native
type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem
(1995) 270:5872–5876
131. Patterson M.L., Atkinson S.J., Knäuper V., Murphy G. Specific collagenolysis by
gelatinase A, MMP-2, is determined by the hemopexin domain and not the
fibronectin-like domain. FEBS Lett (2001) 503:158–162.
132. Xu X, Chen Z, Wang Y, Yamada Y, Steffensen B. Functional basis for the overlap
in ligand interactions and substrate specificities of matrix metalloproteinases-9 and
-2. Biochem J. 2005 Nov 15;392(Pt 1):127-34.
133. Wysocki AB, Staiano-Coico L, Grinnell F. Wound fluid from chronic leg ulcers
contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest
Dermatol. 1993 Jul;101(1):64-8.
134. Xu X, Wang Y, Chen Z, Sternlicht MD, Hidalgo M, Steffensen B.Matrix
metalloproteinase-2 contributes to cancer cell migration on collagen. Cancer Res.
2005 Jan 1;65(1):130-6.
135. Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, Ning L, Fang Z, Wang Y, Zhang L,
Cheng J, Zhang W, Hao X. Differentially expressed genes between primary cancer
and paired lymph node metastases predict clinical outcome of node-positive breast
cancer patients.Breast Cancer Res Treat. 2007 Jul;103(3):319-29.
136. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg
GI.Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation
of the activated form of the membrane metalloprotease. J Biol Chem. 1995 Mar
10;270(10):5331-8.
137. Stanton H, Gavrilovic J, Atkinson SJ, d'Ortho MP, Yamada KM, Zardi L, Murphy
G. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is
promoted by culture on a fibronectin substrate and is concomitant with an increase
in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci. 1998 Sep;111
( Pt 18):2789-98.
138. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G,
Nagase H.Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts.
188

Purification and activation of the precursor and enzymic properties. Eur J Biochem.
1990 Dec 27;194(3):721-30.
139. Crabbe T, Ioannou C, Docherty AJ. Human progelatinase A can be activated by
autolysis at a rate that is concentration-dependent and enhanced by heparin bound
to the C-terminal domain.Eur J Biochem. 1993 Dec 1;218(2):431-8.
140. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley
JP. Activation of matrix metalloproteinase-9 (MMP-9) via a converging
plasmin/stromelysin-1 cascade enhances tumor cell invasion.J Biol Chem. 1999
May 7;274(19):13066-76.
141. Parks WC and Mecham, eds. Matrix Metalloprotienases. NewYork: Academic
Press, 1998.
142. Balachandran K, Sucosky P, Jo H, Yoganathan AP.Elevated cyclic stretch alters
matrix remodeling in aortic valve cusps: implications for degenerative aortic valve
disease. Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H756-64.
143. Olson MW, Gervasi DC, Mobashery S, Fridman R. Kinetic analysis of the binding
of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase
(TIMP)-1 and TIMP-2. J Biol Chem. 1997 Nov 21;272(47):29975-83.
144. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa
gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem. 1991 Jul
15;266(20):13070-5.
145. Ogata Y, Itoh Y, Nagase H. Steps involved in activation of the pro-matrix
metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1
complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem. 1995
Aug 4;270(31):18506-11.
146. Baramova EN, Bajou K, Remacle A, L'Hoir C, Krell HW, Weidle UH, Noel A,
Foidart JM. Involvement of PA/plasmin system in the processing of pro-MMP-9
and in the second step of pro-MMP-2 activation.FEBS Lett. 1997 Mar
24;405(2):157-62.
147. Ogata Y, Enghild JJ, Nagase H.Matrix metalloproteinase 3 (stromelysin) activates
the precursor for the human matrix metalloproteinase 9.J Biol Chem. 1992 Feb
25;267(6):3581-4.
148. Hahn-Dantona E, Ramos-DeSimone N, Sipley J, Nagase H, French DL, Quigley
JP. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model.
189

Regulation by tissue inhibitors of metalloproteinases. Ann N Y Acad Sci. 1999 Jun
30;878:372-87.
149. Hsieh YS, Yang SF, Lue KH, Chu SC, Lu KH. Effects of different molecular
weight hyaluronan products on the expression of urokinase plasminogen activator
and inhibitor and gelatinases during the early stage of osteoarthritis. J Orthop Res.
2008 Apr;26(4):475-84.
150. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada
Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial
fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis.
2000 Jun;59(6):455-61.
151. Buisson-Legendre N, Smith S, March L, Jackson C. Elevation of activated protein
C in synovial joints in rheumatoid arthritis and its correlation with matrix
metalloproteinase 2. Arthritis Rheum. 2004 Jul;50(7):2151-6.
152. Jackson MT, Smith MM, Smith SM, Jackson CJ, Xue M, Little CB. Activation of
cartilage matrix metalloproteinases by activated protein C. Arthritis Rheum. 2009
Mar;60(3):780-91.
153. Miller MC, Manning HB, Jain A, Troeberg L, Dudhia J, Essex D, Sandison A,
Seiki M, Nanchahal J, Nagase H, Itoh Y.Membrane type 1 matrix
metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid
arthritis. Arthritis Rheum. 2009 Mar;60(3):686-97.
154. Zeng ZS, Cohen AM, Guillem JG.Loss of basement membrane type IV collagen is
associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and
MMP-9) during human colorectal tumorigenesis.Carcinogenesis. 1999
May;20(5):749-55.
155. Kenny HA, Kaur S, Coussens LM, Lengyel E.The initial steps of ovarian cancer
cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J
Clin Invest. 2008 Apr;118(4):1367-79.
156. Sholley MM, Gimbrone MA Jr, Cotran RS.Cellular migration and replication in
endothelial regeneration: a study using irradiated endothelial cultures.Lab Invest.
1977 Jan;36(1):18-25.
157. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi
R. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular
endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for
ascites formation. Cancer Res. 2003 Sep 1;63(17):5224-9.
190

158. Kamat AA, Fletcher M, Gruman LM, Mueller P, Lopez A, Landen CN Jr, Han L,
Gershenson DM, Sood AK.The clinical relevance of stromal matrix
metalloproteinase expression in ovarian cancer. Clin Cancer Res. 2006 Mar
15;12(6):1707-14.
159. Morgia G, Falsaperla M, Malaponte G, Madonia M, Indelicato M, Travali S,
Mazzarino MC. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic
(MMP-2, MMP-9) markers of prostate cancer. Urol Res. 2005 Feb;33(1):44-50.
160. Kunishio K, Okada M, Matsumoto Y, Nagao S.Matrix metalloproteinase-2 and -9
expression in astrocytic tumors. Brain Tumor Pathol. 2003;20(2):39-45.
161. Zhang K, Li C, Liu Y, Li L, Ma X, Meng X, Feng D.Evaluation of invasiveness of
astrocytoma using 1H-magnetic resonance spectroscopy: correlation with
expression of matrix metalloproteinase-2. Neuroradiology. 2007 Nov;49(11):913919.
162. Lossos IS, Morgensztern D. Prognostic biomarkers in diffuse large B-cell
lymphoma. J Clin Oncol. 2006 Feb 20;24(6):995-1007.
163. Redondo-Muñoz J, Escobar-Díaz E, Samaniego R, Terol MJ, García-Marco JA,
García-Pardo A. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by
alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways,
,localizes to podosomes, and is involved in cell invasion and migration. Blood.
2006 Nov 1;108(9):3143-51.
164. Buommino E, Baroni A, Canozo N, Petrazzuolo M, Nicoletti R, Vozza A, Tufano
MA. Artemisinin reduces human melanoma cell migration by down-regulating
alphaVbeta3 integrin and reducing metalloproteinase 2 production. Invest New
Drugs. 2008 Oct 28.
165. Kurschat P, Zigrino P, Nischt R, Breitkopf K, Steurer P, Klein CE, Krieg T, Mauch
C.Tissue inhibitor of matrix metalloproteinase-2 regulates matrix
metalloproteinase-2 activation by modulation of membrane-type 1 matrix
metalloproteinase activity in high and low invasive melanoma cell lines. J Biol
Chem. 1999 Jul 23;274(30):21056-62.
166. Buckingham M, Meilhac S, Zaffran S. Building the mammalian heart from two
sources of myocardial cells. Nat Rev Genet. 2005 Nov;6(11):826-35.

191

167. Nakamura A, Manasek FJ.An experimental study of the relation of cardiac jelly to
the shape of the early chick embryonic heart. J Embryol Exp Morphol. 1981
Oct;65:235-56.
168. Simpson DG, Sharp WW, Borg TK, Price RL, Samarel AM, Terracio L.
Mechanical regulation of cardiac myofibrillar structure. Ann N Y Acad Sci. 1995
Mar 27;752:131-40.
169. Price RL, Chintanowonges C, Shiraishi I, Borg TK, Terracio L.Local and regional
variations in myofibrillar patterns in looping rat hearts.Anat Rec. 1996
May;245(1):83-93.
170. Linask KK, Han M, Cai DH, Brauer PR, Maisastry SM. Cardiac morphogenesis:
matrix metalloproteinase coordination of cellular mechanisms underlying heart
tube formation and directionality of looping. Dev Dyn. 2005 Jul;233(3):739-53.
171. Alexander SM, Jackson KJ, Bushnell KM, McGuire PG. Spatial and temporal
expression of the 72-kDa type IV collagenase (MMP-2) correlates with
development and differentiation of valves in the embryonic avian heart. Dev Dyn.
1997 Jul;209(3):261-8.
172. Cai DH, Brauer PR. Synthetic matrix metalloproteinase inhibitor decreases early
cardiac neural crest migration in chicken embryos. Dev Dyn. 2002
Aug;224(4):441-9.
173. Weber KT, Sun Y, Guarda E. Structural remodeling in hypertensive heart disease
and the role of hormones. Hypertension. 1994 Jun;23(6 Pt 2):869-77.
174. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol. 2000
Jul;15(4):264-72.
175. Pearlman ES, Weber KT, Janicki JS, Pietra GG, Fishman AP.Muscle fiber
orientation and connective tissue content in the hypertrophied human heart. Lab
Invest. 1982 Feb;46(2):158-64.
176. Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM,
Coker ML, Etoh T, Spinale FG. Matrix metalloproteinase inhibition attenuates left
ventricular remodeling and dysfunction in a rat model of progressive heart failure.
Circulation. 2001 May 8;103(18):2303-9.
177. Bergman MR, Teerlink JR, Mahimkar R, Li L, Zhu BQ, Nguyen A, Dahi S,
Karliner JS, Lovett DH. Cardiac matrix metalloproteinase-2 expression

192

independently induces marked ventricular remodeling and systolic dysfunction. Am
J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1847-60.
178. Seeland U, Kouchi I, Zolk O, Itter G, Linz W, Böhm M. Effect of ramipril and
furosemide treatment on interstitial remodeling in post-infarction heart failure rat
hearts. J Mol Cell Cardiol. 2002 Feb;34(2):151-63.
179. Brower GL, Levick SP, Janicki JS. Inhibition of matrix metalloproteinase activity
by ACE inhibitors prevents left ventricular remodeling in a rat model of heart
failure. Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3057-64.
180. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH,
McClure CD, Spinale FG, Zile MR. Matrix metalloproteinases/tissue inhibitors of
metalloproteinases: relationship between changes in proteolytic determinants of
matrix composition and structural, functional, and clinical manifestations of
hypertensive heart disease. Circulation. 2006 May 2;113(17):2089-96.
181. Usui ML, Mansbridge JN, Carter WG, Fujita M, Olerud JE. Keratinocyte
migration, proliferation, and differentiation in chronic ulcers from patients with
diabetes and normal wounds. J Histochem Cytochem. 2008 Jul;56(7):687-96.
182. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG.
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2
in chronic wounds. J Clin Invest. 1994 Jul;94(1):79-88.
183. Grzesiak JJ, Pierschbacher MD. Changes in the concentrations of extracellular
Mg++ and Ca++ down-regulate E-cadherin and up-regulate alpha 2 beta 1 integrin
function, activating keratinocyte migration on type I collagen. J Invest Dermatol.
1995 May;104(5):768-74.
184. Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, Santoro
SA, Parks WC. Pro-collagenase-1 (matrix metalloproteinase-1) binds the
alpha(2)beta(1) integrin upon release from keratinocytes migrating on type I
collagen. J Biol Chem. 2001 Aug 3;276(31):29368-74.
185. Stricker TP, Dumin JA, Dickeson SK, Chung L, Nagase H, Parks WC, Santoro SA.
Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix
metalloproteinase-1) interaction. Biol Chem. 3;276(31):29375-81. (2001).
186. Brooks PC, Strömblad S, Sanders LC, von Schalscha TL, Aimes RT, StetlerStevenson WG, Quigley JP, Cheresh DA. Localization of matrix metalloproteinase
MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.
Cell. 1996 May 31;85(5):683-93.
193

187. Steffensen B, Bigg HF, Overall CM. The involvement of the fibronectin type IIlike modules of human gelatinase A in cell surface localization and activation. J
Biol Chem. 1998 Aug 7;273(32):20622-8.
188. Stefanidakis M, Koivunen E.Cell-surface association between matrix
metalloproteinases and integrins: role of the complexes in leukocyte migration and
cancer progression. Blood. 2006 Sep 1;108(5):1441-50.
189. Scragg MA, Ferreira LR.Evaluation of different staining procedures for the
quantification of fibroblasts cultured in 96-well plates. Anal Biochem. 1991
Oct;198(1):80-5.
190. Reyes CD and García AJ. A centrifugation cell adhesion assay for high-throughput
screening of biomaterial surfaces. J Biomed Mater Res A. 1;67(1):328-33 (2003).

191. Mirastschijski U, Haaksma CJ, Tomasek JJ, Agren MS.Matrix metalloproteinase
inhibitor GM 6001 attenuates keratinocyte migration, contraction and
myofibroblast formation in skin wounds. Exp Cell Res. 2004 Oct 1;299(2):46575.
192. Almholt K, Juncker-Jensen A, Laerum OD, Danø K, Johnsen M, Lund LR, Rømer
J.Metastasis is strongly reduced by the matrix metalloproteinase inhibitor
Galardin in the MMTV-PymT transgenic breast cancer model. Mol Cancer Ther.
2008 Sep;7(9):2758-67.
193. DiMicco MA, Patwari P, Siparsky PN, Kumar S, Pratta MA, Lark MW, Kim YJ,
Grodzinsky AJ. Mechanisms and kinetics of glycosaminoglycan release following
in vitro cartilage injury. Arthritis Rheum. 2004 Mar;50(3):840-8.
194. Toth M, Sohail A, Mobashery S, Fridman R. MT1-MMP shedding involves an
ADAM and is independent of its localization in lipid rafts. Biochem Biophys Res
Commun. 2006 Nov 17;350(2):377-84.
195. Krüger A, Arlt MJ, Gerg M, Kopitz C, Bernardo MM, Chang M, Mobashery S,
Fridman R.Antimetastatic activity of a novel mechanism-based gelatinase
inhibitor. Cancer Res. 2005 May 1;65(9):3523-6.
196. Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM,
DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, Fridman R.Tissue
inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix
metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the

194

(Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem.
2000 Dec 29;275(52):41415-23.
197. Galardy RE, Grobelny D, Foellmer HG, Fernandez LA.Inhibition of angiogenesis
by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4methylpentanoyl)]-L-tryptophan methylamide.Cancer Res. 1994 Sep
1;54(17):4715-8.
198. Brown S, Bernardo M., Li Z-H, Kotra LP, Tanaka Y, Fridman R, and Mobashery S
Potent and Selective Mechanism-Based Inhibition of Gelatinases J. Am. Chem.
Soc., 2000, 122 (28) 6799–6800
199. Ward RV, Atkinson SJ, Slocombe PM, Docherty AJ, Reynolds JJ, Murphy
G.Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa
progelatinase by fibroblast membranes. Biochim Biophys Acta. 1991 Aug
30;1079(2):242-6.
200. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, StetlerStevenson WG. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent
mechanism. Cell. 2003 Jul 25;114(2):171-80.
201. Choi WS, Jeon OH, Kim HH, Kim DS. MMP-2 regulates human platelet activation
by interacting with integrin aIIbb3. J Thromb Haemost 2008; 6: 517–23.
202. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces
apoptosis. J Cell Biol. 1994 Feb;124(4):619-26.
203. Grenz H, Carbonetto S, Goodman SL. Alpha 3 beta 1 integrin is moved into focal
contacts in kidney mesangial cells. J Cell Sci. 1993 Jul;105 ( Pt 3):739-51.
204. Terracio L, Rubin K, Gullberg D, Balog E, Carver W, Jyring R, Borg
TK.Expression of collagen binding integrins during cardiac development and
hypertrophy. Circ Res. 1991 Mar;68(3):734-44.
205. Carver W, Molano I, Reaves TA, Borg TK, Terracio L.Role of the alpha 1 beta 1
integrin complex in collagen gel contraction in vitro by fibroblasts. Circ Res. 1991
Mar;68(3):734-44
206. Perris R, Syfrig J, Paulsson M, Bronner-Fraser M. Molecular mechanisms of neural
crest cell attachment and migration on types I and IV collagen. J Cell Sci. 1993
Dec;106 ( Pt 4):1357-68.
207. Schenk S and Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix.
Trends Cell Biol. 2003 Jul; 13(7):366-75.
195

208. Pfaff M, Göhring W, Brown JC, Timpl R. Binding of purified collagen receptors
(alpha 1 beta 1, alpha 2 beta 1) and RGD-dependent integrins to laminins and
laminin fragments. Eur J Biochem. 1994 Nov 1;225(3):975-84.
209. Sun M, Opavsky MA, Stewart DJ, Rabinovitch M, Dawood F, Wen WH, Liu PP.
Temporal response and localization of integrins beta1 and beta3 in the heart after
myocardial infarction: regulation by cytokines. Circulation. 2003 Feb
25;107(7):1046-52.
210. Ray JM, Stetler-Stevenson WG. Gelatinase A activity directly modulates
melanoma cell adhesion and spreading. EMBO J. 1995 Mar 1;14(5):908-17.
211. Simpson DG, Decker ML, Clark WA, Decker RS. Contractile activity and cell-cell
contact regulate myofibrillar organization in cultured cardiac myocytes. J Cell Biol.
1993 Oct;123(2):323-36.
212. Goldsmith EC, Carver W, McFadden A, Goldsmith JG, Price RL, Sussman M,
Lorell BH, Cooper G, Borg TK. Integrin shedding as a mechanism of cellular
adaptation during cardiac growth. Am J Physiol Heart Circ Physiol. 284(6):H222734. 2003
213. Bernardo MM, Brown S, Li ZH, Fridman R, Mobashery S. Design, synthesis, and
characterization of potent, slow-binding inhibitors that are selective for
gelatinases. J Biol Chem. 2002 Mar 29;277(13):11201-7.
214. Rosenblum G, Meroueh SO, Kleifeld O, Brown S, Singson SP, Fridman R,
Mobashery S, Sagi I.Structural basis for potent slow binding inhibition of human
matrix metalloproteinase-2 (MMP-2). J Biol Chem. 2003 Jul 18;278(29):2700915.
215. Manis AE, Bowman JR, Bowlin GL, Simpson DG.Electrospun nitrocellulose and
nylon: Design and fabrication of novel high performance platforms for protein
blotting applications. J Biol Eng. 2007 Oct 10;1:2.

196

APPENDIX 1
Introduction. The principle limitation of conventional IPs is the possible
contamination of the recovered material with the antibodies used to precipitate the antigen
of interest. Conventional IP relies on the capture of the primary antibody/ antigen complex
on to the surface of beads functionalized with protein A or protein G or a combination of
proteins A/G depending on the species of origin for the primary antibody. For example, in
a pull down assay for β1 integrin the starting cell lysate is incubated with a known
concentration of primary antibody. Once captured, the complexes are rinsed several times
and the antigen is eluted using conditions that disrupt the binding of the primary antibody
to the antigen. This may be achieved by changing the ionic strength of rinse buffers, a
change in the pH of the buffers, dissociation induced by boiling of the sample, and/or by a
combination of these conditions. Antigen recovery also can be achieved by exposing the
recovered material to reducing conditions (very harsh by comparison to the other
methods).
Ideally, the antibody is retained on the beads and only the antigen is released;
however, this result is highly dependent upon the starting antibody. More typically the
antigen and antibody complex and the antibody bead complex are broken down, liberating
the primary antibody from the carrier beads. Under these conditions the primary antibody
will “travel” with the antigen in the subsequent analysis. If the recovered material is
processed for Western blot analysis this contaminating primary antibody may be
recognized by the secondary antibodies used to probe the blot. The use of the Seize IP kit
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largely eliminates these cross-reactivity concerns because the primary antibodies used in
the initial recovery are chemically linked to a solid phase support.

Methods
Immunodetection in the infrared range using Odyssey Scanner (LiCor) was utilized
to confirm the source of contaminating signal that was variably present in the evaluation
of samples recovered by routine, conventional IP (See Methods section for Routine IP and
IP of plated CF). Following chemiluminescent detection, PVDF membranes were stripped,
blocked (Li-Cor, 927-40000) and probed at 1:1000 with Mouse anti-MMP-2 antibody. For
infrared imaging, the blot was counterstained at a rate of 1:10,000 with Goat anti-Mouse
700 nM IR Conjugate (Rockland, 610-430-002) and with Goat anti-Rabbit 800 nM IR
(LiCor, 926-32211) conjugate.

Blot was pre-scanned for adjustment of signal to

background in the 700 nM and 800 nM channels. Final scan of blot captured at a resolution
of 84.7µm with an intensity setting of “4” in both channels.

Results
Appendix 1 Figure 1
Routine IP. A suspension of cardiac fibroblast were divided into two groups; lysed
with RIPA buffer that was either supplemented or not supplemented with Complete
protease inhibitor cocktail (Roche, 11 697 498 001) and processed for routine IP against β1
integrin. MMP-2 was detected at a number of molecular weights in the samples recovered
by IP to β1 integrin (Lane 3 and Lane 4), in the raw unprocessed cell lysate (Lane 5), and in
198

lanes used to separate a recombinant MMP-2 protein standard (Lane 6). This antigen was
not detected in the null IP (Lane 1) or in the β1 antibody lane (primary antibody diluted in
Laemmli buffer and run directly on the blot) (Lane2). The application of broad spectrum
protease inhibitors did not disrupt the association of MMP-2 and β1 integrin in this assay
(compare lane 3 with lane 4). In this particular isolation no cross-reactivity of the primary
Rabbit IP antibody was detected when the Western blots were probed for the detection of
the Mouse MMP-2 primary antibody (using Horse anti-Mouse).
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Appendix 1 Figure 2
In a second representative series of experiments Western blots were generated from
a routine IP against β1 integrin from lysates generated from suspended cells, or cells plated
out for 1 hour on collagen, laminin, fibronectin, and poly-l-lysine (Panel A, Lanes 3-7,
respectively). Recovered material was processed for Western blot analysis for the detection
of MMP-2. Secondary Horse anti-Mouse antibody was applied and the blot was developed.
MMP-2 was detected in whole cell lysate (Lane 1). In the null IP (Lane 2) bands were
detected that match the molecular weight expected for intact immunoglobulin (150kDa),
heavy chain (50kDa), and light chain (25kDa). The presence of these bands indicates that
the precipitating antibody is being carried forward in the analysis. This contaminate
interferes with the unambiguous identification of MMP-2 co-precipitated with a β1
immunoprecipitation from lysate of suspended and plated cells (Panel A, Lanes 3-7).
The original PVDF was stripped, re-blocked, and re-probed with Mouse antiMMP-2 antibody (Panels B-D). For infrared imaging, the blot was counterstained with
Goat anti-Mouse 700 nM IR conjugate (Rockland) and with Goat anti-Rabbit 800 nM IR
(LiCor) conjugate. In this assay immunoreactivity was present in the Null IP, indicating
that primary anti-β1 (Rabbit) antibodies used to conduct the original IP cross reacts with
either the anti-MMP-2 (MaB, unlikely) primary, the secondary Horse anti-Mouse HRP
antibody used to probe for the MMP-2 antibody, or both (Panel A, Lane 2). Staining the
resulting blot using an IR tagged antibody demonstrates the spurious signal originates from
the Rabbit anti-β1 integrin antibodies used to conduct the IP (Panel D, Lane 2). Cross
reactivity from the carryover of anti-β1 integrin antibody is likely a product of different lots
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of secondary antibodies used to probe the Western blots. This cross-reactivity occurred in
some experiments and not others, necessitating the use of the Seize IP approach
documented in the main section of this study.
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Appendix 1, Figure 2

Utilization of IR dyes to demonstrate carryover of primary antibody in traditional IP.
The panels represent a single traditional IP experiment against β1 integrin (Anti-Rabbit)
and processed for detection of MMP-2 (Anti-Mouse) using conventional
chemiluminescence (A) and infrared detection as an overlay (B) or in separate detection
channels; 700nM anti-Mouse(C) and 800nM anti- Rabbit. The IR system separates the
contribution of the primary detection of MMP-2 (C) from the background contribution of
Anti-β1 (D), which constrains interpretation of traditional development (A). The initial
design for this experiment was to address the question of is there changes in the amount of
MMP-2 in association with β1 integrin when CF are plated on specific surfaces. Lane 1,
Cell lysate(Input); Lane 2, Null IP(no lysate); Lane 3, CF processed directly from culture
plate; Lanes 4-7, CF plated for 1hr onto Collagen, Laminin, Fibronectin, and Poly-LLysine, respectively; Lane 8, MMP-2 Standard.
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APPENDIX 2
Introduction. The IP experiments in this study were conducted with cells that have
been maintained in culture flasks for varying lengths of time, trypsinized, rinsed several
times and then allowed to recover for 15 minutes in suspension culture. In selected
experiments cells were trypsinized, allowed to recover for 15 minutes and then plated for 1
hour on various substrates prior to processing. Under either condition clear evidence of
MMP-9 was not detectable in cell pellet fractions (as judged by zymography and Western
blot analysis). However, in conditioned media recovered from cultures of CF that had
been plated for 1 hour or for more extended periods of time this protease was readily
detected by gelatin zymography. Unlike MMP-2, it appears that MMP-9 is detectable only
in the conditioned media compartment at the 1 hour time interval.

Methods
Culture plates (Corning, 6 well) were coated with 10 µg/ml fibronectin or poly-llysine overnight at 4˚C. Plates were rinsed 3X with PBS and blocked with 1% BSA at
room temperature for 1 hour. CF were tryspsinized and counted as described, 50 K cells
were delivered in 2 ml of ITS supplemented DMEM per well for each of the time points to
be assessed and incubated from 1 hour to 48 hours. Media samples were collected from the
individual cultures at the appropriate time, mixed 1:1 with Laemmeli Buffer and frozen at 70˚C.
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With the expectation that the absolute concentration of gelatinases would be low in
2 ml of conditioned media from 50K cells, and to avoid the sometimes negative effects
from concentration steps (such as Trichloroacetic acid precipitation), the large format
Protean II XI gel electrophoresis system was used to conduct this specific zymography.
The 20 cm x 20 cm x 0.15 cm format gel with a 20 well comb accommodates a large
loading volume (max 187 µl). In this assay 150 µl of sample from each culture condition
was assayed. Positive control of Gelatinase activity was established with Zymography
Standard (Millipore CC023). From stock, a 1:100 dilution in Laemmeli buffer was made
(Labelled “A”); from this dilution four serial dilutions were made at 1:10 (Labelled B-E).
In each lane 20 µl of each standard sample A-E was loaded. Non-conditioned media was
prepared identical to experimental groups and run as a negative control. Electrophoresis
and subsequent processing for gelatin zymography were conducted as described.

Results
CF plated onto fibronectin and poly-l-lysine exhibit gelatinolytic activity of MMP2 and MMP-9 in the conditioned media fractions as early as 1 hour following plating and
this activity was detected out to at least 48 hours post plating. We can assume that the
continued presence of the pro-MMP-9 results from continued deposition as the pro-form
would otherwise be depleted by the activation cascade of this protease. On the other hand,
levels of pro-MMP-2 seem to accumulate without obvious processing of this enzyme to the
active form in the media fractions. MMP-9 activity in conditioned media at 1 hour is not
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accompanied by any detectable activity in the cell pellet fractions at this time point (See
Appendix 3).
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Appendix 2, Figure 1

Gelatin Zymography. Accumulation of Gelatinases in media conditioned by Cardiac
Fibroblast plated onto fibronectin or poly-l-lysine for 1, 4, 6, 12, 24, and 48 hours, Lanes
1-7 respectively. Dilutions of gelatinase standard (Lanes A-C ) run as positive control
indicate the sensitivity of zymography for small amounts of gelatinase and identify along
with apparent molecular weight the proteases in conditioned media as proMMP-9 and
proMMP-2.

208

APPENDIX 3
Introduction. SB-3CT is a highly specific inhibitor of MMP mediated protease activity
213

. It has known inhibitory effects on the gelatinases, MMP-2 and MMP-9. This reagent

binds to the active site in the enzyme and functions as a competitive inhibitor
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. To

demonstrate the efficacy of this agent for this use, cultures were mixed with 10 µM SB3CT and plated for 1 hour. Cell pellet fractions were separated by SDS gel electrophoresis
and processed for zymography.

Methods
Culture plates were coated with 0.07µg/mm2 fibronectin, cells were cultured as
naïve, vehicle treated (Buffer R) (50 mM HEPES (pH 7.5), 150 mM NaCl, 5 mM CaCl2,
0.01% Brij-35 and 50%DMSO) or 10µM SB-3CT treated. “Buffer R” is the diluent for an
intermediate dilution of stock SB-3CT conducted prior to final dilutions in aqueous media.
Cells were suspended in ITS media, or ITS media supplemented with vehicle or SB-3CT
and incubated 15 minutes prior to plating. Groups plated in triplicate of 40 K cells/well in a
final volume of 2 ml of media. Following a 1 hour incubation media was aspirated
carefully and cultures rinsed 3X with cold PBS; excess PBS was wicked by inverting
culture plates and placing them on top of lint free towels. Plates were placed on ice and 50
µl RIPA was applied per well. Lysates were collected with cell scrapers. Samples were
centrifuged at 10,000 X G at 4˚C for 15 minutes. Supernatant was assayed by Bradford
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Protein assay mixed with Laemmeli buffer at a concentration of 10 µg/30 µl total volume,
heated for 3 minutes at 60˚C, and processed for gelatin zymography.
In a separate parallel experiment cells were treated with GM-6001 at 5µM, with a
matched concentration of DMSO as vehicle control. Following 1 hour of plating,
conditioned media was collected, and centrifuged for 15 minutes at 10,000 X G at 4˚C.
Cultures were rinsed 3X with cold PBS as described and cell pellets were collected as
described. Conditioned Media fractions were run based on equal protein values of 15 µg
per sample in a total of 30 µl volume.

Results

SB-3CT treatment decreased MMP-2 associated activity as determined by Gelatin
zymography (Figure 1, A). As judged by densitometric analysis, the trace (Optical Density
X mm2) values of samples treated with SB-3CT were approximately 50% of vehicle
treated controls (Figure 2, B). Data shows the feasibility of this agent in blocking MMP-2
activity in cell pellet fractions. Treatment of cultures with GM6001 promoted an increase
in pro-MMP-2 that was not detected in the untreated or vehicle control cultures. As this
inhibitor blocks MT1-MMP mediated activity the increase in pro-MMP-2 detected in this
experiment is likely a reflection of decreased processing of pro-MMP-2 on the surface of
the cell to active MMP-2 (Figure 2, A). GM6001 did not appear to impact the activity of
MMP-2 in the conditioned media fraction. We note the activity of MMP-9 in conditioned
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media as “presumptive” as the positive control in this zymogram is a MMP-2 standard.
However, the zymograms in this appendix show clear activity of MMP-2 without the
activity of MMP-9 in cell pellet fractions.
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Appendix 3, Figure 1

A.

B.
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Appendix 3,Figure 2

A.

B.
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APPENDIX 4
Introduction. The running conditions used to prepare an IP for zymographic
analysis are similar, but not completely identical to the conditions used to prepare this
material

for

conventional

Western

Blot

analysis.

In

early

experimentation

immunoreactivity against MMP-2 was present in samples recovered by IP directed at β1
integrin. However, zymographic activity was not detectable in these early samples. Several
explanations could account for this result. However, one concern of note was that the
MMP-2 enzyme was not stable in the putative complex with β1 integrin when samples
were processed for zymography. Alternatively, the enzyme might be stable in the complex
but not present in a form that can be activated in the zymographic gels. Integrin associated
proteases have been reported to be difficult to activate under some circumstances

187

. To

verify that IPs against β1 integrin that have been processed for zymography retain MMP-2
selected samples were processed by IP against β1 integrin, processed for zymography and
then processed directly from the zymographic gels for Western blot analysis. In parallel
with zymographic processing, samples were directly assessed for MMP-2 by Western blot
analysis. These experiments demonstrate that MMP-2 immunoreactivity is present in the
material processed for zymography and at a MW that appears to be consistent with the
MW of the complex identified in the main body of this study. The underlying reasons that
no protease activity was detectable in the IP recovered samples remain unclear. These
results ultimately led to processing the material recovered by IP against β1 integrin in the
presence of SB-3CT. Under these circumstances protease activity was detectable when the
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samples were processed for zymography. Possible reasons for why MMP-2 activity might
be preserved in these experiments include:

-

In the purification of the complex by IP the resultant elution is of sufficiently
high enrichment for the auto-activation and catalysis of MMP-2 to occur and
the inhibitor prevents the processing of a fraction of this population.

-

As described by 187 (who identified collagen mediated binding of MMP-2 to β1
integrin) cell surface bound MMP-2 may be resistant activation.

-

In some instances, there is a cooperative interaction between TIMP-2 and MMP
inhibitors in MT1-MMP mediated activation of MMP-2
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. SB-3CT could be

acting to selectively activate MMP-2 in the immunoprecipitated complex.

-

Alternatively, elution from routine IP was conducted by heating the antigen off
the surface of the Protein A/G beads. Thermal denaturation could result in lack
of enzymatic activity by while the antigenicity of the peptide is maintained. In
comparison, the elution of complexes from the Seize IP is conducted with low
pH buffering and a preservation of enzymatic activity only in the SB-3CT.

One consideration that has not been discussed concerns the limits of detection for
the techniques used in these assays. Zymography standard at a stock concentration of
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0.1mg/ml was diluted 1:100, then as a series of dilutions at 1:10 to test the approximate
limit of detection for zymography. Gelatinase standard was detectable at a 1:10,000
dilution when 20 ul of the diluted samples was developed for 18 hours (Appendix 2). The
starting concentration of standard is supplied as a mixed population of enzyme species.
With this caveat, the total amount of protein detectable by zymography was in the range of
2 ρg. Limits of ECL Plus detection are demonstrated to be as little as 20 ρg of protein in
slot blotting applications
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(Manis 2007). With similar limits of detection, these

techniques should be complimentary in the identification of MMP-2.
The most likely scenario to explain discrepancy discussed regarding the detection
of MMP-2 has origin in the differences in the methods of routine and Seize IP. The
latency of MMP is controlled through an interaction of the pro-peptide sequence with the
Zn+2 of the catalytic domain. This coordination bond or “cysteine switch” stabilizes the
pro-peptide and suppresses MMP-2 activation. When samples recovered by conventional
IP are processed for Western blotting or zymography they were routinely boiled. Heating
this type of can denature proteins and thereby prevent MMP-2 activation. In material
recovered by the Seize IP methodology, the samples are eluted from the beads by a change
in pH. Under these circumstances, lowering the pH can promote the activation of MMP-2.
With the MMP-2 in high concentration in an IP recovered sample, the pH induced
activation could result in the initiation of auto-catalytic activation and self cleavage of
MMP-2. Under these conditions, the presence of an MMP-2 inhibitor such as SB-3CT
could act to preserve a fraction of MMP-2 or block the activation and subsequent
degradation of the isolate. This later explanation seems likely.
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Methods
Immunoprecipitation and gelatin zymography. Gelatin zymography was conducted
on samples recovered by IP against β1 Integrin under conventional methods. Material
recovered by IP was first separated by conventional SDS gel electrophoresis on a 10% slab
gel and transferred to PVDF for Western blot analysis against β1 and/or MMP-2 (AB1952,
Chemicon; IM51, Calbiochem, respectively.) Representative fractions of IPs were then
subjected to gelatin zymography.
Zymography. Equal volumes of whole cell lysate or protein fractions purified by IP
from a suspension of 2 x 106 cells were mixed with Laemmli buffer and separated on a
SDS 10% polyacrylamide gel supplemented with 1.0% gelatin. Gelatinase standards
(Chemicon; 20 µl of stock solutions that had been diluted 1:200) were used as positive
controls to identify MMP-9 and MMP-2 enzymatic activity. In experiments that focused on
MMP-2, proMMP-2 (Calbiochem, PF037) was used as the positive control (20 µl of a
1:200 dilution of the stock solution). Following electrophoretic separation at 120V
(constant voltage), gels were incubated in renaturation buffer (BioRad) for 1 hour and then
transferred into development buffer (Bio-Rad) for 18 hours at 37ºC. Gels were fixed (20%
Methanol, 10% Glacial Acetic Acid, 70% distilled de-ionized H2O) and stained with
Coomassie Blue, G-250 (Bio-Rad). De-stained gels were imaged (Gel Doc 2000, BioRad)
and analyzed by densitometry (Quantity One, BioRad) to characterize gelatinolytic
activity.

217

Following development and documentation, the gelatin zymograms were
transferred to PVDF for Western Blot analysis against MMP-2. The preparation of these
samples was done in the absence of exogenous protease inhibitors (to allow protease
activity associated with IP material to function and degrade the gelatin present in the
zymograms). Lanes were loaded with a whole cell lysate prepared from a cell suspension,
an IP to β1 (AB1952, Chemicon), or recombinant human MMP-2 pro-enzyme standard
(PF037, Calbiochem). The anti-MMP-2 antibody used in these experiments recognizes the
72 kDa latent and 66 kDa active species of MMP-2.
In separate experiments cardiac fibroblasts (2 x 106 cells ) were prepared as a
suspension culture, pelleted, and lysed directly with RIPA buffer in the absence of protease
inhibitors for conventional immunoprecipitation directed against β1 integrin.

Raw cell

lysate and the enriched IP samples were prepared for processing by 10% SDS-PAGE (Gel
1) and for processing by 10%SDS- PAGE, 0.01% Gelatin Zymogram (Gel 2). Following
electrophoresis, Gel 1 was processed for Western blotting against MMP-2. Gel 2 was
processed for Zymography. Images were captured of the developed and stained zymogram.
An additional interval of destaining was conducted by incubating the zymogram in Towbin
buffer prior to overnight transfer (125mA) to PVDF membrane. The samples transferred
from the zymograms were then processed for immunodetection of MMP-2 by conventional
methods.
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Results
Western blotting of cell lysate and IP of β1 integrin confirm the presence of MMP-2
reactivity as compared to recombinant MMP-2 standard (Gel 1: A) in samples that were
processed in parallel as an input for gelatin zymography (Gel 2: B). Similar patterns of
immunoreactive MMP-2 are detected in (A) and (C) for whole cell lysate, IP to β1 integrin
and for MMP-2 positive control. However, the gelatinolytic activity detected (B) does not
follow same this pattern. In whole cell lysate, there are a number of gelatinolytic bands that
are not confirmed as MMP-2 by Western blot although the anti-MMP-2 mAB recognizes
both the 72 kDa latent and 66 kDa active species of MMP-2. The lack of Zymographic
activity from the IP, at the MW expected for MMP-2, is contrasted by the immunoreactive
bands detected by Western blot (C).

219

Appendix 4, Figure 1

Zymography and Western Blotting. Conventional immunoprecipitation to β1 integrin was
assessed in parallel for MMP-2 by Western blot (A) and by Gelatin Zymography (B). At
the conclusion of zymographic processing, the zymogram was transferred and blotted for
MMP-2 (C). This experiment was conducted to verify that MMP-2 was actually retained in
the complex recovered by IP and then processed for zymography. Lack of definitive
zymographic activity in the IP sample is in contrast to the immunodetection of MMP-2.

220

APPENDIX 5
Introduction. MMP-2 is typically bound to TIMP-2; MMP-9 is typically bound to TIMP1. However, TIMP-1 and TIMP-2 can both bind the active form of either enzyme (Ward
1991), making both peptides potential candidates as component elements of the α3β1
integrin MMP-2 complex. Of the two molecules, TIMP-2 probably represents the more
likely binding partner, a specific binding interaction between TIMP-2 and the α3β1 integrin
has been identified 200.

Methods
Following the Seize IP protocol, MMP-2 or β1 was recovered. Next, each sample
was supplemented with β-mecaptoethanol (2.5ul:100ul sample) and heated at 95˚C for 5
min. Western blotting to TIMP-1 (AB800, Chemicon) was conducted on reduced samples
according to the manufacturer’s literature that states that the antibody does not bind well
to the non-reduced protein.

Results
In whole cell lysate immunoreactivity against TIMP-1 was detected; however, in
the enriched fractions isolated by Seize IP directed against MMP-2 and β1 no such activity
was detected for TIMP-1.
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Appendix 5, Figure 1.

Western Blotting to TIMP-1 did not show reactivity in elution steps from IP to MMP-2
(Lanes 1-3) or from IP to β1 integrin (Lanes 4-6). The presence of this small molecular
weight inhibitor was detected in whole cell lysate.
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APPENDIX 6
Introduction. To determine if MMP-2 becomes secondarily associated with the α3β1
integrin complex when a cell lysate is prepared, live cardiac fibroblasts were pre-treated
with the cross-linking agent DTSSP (21578, Pierce). This reagent will cross-link peptides
that are within 12 angstroms of one another on the cell surface. Processing cross-linked
cells makes it possible to determine the spatial relationships that might exist within the
radius of the reagent used to prepare the samples for IP analysis or Western blot analysis.

Methods
Cell surface associated proteins were crosslinked to stabilize protein-protein
interactions using DTSSP (21578, Pierce). This reagent has an effective cross linking
distance of 12 Å and solubility properties limits this crosslinker to the cell surface.

In

these experiments cardiac fibroblasts were plated out onto poly-l-lysine coated 6 well
dishes in ITS media supplemented with 5ul:20ml Gelatinase standard (CC073, Millipore)
or plain ITS media. Following one hour of plating, cultures were rinsed 3X with PBS,
cultures were then supplemented to a final concentration of crosslinker at 1 mM in PBS
and allowed to incubate for 30 minutes at room temperature. The reaction was quenched
with the addition of sufficient Tris (stock solution 1 M, pH 7.5) to bring the final Tris
concentration to 15 mM for a 15 minute incubation interval. At this point cultures were
placed on ice, treated with RIPA buffer, and scraped to collect the cell pellet fraction.
Samples were centrifuged to pellet debris and the supernatant was transferred to clean
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sample tubes and mixed with Laemmeli buffer in preparation for SDS-PAGE. Parallel
cultures without the use of crosslinker were processed for SDS-PAGE. Samples were
separated for Western blotting against MMP-2 and β1 integrin on separate blots.

Results
Application of exogenous gelatinase did not appear to alter the staining patterns
present in the crosslinked (Panels A & C) or native (Panels B & D) cell pellet fractions
(these blots were run on 7.5 % PAGE instead of the 10% Gels that are typically used in
this study, as a result the position of a bands are shifted downward on the gel). Similar
molecular weight bands at 200-210kDa blots stained against MMP-2 in both the
crosslinked and naïve cell pellet suggest that the interaction of MMP-2 and β1 integrin
occurs on the surface of cardiac fibroblast. Further, the application of exogenous gelatinase
(Panel A & B) did not qualitatively increase the amount of staining for MMP-2 as
compared to staining present generated from naïve cells (Panels C & D). The molecular
weight band of 200-210kDa in “unpurified” cell pellets placed in the context of IP data
demonstrating a complex of α3β1: MMP-2 at this same molecular weight suggests 1)
MMP-2 and β1 may be associated on the cell surface 2) that this association is not
dependant on crosslinking of the cell surface, and 3) application of exogenous gelatinase
did not meaningfully increase the amount of MMP-2 in cell pellets.
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Appendix 6, Figure 1

Figure 1. Crosslinking of cell surface. Cells plated on poly-l-lysine were cultured in the
presence and absence of exogenous gelatinase. At the conclusion replicate cultures were
surface crosslinked (Panel A & Panel C) or maintained naïve (Panel B & Panel D). Cell
pellet lysates were separated by PAGE and blotted for MMP-2 and for β1 integrin.
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APPENDIX 7

Introduction. Any loss of cells due to death will artificially reduce the total number of
cells observed in an adhesion assay. As a result of this potential condition cell viability was
tested under a variety of culture conditions.

Methods
Assays were conducted to verify that cell viability remains constant under the
conditions used to define cell adhesion. Many of these assays were conducted on cells that
had been plated and allowed to adhere for a defined interval of time prior to the cultures
being supplemented with drug or vehicle. This approach made it possible that each
experimental condition had the same number of cells at the onset of the assay (this
assumption can not be made if cells are treated in suspension with various drugs and then
plated-if the drug alters adhesion or if the drug reduces viability the total number of cells
will be reduced but the reason will be unknown).
These assays were designed to parallel the cell number used for plating in adhesion
assays (2 K and 40 K/ per well/ 96 well plate). Viability was assessed by two metabolic
based measures; the WST-1 assay and with Calcein AM. The WST-1 assay is typically
used as an assay to measure cell proliferation; in this study it was used to determine the
potential toxicity of the inhibitors (GM-6001 and SB-3CT) used in conventional and
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centrifugal adhesion assays. This colorimetric assay relies on the conversion by
mitochondrial dehydrogenases of the WST-1 tetrazolium salt to formazan. The
accumulated formazan is then measured at an absorbance of ~450 nm. Calcein AM is
metabolically dependant as well; however, it is the metabolic cleavage of this dye that
converts Calcein AM to Calcein, the fluorescently active species of the dye. This
conversion decreases the membrane permeability of the dye thereby “trapping” the dye in
the cell and providing a “direct” measure of cell number. Accumulated Calcein was
measured at 480ex/520em. These assays function to validate the adhesion data and suggest
a cell number/density dependant response to treatment with MMP inhibitors. As the scope
of adhesion assays narrowed, viability testing became more focused and was tailored to
encompass conditions used to evaluate the impact of protease inhibition on cell adhesion.
Viability was assessed on collagen, laminin, and fibronectin under the following sets of
conditions;

Inhibitor

Assay

Cells

Dose/ Vehicle

Per well

Timing

of Incubation

dose

time

After 30min

4 hr

GM-6001

WST-1

40 K

0, 10, 25µM

SB-3CT

WST-1

40 K

0,1,5,10,25µM At plating

4 hr

SB-3CT

WST-1

40 K

0,1,5,10,25µM At plating

24 hr

SB-3CT

WST-1

2K

0,1,5,10,25µM At plating

24 hrs

SB-3CT

Calcein AM

2K

0,1,5,10,25µM At plating

24 hrs
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SB-3CT

WST-2

2K

0,1,5,10,25µM At 24, 26, 6 hr,4 hr,2 hr
28 hr post
plating

Data from viability assays on SB-3CT was expressed as the percent of activity
detected in the untreated, substrate matched control. Data from each plating substrate was
screened by one-way ANOVA (P=<0.001), pairwise multiple comparisons were done
using the Holm-Sidak method with an overall significance level of 0.05.

Results
General Inhibitor: GM 6001. The WST-1 assay was used in these experiments to
detect overt changes in cell viability attributable to the presence of the GM6001 protease
inhibitor. In this assay 40 K cardiac fibroblasts were plated in triplicate on collagen,
laminin, fibronectin, poly-l-lysine or BSA coated surfaces. All experimentation was
conducted with ITS media. Cells were plated for a 30 minute interval, then, the appropriate
doses of inhibitor were delivered to the cultures so that the final concentration of inhibitor
was 0 µM, 10 µM, and 25 µM. These doses were selected based on the manufacturer’s
recommended typical cell culture dose. After an additional 30 minutes (total of 1 hour
post-plating), 10 µl of the WST-1 reagent was added to the cultures. The assay was
allowed to develop for a total of 4 hours. Cell number was interpolated from a five point
standard curve.
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Substrates coated with collagen or fibronectin supported an equal metabolic rate
across all administered doses of the inhibitor (Figure 1). As judged by the WST-1 assay,
total cell number remained constant across all conditions tested on these 2 substrates.
Cultures plated onto laminin coated surfaces showed a decrease in metabolic activity at the
25 µM dose with respect to the 10 µM dose and non-treated controls. Similarly, cultures
plated onto Poly-l-lysine exhibited a decrease in metabolic activity at this same
concentration of inhibitor. On BSA, total cell number, as reported by the WST-1 assay,
was decreased in cultures treated with the 10 µM dose and the 25 µM dose with respect to
non-treated cells. In summary, 10 µM GM6001 appears to be well tolerated by CF when
the cells are plated onto collagen, laminin, fibronectin, poly-l-lysine and BSA at this time
interval. N=1 of triplicates.
Specific Inhibitor: SB-3CT. The impact of the specific inhibitor SB-3CT on cell
viability was also tested over a range of concentrations and culture conditions using the
WST-1 assay. Initial experiments focused on the viability of cardiac fibroblast when
plated in the presence of 1 µM, 5 µM, 10 µM, and 25 µM SB-3CT, or vehicle (Buffer R
25µM) for a 4 hour time interval on Collagen, Laminin, or Fibronectin coated culture
surfaces. At this time point 10 µl of WST-1 reagent was added to the cultures and allowed
to develop for two hours. The metabolic activity of cardiac fibroblast plated under these
conditions was largely unaffected by the presence of varying doses of SB-3CT (Figure 2).
SB-3CT exhibits evidence of a density dependent effect on cell viability. At high
cell density (40 K) the relative number of cells was similar on all surfaces and at all doses
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of inhibitor assayed (1 µM, 5 µM, 10 µM, and 25 µM) at the 6 hour time point (Figure 2).
In control experiments, cultures treated with or without vehicle (Buffer R, 25 µM)
exhibited a metabolic profile that was similar to that of cultures treated with the various
concentrations of the inhibitor.
After 24 hours, a cell density dependent effect of inhibitor became manifest. Cell
viability in cultures treated with 0, 1, and 5 µM inhibitor was similar in low density
(Appendix 7, Figure 4) and high density(Figure 3 cultures (2K vs. 40K), although there
was a subjective evidence of increased metabolic activity with increasing dose of inhibitor.
This pattern diverged at the 10 µM dose of inhibitor. At this dose, viability in low density
cultures (2K) was markedly depressed with respect to control cultures (non-treated and
vehicle matched) plated at the same density. In contrast to these results, the total metabolic
activity present in cultures plated at high cell density (40 K) remained unchanged (and
subjectively higher) when treated with inhibitor. A similar, albeit more pronounced trend
was apparent in cultures treated with the 25 µM concentration. Total metabolic activity
was depressed in cultures plated at low cell density (2 K) with respect to non-treated and
vehicle matched controls. At high cell density (40 K) total metabolic activity was increased
in cultures treated with this dose of inhibitor with respect to non-treated and vehicle
control. The vehicle controls (DMSO matched to 25 µM dose) in these experiments
exhibited a nominal effect on cultures plated at low cell density and little to no effect in
cultures plated at high cell density. N=1 for 40k cells, N=2 for 2k cells at the 24 time
point.
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Calcein AM: Live cell analysis. A potential limitation of a metabolic based assay in
assessing cell number is that changes in metabolic activity can be mistakenly interpreted as
an increase or a decrease in the actual number of cells. To verify the results of the WST-1
metabolic assay Calcein AM was used to characterize cell viability/number in cultures
plated at low cell density (2 K). This reagent is only taken up and retained in live cells. In
these experiments CF were plated in the presence or absence of 1 µM, 5 µM, 10 µM, 25
µM SB3-CT or vehicle (Buffer R, matched concentration) prepared in ITS media for 24
hours on collagen, laminin, or fibronectin (Appendix 7, Figure 5a-c, respectively). Cell
number was then determined by Calcein fluorescence derived from a standard curve of cell
plated in parallel with the experimental cultures. At low doses of inhibitor (1 µM and 5
µM) the increase in metabolic activity detected by the WST-1 was not accompanied by any
detectable change in cell number as measured by the Calcein Live cell assay. However,
without exception, treatment with SB-3CT at the 10 µM dose, and higher, resulted in a
75% decrease in viable cells as compared to both the untreated and vehicle controls at the
24 hour time point.
In summary, the treatment of cardiac fibroblasts with the gelatinase specific
inhibitor (SB-3CT) has effects that are dose and cell density dependant. At low density,
and low dose (5 µM) cell number is not affected; yet, there is a slight increase in the
metabolic activity detected in these cells. It can be postulated that the increased metabolic
activity may be attributed to increased migration, or turnover of adhesions; yet, the reason
is unknown.
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Time component of viability. The specific MMP inhibitor SB-3CT induces dose
dependant changes in cell viability. A time course study was conducted to more fully
characterize the effects of this reagent. In preliminary studies, cells cultured in the presence
of SB-3CT for 24 hours exhibited increased metabolic activity at low dose (5 µM) and
decreased viability at high dose (10 µM). In these experiments cells were plated at low
density (2K) in culture wells coated with collagen, laminin or fibronectin for a total of 30
hours in ITS media (Figure 6a-c). At 2 hours, 4 hours, and 6 hours prior to assessing
metabolic activity, media was aspirated and replaced with media supplemented with 0, 1,
5, or 10 µM SB-3CT or vehicle (DMSO) control. The approach was used to avoid artifacts
that might be induced by changes in adhesion that may occur when cells are plated in the
presence of inhibitor.
The maximum dose over time tolerated by the cultures without a change in viability
is 5 µM for a duration of 2 hours. At time points greater than 2 hours, there is a subjective
decrease in the metabolic activity in these cultures as compared to non-treated and vehicle
matched controls. At 10 µM SB-3CT, there was a detectable decrease in metabolic
activity cell viability within 2 hours. With increasing time of exposure (4 hours and 6
hours) there was a more pronounced decrease in metabolic activity in cultures treated with
10 µM SB-3CT with respect to non-treated and vehicle controls. The decrease in metabolic
activity as a function of dose and time of exposure was similar on all surfaces tested.
(Figure 10).
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Conclusions

While data indicate that there is a decrease in the metabolic activity of cardiac fibroblast
following 2 hours of exposure to 10uM SB-3CT these results do not necessarily translate
as a decrease in the viability of cells in the 1 hour interval used in adhesion assays or
challenge the validity of adhesion results. This statement is based on equivalent data of
initial cell adhesion in SB-3CT treated cultures as compared to control at 1 hour using a
vital dye in conducting centrifugal adhesion assays . The following guidelines should be
adhered to in the application of SB-3CT; short term experiments (1 hour in duration) a
maximum dose of 10uM is tolerated, for longer durations (24 hours in duration) doses of
1uM and 5uM are appropriate. In the application of GM-6001 the maximal tolerated dose
was 10uM for duration of 4 hours of culture.
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Appendix 7, Figure 1
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Appendix 7, Figure 2
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Appendix 7, Figure #3
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Appendix 7, Figure #4
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Appendix 7, Figure 5
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